Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,microtubule motor activity (GO:0003777),0.9081758474200229,2.1056123017512274,0.0,0.0,0.0,14/51,1.10%,KIF11;KIF18B;KIF15;KIF20B;KIF4A;CENPE;KIF14;KIF23;KIF2C;KIFC1;KIF24;KIF18A;KIF20A;KIF22
prerank,motor activity (GO:0003774),0.89399580136841,2.0860664285293367,0.0,0.0,0.0,14/60,1.10%,KIF11;KIF18B;KIF15;KIF20B;KIF4A;CENPE;KIF14;KIF23;KIF2C;KIFC1;KIF24;KIF18A;KIF20A;KIF22
prerank,single-stranded DNA helicase activity (GO:0017116),0.9040060387449068,1.8815817647222848,0.0,0.04372651331066374,0.124,13/19,6.63%,POLQ;PIF1;RAD51;MCM5;DSCC1;RFC4;MCM6;MCM7;MCM2;DNA2;DHX9;RFC2;RFC3
prerank,DNA replication origin binding (GO:0003688),0.8750960980549651,1.8783510464675428,0.0,0.03757294769575245,0.141,16/23,7.74%,MCM5;POLA1;ORC1;DDX11;MCM8;CDC45;MCM10;MCM6;MCM7;MCM2;CDC6;DHX9;MCM3;MCM4;ORC2;ORC3
prerank,microtubule binding (GO:0008017),0.7852306638691391,1.865570664044515,0.0,0.040309474522148295,0.179,48/222,5.75%,PRC1;TPX2;KIF18B;KIF15;KIF20B;CENPE;KIF14;KIF23;KIF2C;NUSAP1;KIFC1;DLGAP5;PLK1;SKA1;BIRC5;FAM83D;SPAG5;RACGAP1;KNSTRN;GTSE1;KIF18A;CEP295;KIF20A;KIF22;CDK5RAP2;CKAP5;GAS2L3;VASH2;SKA2;HAUS8;TERF1;PSRC1;CEP57;MAST2;MAP4K4;CCDC61;HAUS4;HAUS6;MACF1;FAM161A;KIF27;TUBGCP5;SPEF1;CEP57L1;NUMA1;PRNP;MAPT;HAUS7
prerank,single-stranded DNA binding (GO:0003697),0.7780254607588655,1.8281246476241495,0.0,0.09628520315096485,0.415,34/93,7.35%,NEIL3;RAD51AP1;RAD51B;RAD51;MCM5;POLA1;HMGB2;DDX11;RAD51AP2;BRCA2;MCM8;CDC45;DMC1;FAM111A;SMC6;MCM10;MCM6;MCM7;MCM2;RBBP8;RPA1;STN1;MSH3;ERCC4;TDP2;DHX9;HNRNPA1;BLM;MAPT;MCM3;RPA2;MCM4;MLH1;NUCKS1
prerank,DNA secondary structure binding (GO:0000217),0.823511316832621,1.8116924132887822,0.0,0.12348499738158113,0.541,16/31,9.77%,NEIL3;RAD51AP1;CLSPN;RAD51B;GEN1;RAD18;HMGB2;XRCC2;RBBP8;LIN54;BLM;MAPT;HMGB3;RAD51C;KMT2A;HMGB1
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.8470922638589974,1.808879754036319,0.003896103896103896,0.11510787444363468,0.563,8/21,6.00%,POLK;POLQ;POLE;POLA1;POLH;PRIMPOL;POLD3;POLD1
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.8997808354782555,1.8075678665588035,0.002881844380403458,0.10482780012225344,0.571,4/13,4.22%,EXO1;ZGRF1;GEN1;DNA2
prerank,kinesin binding (GO:0019894),0.8310085260689812,1.8033615056996306,0.001221001221001221,0.10390114553553742,0.604,3/27,0.73%,PRC1;KIF18B;FAM83D
prerank,DNA polymerase activity (GO:0034061),0.8400109813577007,1.8030420882292124,0.005121638924455826,0.0951663730391628,0.607,8/22,6.00%,POLK;POLQ;POLE;POLA1;POLH;PRIMPOL;POLD3;POLD1
prerank,ligand-gated anion channel activity (GO:0099095),-0.6151648400275705,-1.781523619353686,0.0076045627376425855,1.0,0.495,11/17,14.92%,GABRB1;GABRB3;GABRA2;GLRB;GLRA1;GABRA3;GLRA3;GABRA5;GABRB2;GABRG2;GABRG1
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.7782517704164198,1.776540151248087,0.004545454545454545,0.15210166302268957,0.799,10/42,6.45%,CCNF;CCNB1;CCNE2;CKS2;CCNB2;CDKN2D;CDKN2C;CCNA2;CCNA1;CCNE1
prerank,"DNA binding, bending (GO:0008301)",0.8774515596907426,1.7623679091818962,0.001388888888888889,0.18223464360394295,0.867,3/14,1.68%,TOP2A;HMGB2;TERF1
prerank,GABA-A receptor activity (GO:0004890),-0.5920674751243185,-1.7506949007940826,0.01694915254237288,0.7345766709050484,0.59,8/18,14.92%,GABRB1;GABRB3;GABRA2;GABRA3;GABRA5;GABRB2;GABRG2;GABRG1
prerank,tubulin binding (GO:0015631),0.7367278726776731,1.7490145509923887,0.0,0.21370971406138964,0.92,39/295,2.50%,PRC1;TPX2;KIF18B;KIF15;KIF20B;CENPE;KIF14;BRCA1;KIF23;KIF2C;NUSAP1;KIFC1;DLGAP5;PLK1;SKA1;BIRC5;FAM83D;SPAG5;RACGAP1;GTSE1;KIF18A;CEP295;KIF20A;KIF22;CDK5RAP2;CKAP5;GAS2L3;VASH2;BRCA2;SKA2;HAUS8;TERF1;PSRC1;CEP57;STMN1;MAST2;MAP4K4;CCDC61;HAUS6
prerank,ATP hydrolysis activity (GO:0140603),0.7494420242783865,1.7413435931408257,0.006825938566552901,0.22760953286213045,0.944,6/41,4.78%,KIF20B;KIF14;CHD1L;ABCA4;DNA2;DHX9
prerank,MHC class II protein complex binding (GO:0023026),-0.6881102703093219,-1.74042066781602,0.012779552715654952,0.5441869055314433,0.633,5/11,10.34%,HSP90AB1;ATP1B1;ANXA11;PKM;CD81
prerank,glutamate receptor binding (GO:0035254),-0.5781998238663707,-1.7347033832369663,0.007220216606498195,0.4342399681766198,0.657,9/17,14.13%,SHANK3;SYNDIG1;IGSF11;HOMER1;SQSTM1;SHISA6;SHANK1;HIP1;DLG4
prerank,damaged DNA binding (GO:0003684),0.7529487037265697,1.7240019593884532,0.01005586592178771,0.27495579065215375,0.977,18/44,11.94%,NEIL3;POLQ;RAD18;HMGB2;AUNIP;SMC6;RBBP8;RPA1;RAD1;ERCC4;POLD1;RPA2;ERCC3;CUL4B;HMGB1;XPA;PCNA;FANCG
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.5186734498276052,-1.7189859579048754,0.010638297872340425,0.3949011557285636,0.698,10/26,15.99%,SLC6A6;SLC16A12;SLC6A1;MPC1;SLC27A1;ABCG2;SLC5A6;SLC16A1;SLC16A4;SLC6A11
prerank,3'-5' DNA helicase activity (GO:0043138),0.8653372970760053,1.711101889183339,0.005405405405405406,0.31315474121668957,0.992,9/16,6.30%,NAV2;MCM5;MCM6;MCM7;MCM2;DHX9;BLM;RECQL;ERCC3
prerank,anion channel activity (GO:0005253),-0.4109661246300339,-1.702891508130436,0.016129032258064516,0.3880925151125539,0.752,21/61,15.68%,GABRB1;ANO3;GABRB3;GABRA2;GLRB;GLRA1;ANO6;ANO1;GABRA3;GLRA3;CLCN7;GPR89B;GPR89A;GABRA5;GABRB2;ANO4;GABRG2;LRRC8B;LRRC8D;GABRG1;TTYH3
prerank,ligand-gated channel activity (GO:0022834),-0.4824285808424035,-1.6878555043845296,0.005780346820809248,0.3802031378908283,0.796,13/29,21.01%,GRIK1;GRIN3A;GABRB1;GRIN2A;GRID2;ANXA6;GRIN2B;GRIK4;GRIA1;GRIN1;GRIA2;GRID1;GRIK2
prerank,glycine binding (GO:0016594),-0.672853865213356,-1.685175356340675,0.011560693641618497,0.34062115970648615,0.8,6/11,14.42%,GRIN3A;GLRB;GLRA1;GRIN2B;GLRA3;GRIN1
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.5143033603968061,-1.6814798028002156,0.011695906432748537,0.3130293537533356,0.814,15/27,17.98%,PRKN;DCUN1D3;RNF180;RNF144B;ZMYM2;RNF19B;SIAH1;DCUN1D5;DCUN1D4;RNF217;ARIH2;RNF125;DCUN1D2;UBE3D;AUP1
prerank,ligand-gated ion channel activity (GO:0015276),-0.48043604026612885,-1.6674015834963531,0.006172839506172839,0.3163748339572516,0.849,8/30,5.81%,GRIK1;GRIN3A;GABRB1;GRIN2A;GRID2;ANXA6;GRIN2B;GRIK4
prerank,endodeoxyribonuclease activity (GO:0004520),0.8014899681851037,1.6658712030268823,0.023076923076923078,0.5140519793287852,0.999,6/20,5.34%,EXO1;ZRANB3;RBBP8;DNA2;ERCC4;MRE11
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.8755446882541396,1.665417364467547,0.014749262536873156,0.48955710493266985,0.999,2/11,4.00%,NEIL3;APEX2
prerank,microtubule plus-end binding (GO:0051010),0.8033245204737586,1.6619204861299928,0.02059202059202059,0.48380056813328415,1.0,4/20,4.92%,KIF2C;KNSTRN;KIF18A;NUMA1
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.47017880315907995,-1.6611762570976605,0.014388489208633094,0.30246870130515896,0.86,17/33,20.27%,PRKN;DCUN1D3;RNF180;RNF144B;ZMYM2;RNF19B;SIAH1;DCUN1D5;DCUN1D4;RNF217;ARIH2;RNF125;DCUN1D2;UBE3D;AUP1;TCERG1;PARK7
prerank,GABA receptor activity (GO:0016917),-0.526049819717646,-1.6587843268974916,0.013333333333333334,0.2840716168124054,0.867,9/21,14.92%,GABRB1;GABRB3;GABRA2;GABBR1;GABRA3;GABRA5;GABRB2;GABRG2;GABRG1
prerank,methylation-dependent protein binding (GO:0140034),0.7210060619563922,1.652245537028334,0.005417118093174431,0.51011507628552,1.0,14/57,8.89%,UHRF1;PHF19;NCAPG2;ATRX;NCAPD3;CBX5;SGF29;SUZ12;MPHOSPH8;FMR1;PHF1;PHF2;ING4;MSL3
prerank,acylglycerol lipase activity (GO:0047372),-0.6432011446911525,-1.6353516574499236,0.011940298507462687,0.3151760476607575,0.898,4/11,9.52%,ABHD6;ABHD12;ABHD16A;ABHD2
prerank,amino acid binding (GO:0016597),-0.47296960788674275,-1.6325021389408745,0.006578947368421052,0.2980671558564254,0.904,8/31,7.51%,GRM7;GRIN3A;GLRB;GLRA1;GRIN2B;NOS3;GLRA3;AARS1
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.803245033284942,1.6279883871769618,0.03551912568306011,0.6183839841465931,1.0,1/16,0.14%,NEIL3
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.6358633276049365,-1.6177216360534303,0.020477815699658702,0.31339920583618064,0.926,8/12,14.92%,GABRB1;GABRB3;GABRA2;GABRA3;GABRA5;GABRB2;GABRG2;GABRG1
prerank,methylated histone binding (GO:0035064),0.703544174385624,1.6169799783075958,0.009615384615384616,0.6551800459718743,1.0,14/62,8.89%,UHRF1;PHF19;NCAPG2;ATRX;NCAPD3;CBX5;SGF29;SUZ12;MPHOSPH8;FMR1;PHF1;PHF2;ING4;MSL3
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.8487719509645602,1.613477494816271,0.03644314868804665,0.6469931282407315,1.0,3/10,6.00%,EXO1;MGME1;POLD1
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.6267722309969764,-1.6041409961045971,0.01904761904761905,0.3285169097224689,0.947,6/11,23.75%,PRMT3;PRMT2;PRMT8;PRMT1;PRMT9;FBXO11
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.584908321790982,-1.6037448618675267,0.028469750889679714,0.31017140584044267,0.947,11/15,24.24%,HS3ST4;HS3ST1;HS6ST3;NDST3;NDST1;HS3ST3A1;HS3ST3B1;NDST2;NDST4;HS3ST2;HS6ST2
prerank,glutamate receptor activity (GO:0008066),-0.526787253374098,-1.5941127343748451,0.0391304347826087,0.3148786141675605,0.957,11/19,21.01%,GRM7;GRIK1;GRM3;GRID2;GRIK4;GRIA1;GRM5;GRM1;GRIA2;GRID1;GRIK2
prerank,histone acetyltransferase binding (GO:0035035),0.7518014106612556,1.5894028846220227,0.04020100502512563,0.7672004987068879,1.0,2/21,1.25%,KANSL1;GLI3
prerank,chloride channel activity (GO:0005254),-0.38234072348133824,-1.5816415290596153,0.0,0.3254609847676224,0.968,20/59,18.82%,GABRB1;ANO3;GABRB3;GABRA2;GLRB;GLRA1;ANO6;ANO1;GABRA3;GLRA3;CLCN7;GABRA5;GABRB2;ANO4;GABRG2;TTYH2;GABRG1;TTYH3;CLCN2;FXYD1
prerank,phospholipase A2 activity (GO:0004623),-0.478488344096415,-1.580051719242061,0.005076142131979695,0.3130461652116468,0.968,10/26,30.71%,PLA2G4A;PLAAT3;PNPLA8;PLA2G7;PLA2G12A;PLA2G15;PRDX6;PNPLA3;PLA2G4C;PLA2G4E
prerank,protein kinase C binding (GO:0005080),0.7025872892681622,1.5780444120558856,0.03665521191294387,0.8079937938449852,1.0,1/43,0.01%,TOP2A
prerank,four-way junction DNA binding (GO:0000400),0.7669138528890606,1.5727831512058061,0.06133333333333333,0.8108549388830293,1.0,10/17,13.81%,RAD51B;GEN1;HMGB2;XRCC2;BLM;HMGB3;RAD51C;HMGB1;MSH6;YY1
prerank,RNA polymerase binding (GO:0070063),0.745217879271051,1.5557373070003944,0.057640750670241284,0.8836933908095964,1.0,4/18,4.78%,BRCA1;ANP32B;NEDD4;DHX9
prerank,MHC class I protein binding (GO:0042288),-0.5988913987383623,-1.5547549531442184,0.04777070063694268,0.3552020977452689,0.978,7/13,29.11%,TAPBP;DERL1;ATP5F1A;ATP5F1B;TAP2;TUBB4B;ABCB9
prerank,poly(U) RNA binding (GO:0008266),0.73831613963937,1.5529258701058986,0.0754226267880364,0.8705959784205364,1.0,12/20,16.12%,PABPC4;PATL1;KHDRBS1;FMR1;HNRNPH1;RBMS2;RBMS3;ATXN1;RBMS1;DAZAP1;PABPC1;PNPT1
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.6179332128964747,-1.5475723189015917,0.03389830508474576,0.35831330918596593,0.984,6/10,14.13%,SHANK3;IGSF11;SQSTM1;SHISA6;SHANK1;DLG4
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.6969249745746875,1.5458934957850416,0.057176196032672114,0.8850999200930048,1.0,7/34,8.19%,CCNB1;INCENP;CKS2;DBF4;STK3;ETAA1;CAB39L
prerank,protein kinase regulator activity (GO:0019887),0.6487344549776207,1.5371842652355712,0.01443298969072165,0.9107183697307947,1.0,13/95,6.80%,TPX2;CCNF;CCNB1;CCNE2;CCNB2;SPDYA;PARVA;GPRC5A;CCNA2;FAF1;CCNA1;CCNE1;WNK1
prerank,magnesium ion binding (GO:0000287),0.6399006482711869,1.5359456068048396,0.008032128514056224,0.8891268858262923,1.0,34/135,13.88%,TOP2A;PLK1;PIF1;FIGNL1;GEN1;MAST2;NLK;TDP2;IDH3A;GSS;HPRT1;DYRK3;RAP2A;NUDT5;STK3;PDXK;MAP3K20;HPGDS;CDC42BPA;LRRK2;PGM1;TPPP;PPA1;MARK2;TKT;CDC42BPG;EYA2;SRPK1;MSH6;SIK2;DUT;DXO;MVK;FOXK2
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.5334934331253524,-1.5348311515941233,0.05514705882352941,0.3578949331211774,0.993,6/16,14.97%,ATP6V0A1;ATP6V0D1;ATP6V0B;ATP6V0A4;ATP6V0C;ATP5F1B
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.5334934331253524,-1.5348311515941233,0.05514705882352941,0.3578949331211774,0.993,6/16,14.97%,ATP6V0A1;ATP6V0D1;ATP6V0B;ATP6V0A4;ATP6V0C;ATP5F1B
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.5045380391094701,-1.5258681927656572,0.058823529411764705,0.3639142757694794,0.996,13/18,36.08%,PIK3R3;SOCS2;PIK3R1;SOCS5;PIK3R6;PIK3R2;WDR81;PIK3R5;SOCS6;CISH;SOCS3;CCKBR;AGAP2
prerank,ubiquitin binding (GO:0043130),0.6598060138431739,1.5257885953764128,0.028784648187633263,0.9217317342241238,1.0,14/73,11.76%,TOP2A;CKS2;RNF168;NEDD4;FAF1;CXCR4;BUB3;FBXW7;UBE2N;RNF31;USP16;IKBKG;ILRUN;ADRM1
prerank,nuclear export signal receptor activity (GO:0005049),0.7728699897316115,1.5165475994129234,0.09370424597364568,0.9474361785504936,1.0,5/11,6.10%,RANBP17;XPO1;XPO4;EIF4ENIF1;CSE1L
prerank,5'-3' exonuclease activity (GO:0008409),0.7578002637052376,1.5157273822523933,0.09587217043941411,0.9249584778742957,1.0,2/14,5.34%,EXO1;MRE11
prerank,lipoprotein particle receptor binding (GO:0070325),-0.46780838554382775,-1.514551068572994,0.0297029702970297,0.37785045743377005,0.997,11/27,17.57%,APOE;HSP90B1;SYT1;LRP1;DNAJA1;RELN;AP2M1;ANKRA2;LDLRAP1;AP2A1;APBB1
prerank,DNA polymerase binding (GO:0070182),0.7248715257804876,1.513338180253654,0.08298755186721991,0.9129719525840735,1.0,9/18,13.75%,FANCD2;RAD51;FANCI;RTEL1;SMARCA4;LONP1;HMGB1;PCNA;SMG6
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.5576404666812258,-1.5096278931261509,0.0728476821192053,0.37455929117209014,0.997,9/13,33.01%,TRMT11;THUMPD3;TRMT10B;TRMT1;METTL1;TRMT10A;WDR4;TRMT1L;TRMT10C
prerank,poly-pyrimidine tract binding (GO:0008187),0.7079653454665177,1.508046230818052,0.08860759493670886,0.9160731931244979,1.0,13/23,16.12%,PABPC4;PATL1;KHDRBS1;FMR1;HNRNPH1;RBMS2;HNRNPU;RBMS3;ATXN1;RBMS1;DAZAP1;PABPC1;PNPT1
prerank,transmitter-gated ion channel activity (GO:0022824),-0.44048142124061107,-1.507727194846451,0.028089887640449437,0.3658293410348078,0.997,15/29,21.01%,GRIK1;GABRB1;GABRB3;GABRA2;GRID2;GRIK4;GABRA3;GLRA3;GABRA5;GABRB2;GABRG2;GABRG1;GRIA2;GRID1;GRIK2
prerank,transcription corepressor binding (GO:0001222),0.68579563284846,1.506590198849715,0.09157509157509157,0.9002418827887678,1.0,8/27,7.79%,EZH2;SUZ12;HDGF;EED;WIZ;CTBP1;LCOR;PHF1
prerank,single-stranded telomeric DNA binding (GO:0043047),0.7726336387854758,1.5038635739235757,0.1099554234769688,0.8911699531430076,1.0,9/11,18.83%,TERF1;RPA1;STN1;HNRNPA1;RPA2;TERF2;HNRNPA2B1;TERF2IP;RAD50
prerank,voltage-gated cation channel activity (GO:0022843),-0.3343412024863105,-1.5034734809275832,0.0,0.36448401029458916,0.997,30/97,20.36%,CACNA2D1;GRIN3A;GRIN2A;KCNC2;HCN1;KCNB1;GRIN2B;KCNQ3;KCNH1;CACNG7;CACNA1B;CACNG4;KCNH7;OPRM1;KCNS3;NCS1;CACNB2;KCNA2;KCNA6;CACNG2;GRIN1;KCNC1;CACNG3;CACNG8;CACNB1;CACHD1;KCNQ1;CACNA2D2;LRRC38;KCNK1
prerank,telomeric DNA binding (GO:0042162),0.671160533801993,1.4902451907049816,0.07646356033452807,0.9412783544126655,1.0,16/32,19.32%,PIF1;TERF1;RPA1;HNRNPD;STN1;BLM;TERF2;SMG6;HNRNPA2B1;TINF2;UPF2;PURA;ACD;TERF2IP;RAD50;TERT
prerank,ATPase binding (GO:0051117),-0.3432158523512603,-1.4818876325223023,0.0,0.4007011088459052,0.999,31/71,24.38%,ATP6V0A1;PSEN1;ATP1B1;ATXN3;CAV1;ATP6V1E1;AR;RALB;ATP6V0A4;NCSTN;ESR1;ATP1B3;TMEM106B;DERL1;SELENOS;TRPC1;NUFIP1;METTL21A;UBXN1;SNU13;NR1H2;NKD2;PDE4D;SVIP;SYVN1;GABARAPL2;PEX26;S100A1;PIH1D1;WFS1;SNX10
prerank,WW domain binding (GO:0050699),0.7000978843834584,1.4801842832821768,0.08489388264669163,0.9680715264759836,1.0,4/26,9.38%,KIF20B;NFE2;PMEPA1;CDC25C
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.5549400489145278,-1.4797386948906737,0.07028753993610223,0.39358335431901337,0.999,8/13,14.92%,GABRA2;GLRB;GLRA1;GABRA3;GLRA3;GABRA5;GABRG2;GABRG1
prerank,deoxyribonuclease activity (GO:0004536),0.7456052232909627,1.4775787486842433,0.11814345991561181,0.9589220232177725,1.0,4/14,10.58%,ZRANB3;ERCC4;MRE11;MBD4
prerank,amyloid-beta binding (GO:0001540),-0.3430152665110995,-1.4731601837894859,0.0,0.3967451625620662,0.999,29/79,18.32%,ITM2B;CST3;GRIN2A;APOE;APBA1;ITM2A;INSR;GRIN2B;TGFB2;TLR4;EPHB2;LRP1;CACNA1B;FZD4;TM2D1;CHRNA7;GRIA1;ATP1A3;CRYAB;GSAP;APBB2;PFDN5;LDLRAP1;GRIN1;GRIA2;APBB1;SORL1;NLGN1;APBA2
prerank,protein kinase activator activity (GO:0030295),0.6397613289097427,1.4714166204260326,0.06601731601731602,0.9692295162016551,1.0,17/60,14.65%,TPX2;INCENP;DBF4;SPDYA;GPRC5A;STK3;WNK1;ETAA1;CAB39L;ABI1;MARK2;CALM2;STRADA;CAB39;TAOK1;STK11;RPTOR
prerank,nuclease activity (GO:0004518),0.6467104607035336,1.4670770853066775,0.06746463547334058,0.9689792717101644,1.0,10/52,13.10%,EXO1;ANKLE1;REXO5;DNA2;RNASE6;MRE11;RNASEH2A;ENPP1;RNASE1;RNASE12
prerank,kinase activator activity (GO:0019209),0.667343432744596,1.4667595007718255,0.12094763092269327,0.949145265747807,1.0,9/30,14.65%,TPX2;SPDYA;GPRC5A;WNK1;MARK2;STRADA;CAB39;STK11;RPTOR
prerank,water transmembrane transporter activity (GO:0005372),0.7507616100372049,1.4651231765357373,0.09495548961424333,0.9361981217259816,1.0,2/11,5.71%,AQP1;PDPN
prerank,histone deacetylase binding (GO:0042826),0.6128365797661608,1.4650247111175463,0.049740932642487044,0.9167411077930065,1.0,15/88,11.17%,TOP2A;KPNA2;GLI3;MIER1;SP2;BCOR;BHLHE41;LCOR;RBBP4;NIPBL;MIER3;MTA3;SFPQ;TAL1;HDAC1
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.41265118881159646,-1.462903875050001,0.043795620437956206,0.3971262016815079,1.0,18/34,24.81%,NDUFS5;NDUFS1;NDUFA9;NDUFB4;NDUFV3;NDUFC2;NDUFS3;NDUFB3;NDUFS4;NDUFA5;NDUFA6;NDUFA4;NDUFB9;NDUFB6;NDUFB10;NDUFA10;NDUFS6;NDUFA1
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.41265118881159646,-1.462903875050001,0.043795620437956206,0.3971262016815079,1.0,18/34,24.81%,NDUFS5;NDUFS1;NDUFA9;NDUFB4;NDUFV3;NDUFC2;NDUFS3;NDUFB3;NDUFS4;NDUFA5;NDUFA6;NDUFA4;NDUFB9;NDUFB6;NDUFB10;NDUFA10;NDUFS6;NDUFA1
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.6526933236841698,1.462434631853922,0.09059633027522936,0.9098227748870307,1.0,7/34,7.46%,EZH2;KMT5A;SETD6;ATPSCKMT;SETD3;EEF1AKMT2;SETD2
prerank,carboxylic acid binding (GO:0031406),-0.3933764597450265,-1.4622060979849885,0.05172413793103448,0.38716308163163826,1.0,9/38,7.13%,GRM7;GRIN3A;GLRB;GLRA1;GRIN2B;NOS3;SESN3;PSAP;GLRA3
prerank,DNA binding (GO:0003677),0.613365272965708,1.455076095970367,0.0,0.9231500830813422,1.0,171/694,14.25%,TOP2A;NEIL3;BRCA1;EXO1;RAD51AP1;POLQ;NR2E3;PHF19;BRIP1;POLE;CLSPN;RAD51B;E2F2;ATAD5;RAD51;PBX4;MCM5;POLA1;GLI2;RAD18;ORC1;TCFL5;WDR76;HMGB2;DDX11;E2F1;RAD51AP2;BRCA2;TIPIN;FOXE1;MCM8;TERF1;CDC45;ILF3;DMC1;MND1;AUNIP;CCDC25;SMC1A;TIMELESS;CBFB;FAM111A;SMC6;MCM10;MCM6;SETX;MCM7;MCM2;PDS5B;TEAD1;RBBP8;CTCF;E2F3;HDGF;RPA1;NFE2;STN1;MSH3;DNA2;SMARCAD1;KHDRBS1;MBD1;RAD1;ERCC4;CUX1;AIFM2;TDP2;DHX9;PRKDC;HNRNPA1;TCF7L1;BLM;TSHZ1;MRE11;THRAP3;MAPT;NFIB;MAEL;MCM3;IKZF1;POLD1;RPA2;MCM4;YAF2;RFC1;GZF1;TCF7L2;ERCC3;PSIP1;SOX6;HP1BP3;TCF4;RFC3;HOXA7;GRHL2;DNASE2;ARID1A;MLH1;NUCKS1;RFX2;POU2F1;TAF12;POLR2A;RC3H2;POU3F2;PHF1;SIM1;LIN9;FOXO3;IRF1;KDM2B;TRIM28;HMGB3;PLAGL2;BCLAF1;GTF3C4;RAD51C;SMARCA4;MSL3;TIGD2;CUL4B;ARID4A;NFYA;PLAGL1;LONP1;HMGB1;MEOX2;CARF;CXXC5;NR4A2;MBD4;HNRNPU;SFPQ;CRLF3;XPA;CHD2;GTF2A1;AHR;QRICH1;PCNA;NKX2-1;TAF4;RORA;FANCG;APLP2;SPTY2D1;FUBP1;ZIC4;RBPJ;KMT2D;MSH6;ZNF496;NR4A1;SMAD4;SOX9;HDAC2;ATF5;ILF2;ELK4;RBMS1;RARB;HEY2;YY1;FOXK2;RLF;FOXL1;POU2F2;ARNT;SMAD3;CAMTA1;DNMT3A
prerank,gamma-tubulin binding (GO:0043015),0.690826299859123,1.4480903576058288,0.10435931307793923,0.9384636411055154,1.0,4/21,4.57%,RACGAP1;CDK5RAP2;BRCA2;TUBGCP5
prerank,nuclear localization sequence binding (GO:0008139),0.7100960152390056,1.4441707326613071,0.10298102981029811,0.9388680304417036,1.0,7/18,15.84%,KPNA2;KPNA3;BRAP;TNPO1;NUP214;KPNA4;IPO5
prerank,BMP binding (GO:0036122),-0.5723601207220728,-1.4441528885534272,0.08490566037735849,0.4155792494512598,1.0,3/11,14.72%,NBL1;BMPR2;ENG
prerank,lysine N-methyltransferase activity (GO:0016278),0.67563490499727,1.4406020704638058,0.14732724902216426,0.937419149913902,1.0,6/20,7.46%,KMT5A;SETD6;ATPSCKMT;SETD3;EEF1AKMT2;SETD2
prerank,acetyltransferase activity (GO:0016407),0.6508242671838874,1.4385733234145275,0.11492890995260663,0.9286816436244941,1.0,2/31,2.00%,ESCO2;NAT14
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.550607987751673,-1.4380217003732492,0.08227848101265822,0.4193141193787606,1.0,7/12,14.53%,INSR;IGF1;SOCS2;PIK3R1;IGF2;IRS1;SHC1
prerank,phospholipase inhibitor activity (GO:0004859),0.7464093675865167,1.4228516710732835,0.14432989690721648,0.9822377741657742,1.0,4/10,11.23%,ANXA9;ANXA2;ANXA5;ANXA1
prerank,exonuclease activity (GO:0004527),0.6273142677462559,1.4187598885522312,0.09429824561403509,0.9834753611469598,1.0,19/46,19.19%,EXO1;REXO5;APEX2;RAD1;MRE11;EXD1;ERI1;ENPP2;ENPP3;CNOT6;ENPP1;EXOSC7;DXO;CNOT7;DCLRE1C;EXOSC10;RAD50;XRN2;ISG20L2
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.6380126468010854,1.4168589088808772,0.11578947368421053,0.9747092802113221,1.0,4/35,2.38%,MELK;MATK;DYRK1A;STYK1
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.5037409955897505,-1.4138727189226274,0.0989399293286219,0.4667303233968767,1.0,11/15,34.98%,PIK3R3;SOCS2;PIK3R1;SOCS5;PIK3R6;PIK3R2;PIK3R5;SOCS6;CISH;SOCS3;CCKBR
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.6460308791219291,1.4096258789466618,0.12750885478158205,0.9901487151413664,1.0,6/28,11.39%,EXO1;AGO2;RNASEH2A;RPP40;POP1;RPP30
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.7121022840382968,1.407153246357302,0.14674735249621784,0.9840562450321867,1.0,4/11,6.88%,ALDH3A1;RDH11;RDH12;RDH14
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.6950097948330839,1.4065860285275427,0.1416058394160584,0.9697774002694808,1.0,6/12,15.36%,PNLDC1;CNOT1;CNOT6L;CNOT6;PAN3;CNOT7
prerank,lipase activity (GO:0016298),-0.3705148833573288,-1.4049745213888132,0.043859649122807015,0.47935933590550467,1.0,9/43,9.52%,LIPA;ABHD6;ABHD5;ABHD12;ABHD16A;LYPLA1;PLA1A;PNPLA8;ABHD2
prerank,retinoic acid binding (GO:0001972),0.6931455377057204,1.4031426076072535,0.14777618364418937,0.9690924709920644,1.0,1/12,3.25%,CYP26B1
prerank,microtubule minus-end binding (GO:0051011),0.7028747150649018,1.3981669877705882,0.1564245810055866,0.9752659748716489,1.0,5/13,5.75%,HAUS4;MACF1;TUBGCP5;NUMA1;HAUS7
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.7041474627246893,1.3878180430250602,0.1575037147102526,1.0,1.0,1/12,0.46%,CDK1
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.4835078724407528,-1.3840481720297322,0.1062992125984252,0.5189697180647407,1.0,10/17,23.61%,GRIK1;GRIN3A;GRIN2A;GRIN2B;GRIK4;GRIA1;GRIN1;GRIA2;GRIK2;PTK2B
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.4304460460502784,-1.383887217463669,0.10784313725490197,0.506939274483065,1.0,7/22,14.97%,ATP6V0A1;ATP6V0D1;ATP6V1E1;ATP6V0B;ATP6V0A4;ATP6V0C;ATP5F1B
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.6543789152263148,1.3836749141251368,0.16266666666666665,1.0,1.0,3/22,9.29%,CDKN3;DUSP12;MTMR2
prerank,kinase binding (GO:0019900),0.5756988370563284,1.3783263838944668,0.002,1.0,1.0,47/434,6.80%,KIF11;PRC1;TPX2;KIF14;CCNB1;SGO1;PLK1;TRIML2;BARD1;FAM83D;RACGAP1;CKS2;BORA;KIF20A;AURKB;CEP192;CEP152;POLA1;CDK5RAP2;CIT;SPDYA;CDKN2D;CNTLN;FBXO5;CDKN2C;RB1;AURKA;TICAM1;TRIP6;TTC28;RHOA;CEP43;GSK3B;CDC6;MAPK4;CHEK2;CCNA2;ADD2;MAPT;VRK2;FAF1;EIF4ENIF1;PTPN2;TCF7L2;MAP3K1;USP37;WNK1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.7037678743150362,1.3779435551037666,0.15703703703703703,0.999196493617483,1.0,3/10,7.46%,NSD2;SETD3;SETD2
prerank,MAP-kinase scaffold activity (GO:0005078),0.7006891561201396,1.3721764185964076,0.17180616740088106,1.0,1.0,4/11,11.74%,KSR1;SPAG9;SH3RF1;MAPK8IP3
prerank,retinoid binding (GO:0005501),0.6398178561846419,1.3710080391922217,0.18032786885245902,0.9983104001170108,1.0,3/22,4.10%,CYP26B1;ALDH1A2;ABCA4
prerank,nucleotidyltransferase activity (GO:0016779),0.6519117739597365,1.370564237473769,0.1702944942381562,0.9853029643275116,1.0,9/19,16.12%,TENT2;CRPPA;NUDT5;TENT4A;PAPSS2;TUT7;TUT1;TUT4;PNPT1
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.39833257689150037,-1.3662736101593878,0.08843537414965986,0.5403683028579142,1.0,9/32,19.13%,KCNC2;KCNB1;KCNQ3;KCNH1;KCNS3;KCNA2;KCNA6;KCNC1;KCNQ1
prerank,nuclear import signal receptor activity (GO:0061608),0.6945773161393661,1.3639469653249587,0.15155807365439095,0.9985584500956094,1.0,3/15,5.08%,KPNA2;KPNA3;TNPO1
prerank,phospholipid transfer activity (GO:0120014),-0.43912338123881767,-1.3636564620738911,0.09777777777777778,0.5357186221123925,1.0,12/21,25.20%,CERT1;PLTP;MTTP;GLTP;TNFAIP8L3;PRELID3B;OSBPL2;PITPNC1;PLEKHA8;PRELID3A;ABCA3;PRELID1
prerank,protein kinase binding (GO:0019901),0.5662865812353249,1.3556136747377825,0.002,1.0,1.0,47/479,6.80%,TOP2A;KIF11;PRC1;TPX2;KIF14;CCNB1;PLK1;TRIML2;FAM83D;RACGAP1;CKS2;BORA;KIF20A;CEP192;CEP152;POLA1;CDK5RAP2;CIT;SPDYA;CDKN2D;CNTLN;FBXO5;PPM1D;CDKN2C;AURKA;TICAM1;RHOA;CEP43;MAP4K2;GSK3B;MAPK4;CHEK2;KHDRBS1;CCNA2;ADD2;SPAG9;PDE3B;MAPT;VRK2;FAF1;PTPN2;TCF7L2;MAP3K1;USP37;CAVIN3;TPR;WNK1
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.5246812328480472,-1.3486802629268737,0.12258064516129032,0.5620911086328022,1.0,7/12,20.56%,VEGFC;CDH5;CADM4;VEGFA;VEGFB;VEGFD;ITGB3
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.4274609751327306,-1.3460470385498076,0.07883817427385892,0.5565601388484388,1.0,9/22,17.57%,APOE;HSP90B1;SYT1;DNAJA1;AP2M1;ANKRA2;LDLRAP1;AP2A1;APBB1
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.542130094518176,-1.3455042101439563,0.11254019292604502,0.5458753606922573,1.0,6/11,25.23%,LEF1;ZXDC;SRRM2;GATA2;HMGA2;THAP7
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.33341024757527604,-1.3427292027290614,0.06329113924050633,0.541343265242645,1.0,14/60,6.20%,EPHA5;ACVR1;FLT1;TEK;NTRK2;MERTK;ACVR2A;TGFBR2;INSR;ACVRL1;PDGFRB;EPHB2;NTRK3;TIE1
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.6422983095159019,1.3398038952854376,0.17871222076215507,1.0,1.0,2/21,2.60%,CDK1;CDK14
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.6422983095159019,1.3398038952854376,0.17871222076215507,1.0,1.0,2/21,2.60%,CDK1;CDK14
prerank,ion channel activity (GO:0005216),-0.3081639549956705,-1.3376488588537128,0.0,0.5431466965484418,1.0,15/80,10.49%,GRIK1;GRIN3A;GABRB1;TRPM7;UNC80;GRIN2A;GRID2;ANXA6;GRIN2B;GRIK4;TMEM63B;TRPM3;TRPC1;CHRNA7;GRIA1
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.4876278922311562,-1.331127103636095,0.14965986394557823,0.5497861504220092,1.0,8/14,28.17%,SPOCK1;TIMP3;SPOCK2;SPOCK3;BST2;TIMP2;LXN;TIMP4
prerank,transcription coregulator binding (GO:0001221),0.5760314457589043,1.3278484835789637,0.16111111111111112,1.0,1.0,15/50,14.89%,EZH2;CIT;SUZ12;CTCF;HDGF;EED;WIZ;CTBP1;LCOR;PHF1;AHR;RORA;SMAD4;SMAD3;PER1
prerank,chloride channel regulator activity (GO:0017081),-0.4828730925429895,-1.327447254634778,0.15714285714285714,0.5490790398999836,1.0,6/14,16.07%,STX8;STX7;SGK1;WNK2;CHRNA7;VAMP8
prerank,metalloendopeptidase activity (GO:0004222),0.5592006733650693,1.3247942665167578,0.1472457627118644,1.0,1.0,19/76,13.83%,KEL;MMP25;MMP24;MMP28;MMP14;TRABD2B;NLN;ADAMTS10;ADAMTS5;ADAMTS14;ADAMTS9;ADAMTSL2;ADAMTS2;ADAMTS16;ADAM17;ADAM19;ADAMTSL3;ADAM9;ADAMTS1
prerank,SH3 domain binding (GO:0017124),-0.32464394806037494,-1.3194413106030092,0.057971014492753624,0.5594358871289553,1.0,24/62,19.28%,SGIP1;ENAH;PRKN;SHANK3;RUFY2;ELMO1;WIPF1;AFAP1L1;ADAM15;PTPN22;RUFY1;ABL1;ARHGAP27;SHANK1;GRB2;SYNJ2;CASP9;SYNJ1;AFAP1L2;GPX1;CBLB;CBL;MICAL1;PTPN12
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.39741243675078397,-1.3186108189357817,0.10404624277456648,0.5505396969894011,1.0,11/28,21.01%,GRIK1;GABRA2;GRID2;GRIK4;GABRA3;GABRA5;CHRNA7;GABRG2;GABRG1;GRID1;GRIK2
prerank,chemorepellent activity (GO:0045499),-0.4246006005565093,-1.3141970652152084,0.13170731707317074,0.5513428772201077,1.0,9/25,18.98%,NRG3;SEMA6A;SEMA6D;SEMA7A;SEMA4D;SEMA3A;SEMA3B;SEMA3C;SEMA5B
prerank,histone methyltransferase activity (GO:0042054),0.5991644077275973,1.314053428343709,0.1953216374269006,1.0,1.0,5/32,7.46%,EZH2;KMT5A;SUZ12;EED;SETD2
prerank,ankyrin binding (GO:0030506),0.6204196876345501,1.3137842573276222,0.19974059662775617,1.0,1.0,3/19,9.46%,RHAG;SPTB;SLC8A1
prerank,histone methyltransferase binding (GO:1990226),0.6771517185489091,1.3137438056220698,0.19791666666666666,1.0,1.0,5/11,10.30%,LCORL;WIZ;LCOR;PHF1;CBX1
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.4641706656186336,-1.3084991660627052,0.12802768166089964,0.5444986816673953,1.0,5/16,8.76%,PTPRG;PTPRB;PTPRD;PTPRZ1;PTPRO
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.4641706656186336,-1.3084991660627052,0.12802768166089964,0.5444986816673953,1.0,5/16,8.76%,PTPRG;PTPRB;PTPRD;PTPRZ1;PTPRO
prerank,chloride transmembrane transporter activity (GO:0015108),-0.45595321085651236,-1.3080402049313462,0.14760147601476015,0.5357481538684788,1.0,9/16,37.40%,CLCN7;SLC1A1;SLC4A8;SLC26A2;SLC26A6;CFTR;CLCN6;SLC26A8;SLC12A5
prerank,methyl-CpG binding (GO:0008327),0.6187201938554119,1.3059869350695683,0.20747422680412372,1.0,1.0,4/22,11.89%,UHRF1;MBD1;CXXC5;ERH
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.4082878905572008,-1.303969185591204,0.15736040609137056,0.5176874881935524,1.0,5/22,16.45%,CHRM2;HTR2C;HTR4;CHRM3;HTR2A
prerank,serotonin receptor activity (GO:0099589),-0.4082878905572008,-1.303969185591204,0.15736040609137056,0.5176874881935524,1.0,5/22,16.45%,CHRM2;HTR2C;HTR4;CHRM3;HTR2A
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.4082878905572008,-1.303969185591204,0.15736040609137056,0.5176874881935524,1.0,5/22,16.45%,CHRM2;HTR2C;HTR4;CHRM3;HTR2A
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.565030226927829,1.302563390341944,0.17456896551724138,1.0,1.0,17/60,17.61%,CDKN3;PPM1G;PPM1D;LRRC40;PHLPP2;TAB1;CTDSPL2;PPP3CA;LRRK2;LRRK1;PPP1CC;MTMR3;PTEN;CTDSPL;UBLCP1;PPP3R1;CDC14A
prerank,double-stranded DNA binding (GO:0003690),0.5505820113828187,1.302228099223707,0.002,1.0,1.0,81/531,11.45%,NEIL3;RAD51AP1;E2F7;E2F8;UHRF1;EN1;RAD51B;E2F2;RAD51;GLI2;GLI3;TCFL5;HMGB2;DDX11;E2F1;RAD51AP2;FOXE1;TERF1;DMC1;MND1;ZNF32;SP3;ZFP41;ELF2;TEAD1;ZSCAN29;SP2;RBBP8;E2F3;HDGF;TFCP2L1;NFE2;MSH3;MBD1;HIVEP1;CUX1;DHX9;PRKDC;BHLHE41;KLF5;TCF7L1;SRF;ELF4;MRE11;MAPT;KLF13;NFIB;SP8;PSIP1;HOXC4;ELF1;GMEB1;TCF4;HOXA7;MYBL2;ELK1;NUCKS1;RFX2;PRRX2;ZBTB2;POU3F2;ZBTB7B;FOXO3;OLIG2;ZNF23;LMX1B;HMGB3;CREB5;KLF11;ZBTB20;ZIC5;HMGB1;HOXB6;MEOX2;NR3C1;NR4A2;HNRNPU;XPA;TBX18;AHR;CPSF4
prerank,intracellular chloride channel activity (GO:0061778),-0.4538327912166783,-1.3012394764723123,0.12915129151291513,0.5067662529169199,1.0,7/16,15.68%,ANO3;ANO6;ANO1;ANO10;ANO4;TTYH2;TTYH3
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.4538327912166783,-1.3012394764723123,0.12915129151291513,0.5067662529169199,1.0,7/16,15.68%,ANO3;ANO6;ANO1;ANO10;ANO4;TTYH2;TTYH3
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.5720417288362305,1.300383854998491,0.1909722222222222,1.0,1.0,5/38,9.66%,SERPINB8;SERPINA9;ANXA2;SERPINE1;AGT
prerank,miRNA binding (GO:0035198),0.5993199183201888,1.298661308975948,0.2066905615292712,1.0,1.0,17/30,19.14%,ZC3H7A;AGO2;HNRNPA1;FMR1;MATR3;TUT7;PUM2;RBM4;TUT4;DDX21;RC3H1;HNRNPA2B1;ZC3H7B;PNPT1;RBM10;ZNF346;SPOUT1
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.533159404305076,-1.2866824200348717,0.19519519519519518,0.5309519493997256,1.0,3/10,13.13%,ATXN3;CYLD;YOD1
prerank,neuropeptide binding (GO:0042923),-0.4280243607567045,-1.2818761536808028,0.15677966101694915,0.5339559323306668,1.0,12/18,52.29%,GPR37;OPRM1;GPR149;SORL1;OPRK1;NMUR2;OPRL1;SSTR2;MC4R;SSTR1;OPRD1;NMUR1
prerank,sequence-specific mRNA binding (GO:1990825),0.6806805949991217,1.2817256537336792,0.2080745341614907,1.0,1.0,4/10,13.79%,TYMS;DHX9;FMR1;DHFR
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.3567510448350829,-1.2767889216513932,0.13385826771653545,0.5382135842502681,1.0,8/38,5.87%,PLA2G4A;KIF16B;PLEKHA5;SNX13;WDR45B;TECPR1;SNX3;SNX21
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.5576387703614067,1.2761540555119457,0.20288248337028825,1.0,1.0,13/44,16.56%,EZH2;NSD2;KMT5A;EED;SETDB2;SETD3;SETD2;KMT2A;KMT2D;KMT5C;ASH1L;SETD4;SUV39H2
prerank,nucleoside-triphosphatase activity (GO:0017111),0.532935968222692,1.2756528361030048,0.06406406406406406,1.0,1.0,36/248,12.26%,KIF18B;KIF15;KIF20B;KIF14;RAB33B;RHOA;GNG8;CHD1L;ABCA4;DNA2;DHX9;RHOT1;RAP2A;ATL2;EFL1;ATL3;RAB22A;GNA13;RAB29;LRRK2;AGAP3;MFN2;SMCHD1;GNAQ;RHOQ;TPPP;DNM2;SRPRA;ABCB10;RAB1A;ATP2B1;DRG1;RAC1;RND2;TSR1;RRAS
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.6601201203714381,1.2722468915723288,0.22105263157894736,1.0,1.0,2/10,2.40%,CDKN2D;CDKN2C
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.618832400512927,1.2670352354416325,0.2200825309491059,1.0,1.0,9/17,18.94%,LBR;PTGR1;DPYD;PTGR2;SRD5A3;TM7SF2;DHCR7;BLVRB;BDH2
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.4521874177798213,-1.2666640668198892,0.16140350877192983,0.5547005329214071,1.0,1/15,0.18%,PLA2G4A
prerank,ATP binding (GO:0005524),0.529047728755749,1.2610158126799227,0.058,1.0,1.0,52/266,11.37%,KIF14;KIFC1;PLK1;PIF1;TRIP13;SMC4;RAD51;MAST2;HASPIN;RRM1;MAP4K4;KSR1;STK17B;MCM6;BMPR1A;RTEL1;MTHFD1L;MAP4K2;GCK;NLK;CARS2;DHX9;PMVK;GSS;SARS2;BLM;DYRK3;STK3;MYH10;PDXK;WNK1;MAP3K20;CDC42BPA;GUK1;DARS2;ABCF3;LONP1;PIM1;PPIP5K1;MARK2;PXK;TGFBR1;P2RY1;MYO9B;CDC42BPG;HNRNPU;ENPP1;ABCA1;SRPK1;PRPS1L1;PRPS1;TWF1
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.5644047348516417,1.2608285574751124,0.23681125439624853,1.0,1.0,16/34,21.20%,PNLDC1;ERI2;CNOT1;CNOT6L;ERI1;CNOT6;PAN3;EXOSC7;ERI3;CNOT7;PNPT1;ANGEL2;EXOSC10;XRN2;PAN2;DIS3
prerank,regulatory RNA binding (GO:0061980),0.5674023417838965,1.2588808853900253,0.22209436133486765,1.0,1.0,18/38,19.14%,ZC3H7A;AGO2;DHX9;HNRNPA1;FMR1;MATR3;TUT7;PUM2;RBM4;TUT4;DDX21;RC3H1;HNRNPA2B1;ZC3H7B;PNPT1;RBM10;ZNF346;SPOUT1
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.5303602083189707,1.2567413244258665,0.007,1.0,1.0,106/597,12.93%,BRCA1;KIF2C;E2F7;E2F8;EN1;E2F2;MCM5;POLA1;GLI2;CDK5RAP2;ORC1;GLI3;TCFL5;HMGB2;DDX11;E2F1;FOXE1;MCM8;CDC45;MCM10;ZNF32;MCM6;SP3;MCM7;MCM2;ZFP41;ELF2;TEAD1;ZSCAN29;SP2;CTCF;E2F3;CDC6;TFCP2L1;NFE2;BCOR;HIVEP1;CUX1;DHX9;BHLHE41;KLF5;TCF7L1;SRF;ELF4;ZNF568;ZW10;KLF13;NFIB;TBL1XR1;SP8;MCM3;MCM4;TCF7L2;HOXC4;SOX6;ELF1;ORC2;GMEB1;TCF4;HOXA7;PSPC1;MYBL2;ELK1;RFX2;PRRX2;ZBTB2;ORC3;POU3F2;ZBTB7B;FOXO3;OLIG2;IRF1;ZNF23;LMX1B;SMAD6;BNC2;YAP1;CREB5;KLF11;NONO;ARID4A;NFYA;ZBTB20;ZIC5;HMGB1;HOXB6;MEOX2;NR3C1;NR4A2;MBD4;HNRNPU;SFPQ;TAL1;HNRNPL;XPA;TBX18;AHR;CPSF4;NKX2-1;ZIC4;KMT2D;NR4A1;SMAD4;SOX9;ATF5;ELK4
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.41713741792632353,-1.2562260664450633,0.18292682926829268,0.570940048962027,1.0,10/19,21.01%,GRIK1;GABRA2;GRID2;GRIK4;GABRA3;GABRA5;GABRG2;GABRG1;GRID1;GRIK2
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.6349385180766903,1.2553399313779545,0.25,1.0,1.0,1/11,1.84%,AQP1
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.5453788138627962,1.2523213269406852,0.23076923076923078,1.0,1.0,7/48,12.45%,RHD;RHAG;AQP1;CALHM2;TRPM2;PIEZO1;TRPM4
prerank,leak channel activity (GO:0022840),0.5925979546934564,1.2480455044001129,0.25,1.0,1.0,4/18,12.70%,RHAG;KCNK2;KCNK12;KCNK6
prerank,mRNA methyltransferase activity (GO:0008174),-0.48746199763669096,-1.246223049301071,0.1724137931034483,0.5864238126585086,1.0,6/12,16.11%,METTL16;NSUN2;TRMT61B;METTL14;PCIF1;CMTR1
prerank,amino acid:sodium symporter activity (GO:0005283),-0.4863043381914351,-1.2447477513543965,0.2302839116719243,0.5815602607210654,1.0,5/11,19.58%,SLC1A2;SLC6A1;SLC1A1;SLC6A11;SLC6A15
prerank,PDZ domain binding (GO:0030165),0.5259326806186007,1.244672214257843,0.21170212765957447,1.0,1.0,9/61,10.56%,KIF14;CIT;ATP2B4;PDZK1;TGFBR3;CRIM1;LLGL2;ERC1;ATP2B1
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.6028677559202797,1.2440281136668647,0.2361878453038674,1.0,1.0,4/18,8.59%,ALDH3A1;ALDH8A1;ALDH1A2;ALDH1A1
prerank,CARD domain binding (GO:0050700),-0.4520766282212411,-1.2427793506726164,0.20068027210884354,0.5778244408131146,1.0,4/14,12.04%,CARD16;CASP4;NOD1;IRGM
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.5681359274266363,1.2416779132035363,0.25903614457831325,1.0,1.0,3/28,2.81%,TTK;AURKB;AURKA
prerank,protein serine/threonine kinase activity (GO:0004674),0.5218767412161353,1.2406814726061197,0.056056056056056056,1.0,1.0,77/334,14.67%,PBK;NEK2;MELK;CDK1;TTK;PLK1;MASTL;AURKB;NEK3;CIT;PLK4;HUNK;MAST2;MAP4K4;DYRK1A;STK17B;CDK14;BMPR1A;MAP3K14;AURKA;ROCK2;MAP4K2;GSK3B;STK10;NLK;MAPK4;CHEK2;MYLK3;CASK;PRKDC;DYRK3;VRK2;STK24;STK3;NRK;MAP3K1;WNK1;MAP3K20;CHEK1;CDC42BPA;CDK2;LRRK2;GRK5;RIOK3;MAP3K4;ROCK1;CSNK2A2;PIM1;MARK2;TGFBR1;CAMK1D;CDC42BPG;RPS6KC1;EIF2AK3;SRPK1;PRKCB;GAK;PRKCA;PDPK1;GRK3;ULK2;CSNK1G2;AAK1;BRD4;SIK2;MAPKAPK3;PRKCE;CDK19;PRKCI;PKMYT1;PLK2;PRKD1;NRBP1;TAOK1;STK11;VRK1;CDK8
prerank,lysophospholipase activity (GO:0004622),-0.3975879940201841,-1.2399948978553967,0.19047619047619047,0.5757948487932789,1.0,7/20,14.51%,PLA2G4A;ABHD12;PNPLA6;ABHD16A;LYPLA1;GDPD3;GDPD1
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.5057349859934559,-1.234269508873896,0.20414201183431951,0.5815154464152525,1.0,5/10,14.92%,GABRA2;GABRA3;GABRA5;GABRG2;GABRG1
prerank,protein homodimerization activity (GO:0042803),0.513639461062692,1.2335027927090505,0.026,1.0,1.0,100/589,12.90%,TOP2A;CENPF;KIF20B;ECT2;CIP2A;TRIML2;BARD1;KNSTRN;PON1;GEN1;TERF1;CEP57;RBM44;TRIM37;BMPR1A;DGCR8;CEP43;MTHFD1L;UPB1;FGFR2;CRPPA;STK10;MSH3;MAPK4;CHEK2;ACTN4;KIT;DCK;ADD2;WDR54;TPM4;BHLHE41;SNX1;LHPP;SRF;GSS;BLM;DPYD;PDLIM4;NUDT5;XDH;PDXK;SOX6;EXD1;PDGFRA;TPR;PML;FMR1;ATG7;TXN;HPGDS;ZBTB7B;SH3GLB1;SPPL2B;ZHX2;HSPB6;FBLN5;LRRK2;RNF40;GOLGA5;CPQ;DARS2;SMCHD1;TYR;MTMR1;TPPP;DSCAML1;CDA;AGXT;ABCB10;KMT2A;TKT;NPR3;IKBKG;SRGAP2;TARS2;MYO9B;ENPP1;SFPQ;RBPMS2;BOK;XPA;TBX18;AHR;PRPS1L1;PRPS1;ASMT;TERF2;CLCN1;HOGA1;APPL2;ZHX3;ACHE;MSH6;TRIM6;GYG1;SMAD4;CPOX;MKLN1;ATP5IF1
prerank,MHC protein binding (GO:0042287),-0.40403687750938055,-1.229535238934472,0.21367521367521367,0.5846815057383901,1.0,9/20,29.11%,TAPBP;DERL1;CD81;ATP5F1A;ATP5F1B;TAP2;TUBB4B;CD74;ABCB9
prerank,adenyl ribonucleotide binding (GO:0032559),0.5152568630281054,1.2286133256241554,0.07,1.0,1.0,56/291,11.37%,KIF14;KIFC1;PLK1;PIF1;TRIP13;SMC4;RAD51;MAST2;HASPIN;RRM1;MAP4K4;KSR1;STK17B;MCM6;BMPR1A;RTEL1;MTHFD1L;MAP4K2;GCK;NLK;CARS2;DHX9;PMVK;GSS;SARS2;BLM;DYRK3;STK3;MYH10;PDXK;SLC19A1;WNK1;MAP3K20;CDC42BPA;GUK1;DARS2;ABCF3;LONP1;PIM1;PPIP5K1;MARK2;PXK;MPPED2;MIEF1;TGFBR1;P2RY1;MYO9B;CDC42BPG;HNRNPU;ENPP1;ABCA1;RAPGEF4;SRPK1;PRPS1L1;PRPS1;TWF1
prerank,lipase activator activity (GO:0060229),0.6433522157401612,1.228511377327135,0.25892857142857145,1.0,1.0,4/10,15.30%,ARHGAP6;PDPK1;BTK;SRC
prerank,carboxy-lyase activity (GO:0016831),0.5740997351819122,1.2273010860292348,0.2620519159456119,1.0,1.0,2/23,3.64%,ACMSD;GGCX
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.5892030193723314,1.2237242538683797,0.2710997442455243,1.0,1.0,1/18,0.70%,BIRC5
prerank,voltage-gated sodium channel activity (GO:0005248),-0.3881869376672073,-1.2222946292198178,0.18,0.5935227783258882,1.0,10/22,32.32%,HCN1;SCN1A;SCN9A;SCN3A;SCN8A;SCN1B;SCN4B;CACNA1H;CACNA1I;SCN3B
prerank,calcium-release channel activity (GO:0015278),0.5859546472420195,1.2169858542147174,0.2654494382022472,1.0,1.0,8/17,16.20%,RASA3;ITPR1;TRPA1;TPCN1;TRPM2;ITPR3;PKD2;TPCN2
prerank,poly-purine tract binding (GO:0070717),0.5516106620850821,1.2162128707582123,0.2766990291262136,1.0,1.0,15/27,16.12%,PABPC4;PATL1;KHDRBS1;FMR1;RBMS2;HNRNPU;RBMS3;ATXN1;RBMS1;LARP4;DAZAP1;PABPC1;ZC3H14;DDX1;PNPT1
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.5531892708611703,1.2161560917776428,0.27014218009478674,1.0,1.0,9/31,14.62%,UBE2T;UBE2C;UBE2S;UBE2K;UBE2N;UBE2R2;UBE2J1;UBE2QL1;BIRC6
prerank,peptidoglycan binding (GO:0042834),-0.5021963769379696,-1.2132463218237062,0.24758842443729903,0.6072162432860557,1.0,3/10,15.31%,NOD1;HK1;PGLYRP1
prerank,MAP kinase kinase activity (GO:0004708),-0.4390628927868093,-1.2118195494745891,0.2210144927536232,0.6020048729550992,1.0,4/15,3.69%,MAPK10;MAP2K6;PAK3;MAP2K5
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.5497234770530086,1.2115627731495615,0.26951219512195124,1.0,1.0,12/28,23.79%,FADD;TRIM37;CASP8AP2;EDA;RIPK1;TRAF6;TRAF2;FEM1B;TRAF4;DAB2IP;BID;BABAM2
prerank,protein phosphatase 1 binding (GO:0008157),-0.38015238074523117,-1.2099531964369667,0.20095693779904306,0.5990210160675918,1.0,7/21,22.51%,PPP1R16B;SHOC2;PPP1R3B;SH3RF2;PPP1R11;KCNQ1;PPP1R3C
prerank,death receptor binding (GO:0005123),0.589070882908623,1.2097553428884782,0.2775453277545328,1.0,1.0,8/15,23.49%,FADD;CASP8AP2;EDA;NGF;RIPK1;FEM1B;DAB2IP;BID
prerank,3'-5' exonuclease activity (GO:0008408),0.533733702340858,1.208409673990497,0.2663706992230855,1.0,1.0,20/45,21.39%,PNLDC1;ERI2;RAD1;CNOT6L;MRE11;POLD1;EXD1;ERI1;CNOT6;EXOSC7;ERI3;CNOT7;PNPT1;ANGEL2;EXOSC10;RAD50;XRN2;PAN2;DIS3;TRIR
prerank,protein heterodimerization activity (GO:0046982),0.5051335500375235,1.2042447578753375,0.15646940822467403,1.0,1.0,35/178,16.64%,TOP2A;BARD1;SAE1;SMC1A;AURKA;SMC3;ADD2;TPM4;BHLHE41;SNX1;BMP6;TCF4;FMR1;ZHX2;SIM1;BDKRB2;CYBB;IKBKG;NR4A2;BOK;GTF2A1;AHR;ZHX3;MICU1;NR4A1;ARNT;ITGB1;VAPA;FXR1;KCNB2;ADD1;TP53;GABBR2;METTL3;ARNT2
prerank,U6 snRNA binding (GO:0017070),0.589833199164881,1.1969518996718467,0.2808988764044944,1.0,1.0,8/14,19.18%,LSM3;DDX39B;TUT1;LSM2;LSM7;LSM4;PRPF4;LARP7
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.541100735623475,1.1959829286547217,0.27537922987164526,1.0,1.0,9/34,14.62%,UBE2T;UBE2C;UBE2S;UBE2K;UBE2N;UBE2R2;UBE2J1;UBE2QL1;BIRC6
prerank,insulin-like growth factor binding (GO:0005520),-0.42319278505307645,-1.1896165914139551,0.23703703703703705,0.641014355484759,1.0,5/15,13.87%,ITGA6;INSR;ITGB4;IGFBP4;IGF2R
prerank,SUMO binding (GO:0032183),0.5879654079943444,1.1849084826279133,0.29827089337175794,1.0,1.0,8/13,23.59%,CASP8AP2;SERBP1;PML;HERC2;SIMC1;RNF111;UBA2;USP25
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",-0.4219777361480315,-1.1845282597539066,0.23404255319148937,0.6450362575617411,1.0,9/16,45.40%,PIR;ETHE1;ALOX12;ADI1;BCO2;HGD;ALOXE3;HAAO;ALOX5
prerank,histone acetyltransferase activity (GO:0004402),0.5435519998099262,1.1831601798649114,0.3068720379146919,1.0,1.0,17/30,24.06%,BRCA2;HAT1;EPC2;ARRB1;SRCAP;EPC1;TADA2A;MCM3AP;BAZ1A;KAT6A;TAF10;NAA60;NAA40;CLOCK;NAA50;KAT2A;ATF2
prerank,metal ion transmembrane transporter activity (GO:0046873),0.5477532471781827,1.1796634119870284,0.31456548347613217,1.0,1.0,6/27,10.56%,AQP1;ATP2B4;ITPR1;MAGT1;CNNM4;ATP2B1
prerank,voltage-gated ion channel activity (GO:0005244),-0.4347657749974402,-1.1796215014679805,0.2692307692307692,0.6488414255673057,1.0,4/14,9.25%,HCN1;ANO6;GPR89B;GPR89A
prerank,metallopeptidase activity (GO:0008237),0.49048311455406635,1.178973460356015,0.2535641547861507,1.0,1.0,23/113,14.29%,KEL;BMP1;MMP25;MMP24;MMP28;MMP14;ADAM12;TRABD2B;NLN;ADAMTS10;ADAMTS5;ADAMTS14;ADAMTS9;ADAMTSL2;PSMD14;ADAMTS2;ADAMTS16;ADAM17;ADAM19;ADAMTSL3;ADAM9;ADAMTS1;BRCC3
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.29039866949984716,-1.1779041494559312,0.14814814814814814,0.6451943499293209,1.0,25/57,24.81%,COX4I1;COX5A;NDUFS5;NDUFS1;NDUFA9;NDUFB4;NDUFV3;NDUFC2;NDUFS3;NDUFB3;NDUFS4;NDUFA5;NDUFA6;NDUFA4;NDUFB9;UQCR10;UQCRQ;COX8A;NDUFB6;NDUFB10;NDUFA10;COX5B;NDUFS6;UQCRC1;NDUFA1
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.5990634263564019,1.1777921224389214,0.290519877675841,1.0,1.0,5/11,12.31%,RASA3;ITPR1;TRPA1;TRPM2;ITPR3
prerank,transcription cis-regulatory region binding (GO:0000976),0.4940808967870855,1.1762757483552209,0.108,1.0,1.0,84/406,16.00%,BRCA1;E2F7;E2F8;UHRF1;E2F2;CDK5RAP2;GLI3;RBL1;HMGB2;E2F1;ZBTB8A;ZFP69;RB1;SP3;SETX;ETV6;ZFP41;TWIST2;TEAD1;CTCF;E2F3;AGO2;TFDP1;NFE2;BCOR;ACTN4;RFXAP;CUX1;NFIL3;ZNF568;TBL1XR1;TCF7L2;SOX6;GRHL2;PSPC1;ELK1;ZBTB7B;SIM1;FOXO3;IRF1;LMX1B;SMAD6;BNC2;YAP1;ZFP90;KLF11;NONO;ARID4A;NFYA;ZBTB20;PLAGL1;LONP1;HMGB1;NR3C1;SFPQ;TAL1;HNRNPL;HDAC1;TBX18;AHR;NKX2-1;TAF4;RORA;STOX1;KMT2D;SMAD4;SOX9;ATF5;TWIST1;YY1;FOXK2;POU2F2;ARNT;SMAD3;FOXM1;PER1;RBAK;ATF1;RUNX1;DR1;NFKB1;ZNF25;DRAP1;TP53
prerank,ubiquitin-protein transferase activity (GO:0004842),0.4956847363537771,1.1752944147534012,0.134,1.0,1.0,67/346,14.73%,DTL;BRCA1;NEURL1B;UHRF1;TRIML2;BARD1;UBE2T;UBE2C;UBE2S;RFWD3;RNF168;TRIM37;BRAP;PDZRN3;RNF220;UBE2K;BCOR;UHRF2;MYCBP2;NEDD4;UBR4;SIAH2;RNF43;FANCL;TRIM59;PML;UBE2N;RNFT2;CUL5;PRPF19;MEX3C;RC3H2;RNF31;UBR5;RNF40;VPS18;TRIM28;SMURF1;UBE2R2;CUL3;SH3RF1;CUL4B;OBI1;RNF145;HERC2;SMURF2;TRIM63;FBXW11;TRIP12;TRIM6;ITCH;RNF121;UBE2J1;IRF2BP1;ZNRF2;BTRC;FBXO25;FBXO27;XIAP;HLTF;RC3H1;UBE2QL1;TRIM5;RNF114;BIRC6;ZNRF1;ZFP91
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",-0.39029138407435315,-1.170870842715004,0.256,0.6550491333943176,1.0,17/18,61.01%,DHRS11;HSD17B7;HSD17B8;HSD11B1;HSD17B10;HSD17B2;HSD3B7;HSD17B14;HSD17B1;SRD5A2;HSD3B2;AKR1C1;DHRS9;RDH16;HSD17B6;HSD17B3;RDH5
prerank,titin binding (GO:0031432),-0.44463978914723273,-1.169641605533137,0.2604166666666667,0.6506587914426847,1.0,2/13,2.13%,CAMK2D;CALM1
prerank,5'-nucleotidase activity (GO:0008253),-0.434836655669614,-1.1692119477230667,0.2508250825082508,0.644040891468871,1.0,6/13,30.12%,NT5M;NT5C3B;NT5DC1;NT5C3A;NT5DC3;NT5C1A
prerank,syntaxin binding (GO:0019905),-0.300670008579103,-1.1675536241064677,0.20588235294117646,0.640390475716914,1.0,25/61,21.26%,UNC13B;STX8;STXBP5L;SNAP47;NAPG;SYT1;STX7;STX6;SYNPR;VPS11;SNPH;ABL1;SNAP29;SYT12;CPLX1;SNAP25;VAMP8;VAMP3;SYPL1;SYT10;RAB11A;SYT6;VPS52;VAMP1;SYT2
prerank,sequence-specific DNA binding (GO:0043565),0.4913409338701229,1.1673470076528778,0.063,1.0,1.0,99/590,14.18%,E2F7;E2F8;NR2E3;UHRF1;EN1;PIF1;E2F2;PBX4;GLI2;GLI3;TCFL5;E2F1;FOXE1;TERF1;CBFB;ZNF32;SP3;ZFP41;ELF2;TEAD1;ZSCAN29;SP2;CTCF;E2F3;HNRNPD;TFCP2L1;NFE2;STN1;MBD1;HIVEP1;CUX1;BHLHE41;KLF5;TCF7L1;SRF;ELF4;MAPT;KLF13;NFIB;MAEL;SP8;GZF1;TCF7L2;HOXC4;ELF1;GMEB1;TCF4;HOXA7;GRHL2;MYBL2;ELK1;RFX2;POU2F1;PRRX2;ZBTB2;POU3F2;ZBTB7B;FOXO3;OLIG2;KDM2B;ZNF23;LMX1B;PLAGL2;CREB5;KLF11;ZBTB20;ZIC5;LONP1;KMT2A;HOXB6;MEOX2;CXXC5;NR3C1;NR4A2;HNRNPU;XPA;TBX18;AHR;CPSF4;TERF2;RORA;ERH;ZIC4;RBPJ;NR4A1;SMAD4;SOX9;HDAC2;ATF5;ELK4;RARB;HEY2;SMG6;YY1;FOXK2;FOXL1;POU2F2;ARNT;SMAD3
prerank,metal ion binding (GO:0046872),0.48592983290104275,1.1660029654936093,0.094,1.0,1.0,71/477,13.10%,TOP2A;EFCAB11;MELK;PLK1;PIF1;PON1;FIGNL1;GEN1;CDH15;MAST2;LOXL2;SCUBE1;ADGRV1;PLSCR2;CDH18;CDH24;ANXA9;ANXA2;FBN1;NLK;ITPR1;PAM;TDP2;IDH3A;TPM4;PRNP;GSS;HPRT1;DYRK3;CDH4;RAP2A;NUDT5;STK3;ANXA3;PDXK;NDUFAB1;ANXA5;CABCOCO1;MAP3K20;ENPP2;HPGDS;CDC42BPA;PPP3CA;ENPP3;LRRK2;FKBP9;PGM1;ATP2A2;TPPP;PPA1;SLC8A1;MARK2;TKT;CDC42BPG;EYA2;ENPP1;TRPM2;CALM2;SRPK1;ANXA1;POSTN;CALB1;MICU1;ITPR3;TRPM4;MSH6;MAN1C1;SIK2;DUT;MEX3B;DXO
prerank,endonuclease activity (GO:0004519),0.5136758306766548,1.1620018639778151,0.30066079295154186,1.0,1.0,5/49,5.34%,ANKLE1;ZRANB3;AGO2;ERCC4;MRE11
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.45139256610500844,-1.1588022172968813,0.2852852852852853,0.653700700607427,1.0,5/11,37.61%,KCNJ3;KCNQ1;KCNJ8;KCNE4;KCNH2
prerank,cation:chloride symporter activity (GO:0015377),-0.4793777773267809,-1.1580111725234785,0.2839506172839506,0.6480348021966458,1.0,3/10,15.29%,SLC6A1;SLC12A9;SLC12A2
prerank,protein tyrosine kinase activity (GO:0004713),0.4876321065432003,1.1527818496856597,0.2802874743326489,1.0,1.0,13/108,7.76%,MELK;TTK;WEE1;MATK;DYRK1A;STYK1;BAZ1B;FGFR4;FGFR2;KIT;MUSK;PDGFRA;EPHA4
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.40416286408370883,-1.152681634248621,0.2743682310469314,0.6539251489210252,1.0,10/15,55.12%,CCR9;CMKLR1;CX3CR1;CCR5;CCR2;GPR17;CCRL2;CCR1;ACKR4;CCR6
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.515507493197069,1.1508954416771087,0.3258026159334126,1.0,1.0,14/33,21.20%,PNLDC1;ERI2;CNOT6L;ERI1;CNOT6;EXOSC7;ERI3;CNOT7;PNPT1;ANGEL2;EXOSC10;XRN2;PAN2;DIS3
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.4074035723210188,-1.1502797362040196,0.25752508361204013,0.6516522423923846,1.0,6/14,37.61%,KCNJ3;KCNQ1;KCNJ8;KCNE4;KCNIP2;KCNH2
prerank,leucine zipper domain binding (GO:0043522),0.5885851938833018,1.1459809966213637,0.35106382978723405,1.0,1.0,3/10,11.26%,PMF1;ERC1;MRTFA
prerank,lysine-acetylated histone binding (GO:0070577),0.5446033204534637,1.1457958445010636,0.3145780051150895,1.0,1.0,9/20,20.85%,BRD9;PHIP;SMARCA4;KMT2A;BRD4;MLLT3;PSME4;ATAD2B;TRIM24
prerank,acetylation-dependent protein binding (GO:0140033),0.5446033204534637,1.1457958445010636,0.3145780051150895,1.0,1.0,9/20,20.85%,BRD9;PHIP;SMARCA4;KMT2A;BRD4;MLLT3;PSME4;ATAD2B;TRIM24
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.5129159112754484,1.1456819361391695,0.34349355216881594,1.0,1.0,7/34,10.38%,RACGAP1;IQGAP2;GBF1;ZFYVE16;ZFYVE1;MAPKAP1;CYTH3
prerank,GTPase regulator activity (GO:0030695),0.4831710642027538,1.1437767761540287,0.22022022022022023,1.0,1.0,41/212,10.40%,IQGAP3;ECT2;RACGAP1;ARHGAP22;ARHGAP11A;USP6NL;IQGAP2;RGS12;GPSM2;ARHGAP10;ARHGAP28;ASAP1;DEPDC5;EVI5L;ACAP2;TBC1D25;ARHGAP18;OCRL;STXBP5;TBC1D13;ARRB1;CDC42EP2;TBC1D2B;ARHGAP24;ASAP2;LRRK2;SYDE2;ALDH1A1;ARHGAP19;GNAQ;TBC1D7;RGS3;CPEB2;RIC8B;LLGL2;NPRL3;RANGAP1;SRGAP2;ERRFI1;ARHGAP35;MYO9B
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.35705556869691335,-1.142653567164086,0.27896995708154504,0.6622826778474171,1.0,6/23,4.91%,KIF16B;PLEKHA5;WDR45B;CLVS1;SNX14;SNX3
prerank,E-box binding (GO:0070888),0.5162416415083539,1.1423210319516977,0.32407407407407407,1.0,1.0,9/34,17.61%,ATOH8;ZEB1;BHLHE41;TCF4;TAL1;AHR;TWIST1;PER1;TFAP4
prerank,nucleotidase activity (GO:0008252),-0.4063475983030466,-1.1418282455052935,0.2805755395683453,0.6569413564242265,1.0,6/15,23.64%,BPNT2;NT5M;NT5C3B;NT5DC1;NT5C3A;NT5DC3
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.5546784717887316,1.140677945860844,0.3337696335078534,1.0,1.0,6/18,14.13%,ANXA2;RAB10;ANXA1;PDLIM5;BAIAP2L1;TMOD3
prerank,vitamin D receptor binding (GO:0042809),0.5690529744320129,1.1406623445733948,0.33861671469740634,1.0,1.0,5/14,13.71%,MED14;THRAP3;MED30;MED24;MED1
prerank,lipid phosphatase activity (GO:0042577),-0.43030527285560727,-1.1404119660332457,0.2857142857142857,0.6530641907585585,1.0,5/14,20.92%,PLPPR1;PLPP3;INPP5K;EPHX2;PLPPR4
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.34272852077723803,-1.1402400428745914,0.2222222222222222,0.646360370749792,1.0,8/27,19.50%,SLC22A8;ANO1;SLC22A6;SLC5A5;SLC26A11;SLC25A11;SLC26A2;LRRC8A
prerank,calcium-activated potassium channel activity (GO:0015269),0.5751926825283815,1.1390718343144963,0.3249258160237389,1.0,1.0,4/11,14.58%,KCNN4;KCNMB2;KCNMB3;KCNMB4
prerank,signal sequence binding (GO:0005048),0.5171345744498738,1.138688416360786,0.33727810650887574,1.0,1.0,4/35,5.08%,KPNA2;KPNA3;BRAP;TNPO1
prerank,dynactin binding (GO:0034452),0.5701683034487615,1.1368189308697598,0.3383977900552486,1.0,1.0,3/12,6.76%,GSK3B;MAPT;BICD2
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.5729588167435151,1.1351953016132392,0.34502923976608185,1.0,1.0,4/12,18.04%,AIFM2;NQO1;CRYZL1;DHRS4
prerank,ion gated channel activity (GO:0022839),-0.3604805534718907,-1.1339857488053582,0.2708333333333333,0.6542639961119016,1.0,9/24,15.68%,ANO3;ANO6;ANO1;ANO10;TMEM63B;ANO4;KCNT1;TTYH2;TTYH3
prerank,sodium channel activity (GO:0005272),-0.31529285699183984,-1.130150741238812,0.226890756302521,0.657041867483491,1.0,10/37,21.01%,GRIK1;HCN1;SCN1A;GRIK4;SCN9A;SCN3A;SCN8A;SCN1B;KCNK1;GRIK2
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.5666366377415735,1.1294965227289366,0.345578231292517,1.0,1.0,7/14,19.87%,RPP40;TSEN34;POP1;RPP30;TSEN2;PRORP;RPP21
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.5168294676233607,1.127936821119075,0.35336538461538464,1.0,1.0,10/29,17.54%,CIT;CDKN2D;CDKN2C;PKIG;SPRED1;CDKN1B;RPTOR;SPRED2;PRKAR2B;PRKAR2A
prerank,fibroblast growth factor binding (GO:0017134),0.5248984313358896,1.125255772552275,0.3473282442748092,1.0,1.0,4/21,9.18%,CEP57;FGFR4;FGFR2;FGFRL1
prerank,single-stranded RNA binding (GO:0003727),0.4948857145683634,1.1248063383855416,0.3407079646017699,1.0,1.0,12/43,15.68%,DDX11;ILF3;AGO2;DHX9;HNRNPA1;EIF4H;FMR1;LONP1;HNRNPU;STRBP;AQR;FXR1
prerank,neuropeptide receptor activity (GO:0008188),-0.33007571476503683,-1.1240555014035714,0.24516129032258063,0.6652559497794758,1.0,5/29,10.66%,SORCS3;SORCS1;GPR37;OPRM1;HCRTR2
prerank,ATPase activator activity (GO:0001671),-0.36682005085919855,-1.1169258233275923,0.30414746543778803,0.6753950840691305,1.0,5/20,8.41%,ATP1B1;DNAJC24;DNAJC19;DNAJA1;ATP1B3
prerank,chloride channel inhibitor activity (GO:0019869),-0.452197750045616,-1.1168780540553904,0.35919540229885055,0.6685258377126242,1.0,3/10,5.02%,STX8;STX7;WNK2
prerank,copper ion binding (GO:0005507),0.4925735715272853,1.1161825712139426,0.36310904872389793,1.0,1.0,10/42,17.26%,LOXL3;LOXL2;PAM;PRNP;SOD3;TYR;COA6;TP53;LACC1;CCS
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.4807567528247618,1.1157557435657315,0.3490364025695932,1.0,1.0,12/69,16.84%,ESCO2;CERS6;CERS5;SOAT1;PORCN;ZDHHC18;SOAT2;ZDHHC15;HHAT;KAT6A;ZDHHC3;ZDHHC21
prerank,purinergic nucleotide receptor activity (GO:0001614),0.5562265130840631,1.1152524834603037,0.34668508287292815,1.0,1.0,2/15,10.38%,GPR171;P2RY1
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.5474583869182609,1.1105977061444308,0.34864864864864864,1.0,1.0,3/15,8.59%,ALDH3A1;ALDH1A2;ALDH1A1
prerank,receptor tyrosine kinase binding (GO:0030971),-0.27092914535641943,-1.1092499158136524,0.208955223880597,0.6805861579023591,1.0,19/56,18.94%,NRG3;GRB14;GAS6;SQSTM1;PIK3R1;DUSP3;SOCS5;TOB1;IRS1;FLT3LG;ANGPT2;PTPN14;SHC1;ELMO2;FIZ1;CBLB;SHC4;CBL;SHC3
prerank,symporter activity (GO:0015293),-0.46375948127742683,-1.1064522237838055,0.3244047619047619,0.6802985852759608,1.0,3/10,23.01%,SLC5A6;SLC5A5;MFSD2A
prerank,pseudouridine synthase activity (GO:0009982),-0.4122679436981713,-1.1063332718216978,0.32792207792207795,0.6738133359852817,1.0,11/13,45.58%,PUS10;TRUB1;DKC1;PUS3;RPUSD4;PUS1;PUS7L;RPUSD1;PUSL1;RPUSD2;RPUSD3
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.4548449606985618,-1.1061342995567707,0.3488372093023256,0.6675164295022596,1.0,5/10,17.97%,PIK3R3;PIK3C2B;ATM;PIK3CD;PIK3CA
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.4620406450985136,1.1049580175969387,0.207,1.0,1.0,77/431,12.45%,KIF14;KIFC1;PLK1;PIF1;TRIP13;SMC4;RAD51;RANBP17;TUBB6;MAST2;HASPIN;TUBA1C;RRM1;MAP4K4;KSR1;STK17B;MCM6;BMPR1A;TUBE1;RTEL1;RHOA;MTHFD1L;MAP4K2;GCK;RAB10;NLK;CARS2;RRAD;DHX9;PMVK;GSS;SARS2;BLM;DYRK3;RHOT1;RAP2A;STK3;MYH10;PDXK;ATL2;WNK1;MAP3K20;ATL3;CDC42BPA;RAB22A;RAB29;RASEF;TUBD1;LRRK2;GUK1;DARS2;ABCF3;RHOQ;DNM2;LONP1;PIM1;PPIP5K1;MARK2;PXK;TGFBR1;P2RY1;MYO9B;CDC42BPG;HNRNPU;ENPP1;ABCA1;DRG1;SRPK1;PRPS1L1;PRPS1;TWF1;RAC1;RND2;TSR1;RRAS;SEPHS1;MSH6
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.5544059576107466,1.1036181247052934,0.3680456490727532,1.0,1.0,6/14,16.13%,MTMR14;MTMR1;MTMR2;MTMR9;MTMR3;PTEN
prerank,thyroid hormone receptor binding (GO:0046966),0.5099485506376404,1.0993007892472546,0.38674698795180723,1.0,1.0,12/28,20.19%,TRIP6;THRAP3;MED30;MED24;ZNHIT3;TRIP12;MED1;JMJD1C;BRD8;ARID5A;MED16;GTF2B
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.42209089674303085,-1.097416396174573,0.3708609271523179,0.6819914182171303,1.0,7/13,20.79%,PIP4K2A;PIP4K2B;PIK3C2B;PIP5K1A;PIK3CD;PIK3CA;PIP4K2C
prerank,semaphorin receptor binding (GO:0030215),-0.3538458965127902,-1.094851319808375,0.32727272727272727,0.681319439937749,1.0,17/23,38.76%,SEMA6A;SEMA6D;SEMA7A;SEMA4D;SEMA3A;SEMA3B;SEMA3C;SEMA5B;RIT2;SEMA6C;SEMA3G;SEMA4C;SEMA4A;SEMA4G;SEMA3E;SEMA3F;SH3BP1
prerank,H4 histone acetyltransferase activity (GO:0010485),0.5744365573874152,1.094394620293736,0.3826219512195122,1.0,1.0,3/10,8.89%,BRCA2;HAT1;MSL3
prerank,actinin binding (GO:0042805),0.5188142193076902,1.09372960298302,0.37755102040816324,1.0,1.0,8/21,15.93%,CSRP2;PDLIM4;CACNA1C;PDLIM5;SYNPO2;PKD2;NFKB1;CSRP3
prerank,pre-mRNA binding (GO:0036002),0.49613710124274985,1.0934361475531433,0.373639661426844,1.0,1.0,8/28,13.57%,TRA2B;HNRNPA1;SLBP;ERI1;CELF2;HNRNPU;HNRNPL;RBM4
prerank,insulin-like growth factor I binding (GO:0031994),-0.4095029927250706,-1.0927640665683427,0.375,0.6795692560137391,1.0,4/13,13.10%,ITGA6;INSR;ITGB4;IGFBP4
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.5262655791236379,1.0919821833296648,0.38767650834403083,1.0,1.0,7/20,14.82%,MAGI3;CASK;GUK1;DTYMK;TJP2;DLG1;AK7
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.5536853810283962,1.0914476282420236,0.3753623188405797,1.0,1.0,5/12,11.07%,TENT2;TENT4A;TUT1;PAPOLB;TENT5D
prerank,calcium channel regulator activity (GO:0005246),-0.30185429678402986,-1.0901959425242003,0.29936305732484075,0.6792789812459218,1.0,13/37,21.17%,PRKG1;CALM1;FKBP1A;SGK1;CACNG7;NRXN1;CACNG4;SLC30A1;SRI;CACNG8;INAFM1;REM1;PACSIN3
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.5413893080348645,1.088523685505552,0.3949930458970793,1.0,1.0,6/16,16.13%,MTMR14;MTMR1;MTMR2;MTMR9;MTMR3;PTEN
prerank,adenylate cyclase binding (GO:0008179),-0.4422279448697738,-1.0884540963003946,0.3482142857142857,0.6766675409697205,1.0,3/10,6.53%,CALM1;AKAP6;CAP1
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.5439817061025605,1.08803849097637,0.36694677871148457,1.0,1.0,2/14,5.42%,RDH11;RDH12
prerank,actin binding (GO:0003779),0.4564783672728946,1.0825541687018418,0.3691073219658977,1.0,1.0,47/170,17.85%,KIF18A;GAS2L3;ANLN;VASH2;IQGAP2;SYNE2;MACF1;SPTB;PARVA;ACTN4;ADD2;SPEF1;PDLIM4;SLC6A2;MAPT;SSH2;MLPH;MYH10;CXCR4;MICAL3;PHACTR1;LRRK2;EPS8L1;EMD;MYO9B;HNRNPU;SMTN;CAPZA1;MRTFA;TWF1;PHACTR2;EZR;PDLIM5;DMTN;SYNPO2;PRKCE;TLN2;ITGB1;LCP1;DBN1;ADD1;PLEKHH2;VPS16;TNNT3;COBL;SHROOM2;TRPV4
prerank,tau protein binding (GO:0048156),-0.30755308737903664,-1.0767065026549842,0.288135593220339,0.6966448361128447,1.0,12/40,7.68%,EP300;MARK3;HSP90AB1;ACTB;APOE;TAOK2;BIN1;BRSK1;PRKAA1;PPP2CB;LGMN;MAP1A
prerank,phosphatase binding (GO:0019902),0.4500061197617384,1.075541833758599,0.3748723186925434,1.0,1.0,30/105,18.54%,NEK2;CEP192;MAST2;ANAPC7;KCNN4;CDC27;PDLIM4;RPA2;WNK1;ANK1;MTMR9;EIF2AK3;AP3B1;CHCHD3;SPRED1;DLG1;CDKN1B;SMAD3;MTMR3;TP53;ANAPC5;PPP3R1;SIRPA;MVP;PPME1;SMAD2;TERF2IP;MAPK14;BAD;KIFAP3
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.3838402792514196,-1.07405879476898,0.3786764705882353,0.6967088610592166,1.0,3/15,4.91%,PLA2G4A;PLEKHA5;SNX3
prerank,GTPase activator activity (GO:0005096),0.4510361377068969,1.072591860385901,0.342,1.0,1.0,60/313,10.85%,IQGAP3;ECT2;RACGAP1;ARHGAP22;PCP2;ARHGAP11A;USP6NL;IQGAP2;RANGRF;DENND2C;ARHGAP10;FNIP1;ARHGAP28;ASAP1;RCBTB2;DEPDC5;EVI5L;MYCBP2;ACAP2;TBC1D25;ARHGAP18;DENND4C;OCRL;STXBP5;TBC1D13;FGD4;DNMBP;EIF2B1;DENND2A;ARRB1;VAV2;CDC42EP2;TBC1D2B;FGD1;ARHGAP24;ASAP2;LRRK2;ANKRD27;RAB3IL1;SYDE2;ALDH1A1;ARHGAP19;GNAQ;TBC1D7;FARP1;RGS3;RIC8B;LLGL2;EPS8L1;DENND5A;NPRL3;RANGAP1;SRGAP2;ERRFI1;ARHGAP35;CYTH3;MYO9B;HERC2;FGD6;RAPGEF4
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.5402694997497882,1.069794029478915,0.3814147018030513,1.0,1.0,3/13,8.59%,ALDH3A1;ALDH1A2;ALDH1A1
prerank,LRR domain binding (GO:0030275),0.5333796986038952,1.0694801486090963,0.4050073637702504,1.0,1.0,4/14,11.26%,PMF1;ROBO1;ERC1;MRTFA
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.4937911496169216,1.0680054511446375,0.3863080684596577,1.0,1.0,5/27,7.55%,PRIM1;POLR1A;PRIMPOL;POLR1B;POLR2A
prerank,ubiquitin protein ligase activity (GO:0061630),0.4490877029621982,1.064557511444402,0.3691073219658977,1.0,1.0,47/228,15.89%,NEURL1B;UHRF1;TRIML2;RFWD3;TRIM37;BRAP;PDZRN3;RNF220;UBE2K;UHRF2;MYCBP2;NEDD4;UBR4;SIAH2;RNF43;FANCL;TRIM59;RNFT2;PRPF19;MEX3C;RC3H2;UBR5;VPS18;SMURF1;CUL3;SH3RF1;RNF145;HERC2;SMURF2;UBOX5;TRIM63;TRIP12;TRIM6;ITCH;RNF121;IRF2BP1;ZNRF2;FBXO27;XIAP;HLTF;RC3H1;TRIM5;RNF114;ZNRF1;FBXO17;NSMCE1;ASB2
prerank,vinculin binding (GO:0017166),0.5497184163241147,1.0605508629814602,0.40883190883190884,1.0,1.0,4/11,11.62%,CTNNA1;SORBS3;TLN1;SYNM
prerank,mRNA 3'-UTR binding (GO:0003730),0.44870183780686584,1.0600082919566813,0.4194560669456067,1.0,1.0,26/79,16.00%,ILF3;PABPC4;LARP4B;SERBP1;FMR1;YBX3;RBMS2;RNF40;CELF2;LARP1;TUT1;CPEB2;PUM2;HNRNPU;RBMS3;MEX3D;RBMS1;RBM4;LARP4;DAZAP1;RC3H1;PABPC1;SECISBP2;HNRNPA2B1;FXR1;TP53
prerank,voltage-gated calcium channel activity (GO:0005245),-0.29333484944091615,-1.0574699808794708,0.3709677419354839,0.7298501833826196,1.0,13/37,19.38%,CACNA2D1;CACNG7;CACNA1B;CACNG4;OPRM1;NCS1;CACNB2;CACNG2;CACNG3;CACNG8;CACNB1;CACHD1;CACNA2D2
prerank,phospholipase activity (GO:0004620),-0.2508157182616107,-1.0567660418868532,0.3114754098360656,0.7246869484749251,1.0,11/67,9.50%,PLA2G4A;PLAAT3;ABHD6;ABHD12;PNPLA6;ABHD16A;LYPLA1;PLCB3;PNPLA8;PLD3;GPLD1
prerank,protein tyrosine kinase binding (GO:1990782),-0.25204944427249365,-1.0534440277325543,0.35555555555555557,0.7266502954932174,1.0,24/71,18.94%,NRG3;ACVR1;GRB14;BMPR2;NEDD9;GAS6;SQSTM1;CDH5;DUSP3;DUSP22;SOCS5;TOB1;FLT3LG;GRM5;ANGPT2;PTPN14;PTPN11;SHC1;ELMO2;FIZ1;CBLB;SHC4;CBL;SHC3
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),-0.23568839899244948,-1.0504334893975429,0.3225806451612903,0.7270520422877519,1.0,30/91,21.23%,KIF16B;PLEKHA5;KRIT1;ADAP2;WDR45B;STXBP6;CLVS1;SNX14;SNX3;KCNH1;TTPAL;SNX21;LAPTM4B;SYT7;SYTL2;PFN1;GSN;VILL;HIP1;LDLRAP1;SDCBP;RPH3A;FCHO2;COMMD1;EXOC1;KCNQ1;RAB35;TIRAP;AVIL;OSBPL2
prerank,histone deacetylase activity (GO:0004407),0.4970409175736108,1.0496627277738566,0.42578125,1.0,1.0,9/19,22.00%,MIER1;MIER3;HDAC8;HDAC1;HDAC2;MIER2;HDAC4;SIRT2;SIRT3
prerank,Notch binding (GO:0005112),-0.3328120602606192,-1.0475952698660835,0.37264150943396224,0.726897702580011,1.0,9/22,20.44%,DNER;SNED1;JAG1;KCTD10;DTX1;JAG2;NOTCH4;SNW1;HIF1AN
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.440305020974971,1.0463894266941265,0.333,1.0,1.0,123/732,14.89%,E2F7;E2F8;NR2E3;UHRF1;MXD3;EN1;E2F2;MYBL1;PBX4;GLI2;GLI3;TCFL5;HMGB2;E2F1;FOXE1;ATOH8;ZNF32;PBX3;SP3;HOXC5;TEAD1;ZSCAN29;SP2;ZEB1;CTCF;E2F3;TFCP2L1;NFE2;ZNF260;HIVEP1;NFIA;DHX9;WIZ;ZFP62;NFIL3;BHLHE41;KLF5;TCF7L1;SRF;ELF4;CCAR1;THRAP3;ZNF568;KLF13;NFIB;ZNF697;SP8;IKZF1;GZF1;TCF7L2;HOXC4;SOX6;ELF1;GMEB1;TCF4;HOXA7;GRHL2;GLIS3;MYBL2;ELK1;RFX2;POU2F1;PROX2;MXD1;PRRX2;ZBTB2;POU3F2;ZBTB7B;FOXO3;OLIG2;IRF1;ZNF23;CREB5;KLF11;HOXB3;ZBTB25;NFYA;ZBTB20;PLAGL1;ZIC5;HOXB6;TEAD3;MEOX2;CARF;NR3C1;NR4A2;MYPOP;HNRNPU;KCNIP3;TAL1;ZBTB24;HDAC1;CHD2;TBX18;AHR;ZNF585B;ZNF585A;KLF9;NKX2-1;RORA;ZIC4;RBPJ;ZNF496;NR4A1;SMAD4;SOX9;ZNF394;ELK4;RARB;HEY2;YY1;FOXK2;FOXL1;POU2F2;ARNT;SMAD3;FOXP4;DNMT3A;RUVBL2;E2F4;SOX1;ZNF445;PER1
prerank,channel activity (GO:0015267),0.4627881668576786,1.0462752569110434,0.41824249165739713,1.0,1.0,6/41,12.23%,AQP1;TRPA1;PDPN;MCUB;SLC14A1;CHRNB1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.541475994123418,1.0398690746984112,0.43154761904761907,1.0,1.0,3/10,17.14%,ADA;CDA;LACC1
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.4375538060086268,1.0386074836958668,0.4258517034068136,1.0,1.0,46/232,15.89%,NEURL1B;UHRF1;TRIML2;RFWD3;TRIM37;BRAP;PDZRN3;RNF220;UHRF2;MYCBP2;NEDD4;UBR4;SIAH2;RNF43;FANCL;TRIM59;RNFT2;PRPF19;MEX3C;RC3H2;UBR5;VPS18;SMURF1;CUL3;SH3RF1;RNF145;HERC2;SMURF2;TRIM63;NSMCE2;TRIP12;TRIM6;ITCH;RNF121;IRF2BP1;ZNRF2;FBXO27;XIAP;HLTF;RC3H1;TRIM5;RNF114;ZNRF1;FBXO17;NSMCE1;ASB2
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.5196654032117354,1.0359398706900629,0.41316526610644255,1.0,1.0,5/12,18.50%,CASP8AP2;APAF1;CTSH;BCL2L13;BAD
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.43381577651729486,1.030569978404388,0.44144144144144143,1.0,1.0,41/188,16.00%,BRCA1;CDK5RAP2;HMGB2;CTCF;LIN54;BCOR;DHX9;ZNF568;TBL1XR1;TCF7L2;SOX6;PSPC1;ELK1;FOXO3;IRF1;SMAD6;BNC2;YAP1;KLF11;NONO;ARID4A;NFYA;ZBTB20;HMGB1;SFPQ;TAL1;HNRNPL;TBX18;AHR;NKX2-1;KMT2D;SMAD4;ATF5;YY1;FOXK2;POU2F2;SMAD3;PER1;RUNX1;NFKB1;TP53
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.3888162781101293,-1.0304670204004702,0.40893470790378006,0.7629659151109838,1.0,6/13,20.56%,IL1R1;PDGFRB;PDGFD;VEGFA;VEGFD;ITGB3
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.4225480381537407,-1.0299146570214162,0.42329545454545453,0.7575681674779509,1.0,6/10,25.82%,DPP9;DPP8;PRCP;DPP10;FAP;DPP3
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.5328525098816241,1.0294413686847923,0.4479315263908702,1.0,1.0,3/12,8.24%,AGO2;EIF4E;LARP1
prerank,aspartic-type endopeptidase activity (GO:0004190),0.5140944174658943,1.0293076687377778,0.4446064139941691,1.0,1.0,2/12,7.85%,CTSE;SPPL2B
prerank,ribonuclease P activity (GO:0004526),0.5307336356352663,1.0291351403018305,0.44573082489146165,1.0,1.0,5/11,19.87%,RPP40;POP1;RPP30;PRORP;RPP21
prerank,poly(A) binding (GO:0008143),0.4767322884098247,1.0242208610471366,0.43198992443324935,1.0,1.0,10/21,15.79%,PABPC4;KHDRBS1;RBMS2;HNRNPU;RBMS3;RBMS1;LARP4;PABPC1;ZC3H14;DDX1
prerank,Hsp70 protein binding (GO:0030544),-0.29519794525582344,-1.0225913861473386,0.38235294117647056,0.7693894329819256,1.0,12/31,24.47%,PRKN;DNAJA1;GPR37;PACRG;STUB1;DNAJC18;METTL21A;PPEF2;DNAJB12;RPS3;TSC1;HIKESHI
prerank,death receptor activity (GO:0005035),-0.4013350650211357,-1.0217366659088387,0.43130990415335463,0.7647661704645444,1.0,4/11,11.67%,TNFRSF19;FAS;TNFRSF11A;TNFRSF1B
prerank,chemokine binding (GO:0019956),0.46115212329495114,1.019732635039961,0.4417767106842737,1.0,1.0,6/30,15.01%,PLP2;PDPN;CXCR4;HMGB1;ITGB1;ITGAV
prerank,bHLH transcription factor binding (GO:0043425),0.487171700526157,1.0192534489901384,0.45984455958549225,1.0,1.0,4/19,14.18%,FHL2;BHLHE41;TWIST1;SMAD3
prerank,myosin binding (GO:0017022),0.4460146270575211,1.0179192602102476,0.46601941747572817,1.0,1.0,10/55,9.48%,TRIOBP;TRAK1;RHOA;KIRREL1;RAB10;STXBP5;MLPH;CXCR4;SPATA6;LLGL2
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.42689429854522976,1.017330143142947,0.475,1.0,1.0,49/269,14.18%,BRCA1;CCNB1;UBE2T;UBE2C;RAD18;SMC6;TRIM37;RB1;TRIOBP;GSK3B;UBE2K;DDRGK1;GPI;NLK;CHEK2;FAF1;CXCR4;RPA2;SLF1;FANCL;ARRB1;FBXW7;PML;UBE2N;CUL5;POLR2A;RNF31;STAM;RNF40;TRIM28;MFN2;SMAD6;CUL3;AXIN2;CUL4B;PSMD1;IKBKG;HERC2;PARP9;UBOX5;ARRDC1;BAG5;SUMO2;CASP8;ITCH;UBE2J1;SPOP;HLTF;SMAD3
prerank,flavin adenine dinucleotide binding (GO:0050660),0.44428943017542116,1.0154191954243879,0.4692982456140351,1.0,1.0,14/53,15.05%,AIFM2;DPYD;MTHFR;XDH;MICAL3;AGPS;QSOX1;NOX4;CYBB;SQOR;KMO;GFER;ACADL;CYB5R1
prerank,fatty acid synthase activity (GO:0004312),-0.42487302294078655,-1.0146040983596163,0.4411764705882353,0.7757875389650394,1.0,6/10,34.37%,ELOVL7;ELOVL6;CBR4;ELOVL1;OXSM;MCAT
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.4268892220199143,1.0139049632601247,0.452,1.0,1.0,149/831,16.00%,E2F7;E2F8;NR2E3;MXD3;EN1;E2F2;MYBL1;PBX4;GLI2;GLI3;TCFL5;RBL1;E2F1;FOXE1;ATOH8;ZBTB8A;ZFP69;ZNF32;PBX3;RB1;SP3;HOXC5;ETV6;ZFP41;TWIST2;TEAD1;ZSCAN29;SP2;ZEB1;CTCF;E2F3;TFDP1;TFCP2L1;NFE2;ZNF260;ACTN4;RFXAP;HIVEP1;NFIA;CUX1;DHX9;WIZ;ZFP62;NFIL3;BHLHE41;KLF5;TCF7L1;SRF;ELF4;CCAR1;THRAP3;ZNF568;KLF13;NFIB;ZNF697;SP8;IKZF1;GZF1;TCF7L2;HOXC4;SOX6;ELF1;GMEB1;TCF4;HOXA7;GRHL2;GLIS3;MYBL2;ELK1;RFX2;POU2F1;PROX2;MXD1;PRRX2;ZBTB2;POU3F2;ZBTB7B;SIM1;FOXO3;OLIG2;IRF1;ZNF23;LMX1B;ZFP90;CREB5;KLF11;HOXB3;ZBTB25;NFYA;ZBTB20;PLAGL1;ZIC5;HOXB6;TEAD3;MEOX2;CARF;NR3C1;NR4A2;MYPOP;HNRNPU;KCNIP3;TAL1;ZBTB24;HDAC1;CHD2;TBX18;GTF2A1;ZNF585B;ZNF585A;KLF9;NKX2-1;RORA;STOX1;ZIC4;RBPJ;ZNF496;NR4A1;SMAD4;SOX9;ZNF394;ATF5;ELK4;TWIST1;RARB;HEY2;YY1;FOXK2;FOXL1;POU2F2;ARNT;SMAD3;FOXP4;DNMT3A;RUVBL2;FOXM1;E2F4;SOX1;ZNF445;PER1;RBAK;ATF1;PKNOX2;RUNX1;NFKB1;HOXB7;ZNF112;ZNF25;ZBTB7C;TP53
prerank,phosphatase activator activity (GO:0019211),0.5114127906490837,1.0138114498596364,0.42796005706134094,1.0,1.0,6/14,20.20%,FRS2;PPP2R5C;CALM2;BMP2;PPP2R5B;PHACTR4
prerank,hexosaminidase activity (GO:0015929),0.5229268368256085,1.0104913628914243,0.4570596797671033,1.0,1.0,2/12,3.31%,SPAM1;HYAL1
prerank,exopeptidase activity (GO:0008238),-0.25899206514464695,-1.0095812624513743,0.42424242424242425,0.7819955787993682,1.0,12/50,14.52%,LNPEP;CPE;CTSZ;LAP3;ACE;METAP1D;ENPEP;CTSA;DPP9;DPP8;XPNPEP1;PRCP
prerank,retinoic acid receptor binding (GO:0042974),0.4834913587535145,1.0056529841382758,0.4536784741144414,1.0,1.0,7/17,20.59%,CNOT1;ACTN4;ASXL1;NR4A2;MED1;ARID5A;MED25
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.42296740253791765,1.004659803354069,0.503,1.0,1.0,130/731,16.00%,E2F7;E2F8;NR2E3;MXD3;EN1;E2F2;MYBL1;PBX4;GLI2;GLI3;TCFL5;E2F1;FOXE1;ATOH8;ZNF32;PBX3;SP3;HOXC5;TEAD1;ZSCAN29;SP2;ZEB1;CTCF;E2F3;TFCP2L1;NFE2;ZNF260;HIVEP1;NFIA;DHX9;WIZ;ZFP62;NFIL3;BHLHE41;KLF5;TCF7L1;SRF;ELF4;CCAR1;THRAP3;ZNF568;KLF13;NFIB;ZNF697;SP8;IKZF1;GZF1;TCF7L2;HOXC4;SOX6;ELF1;GMEB1;TCF4;HOXA7;GRHL2;GLIS3;MYBL2;ELK1;RFX2;POU2F1;PROX2;MXD1;PRRX2;ZBTB2;POU3F2;ZBTB7B;FOXO3;OLIG2;IRF1;ZNF23;CREB5;KLF11;HOXB3;ZBTB25;NFYA;ZBTB20;PLAGL1;ZIC5;HOXB6;TEAD3;MEOX2;CARF;NR3C1;NR4A2;MYPOP;HNRNPU;KCNIP3;TAL1;ZBTB24;HDAC1;CHD2;TBX18;AHR;ZNF585B;ZNF585A;KLF9;NKX2-1;RORA;ZIC4;RBPJ;ZNF496;NR4A1;SMAD4;SOX9;ZNF394;ELK4;TWIST1;RARB;HEY2;YY1;FOXK2;FOXL1;POU2F2;ARNT;SMAD3;FOXP4;DNMT3A;RUVBL2;E2F4;SOX1;ZNF445;PER1;ATF1;PKNOX2;RUNX1;NFKB1;HOXB7;ZNF112;ZBTB7C;TP53
prerank,nucleosomal DNA binding (GO:0031492),0.4718873414794077,1.0043072814406147,0.44710327455919396,1.0,1.0,13/21,25.03%,SMARCC1;RBBP4;SMARCA4;HDAC1;HDAC2;MBD3;MBD2;CHD4;SMARCC2;H3-3A;ACTL6A;SMARCB1;HNRNPC
prerank,cAMP binding (GO:0030552),-0.39003103191108457,-1.0031465388688487,0.4489795918367347,0.7916305575484631,1.0,5/11,18.18%,HCN1;CNBD2;PDE10A;PDE2A;PDE4D
prerank,CoA hydrolase activity (GO:0016289),-0.35162518188183106,-1.0020355071020262,0.4392156862745098,0.7873014333612559,1.0,6/16,25.52%,ACOT11;NUDT7;ACOT7;ACOT13;ACOT6;HIBCH
prerank,cardiolipin binding (GO:1901612),0.5156522335162206,1.001384634891086,0.4566929133858268,1.0,1.0,2/10,14.38%,STOML2;GSDMD
prerank,beta-tubulin binding (GO:0048487),0.45156275849859406,1.001155905460266,0.4678362573099415,1.0,1.0,8/31,17.85%,RACGAP1;SMC3;UXT;EMD;TAOK1;EML4;TBCD;TRPV4
prerank,phospholipase activator activity (GO:0016004),0.5252296229691876,0.9988525770303023,0.47305389221556887,1.0,1.0,4/10,15.30%,ARHGAP6;PDPK1;BTK;SRC
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.51076256940754,0.9961551142401558,0.4685714285714286,1.0,1.0,7/12,24.66%,POU2F1;HDAC1;GTF2A1;RUVBL2;GTF2B;H3-3A;RELA
prerank,nuclear receptor coactivator activity (GO:0030374),0.42880640785222796,0.9935271085739761,0.48630887185104055,1.0,1.0,14/52,13.71%,MED14;ACTN4;CCAR1;THRAP3;MED30;ELK1;CNOT6;MED24;NCOA2;PRKCB;SLC30A9;NCOA7;PPRC1;MED1
prerank,tau-protein kinase activity (GO:0050321),0.47016847585821386,0.9913172503274628,0.4703656998738966,1.0,1.0,5/20,9.80%,DYRK1A;ROCK2;GSK3B;ROCK1;MARK2
prerank,GTPase inhibitor activity (GO:0005095),0.49051968118420086,0.990521580963138,0.4660894660894661,1.0,1.0,4/13,16.57%,IQGAP2;CPEB2;IPO5;TNK2
prerank,P-type ion transporter activity (GO:0015662),0.5014308356249702,0.9902900720928712,0.4750733137829912,1.0,1.0,3/12,10.56%,ATP2B4;ATP2A2;ATP2B1
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.4144702883890803,0.9898218950923678,0.5201207243460765,1.0,1.0,22/173,11.24%,E2F8;EN1;TCFL5;ZFP69;ETV6;SP2;ZEB1;CTCF;NFIL3;BHLHE41;GZF1;MXD1;ZBTB2;FOXO3;ZFP90;ZBTB25;ZBTB20;PLAGL1;NR3C1;MYPOP;KCNIP3;TBX18
prerank,disordered domain specific binding (GO:0097718),0.4679940730413433,0.989739159761912,0.47167487684729065,1.0,1.0,7/23,17.44%,PPIL1;RB1;NUMA1;CALM2;TP53;KCNA1;SMAD2
prerank,FAD binding (GO:0071949),0.46965048892780537,0.9880042752891401,0.4779874213836478,1.0,1.0,6/24,9.82%,MTHFR;MICAL3;AGPS;QSOX1;SQOR;KMO
prerank,cadherin binding (GO:0045296),0.4155371769754932,0.9833652568532022,0.571,1.0,1.0,67/315,15.75%,DIAPH3;CIP2A;CCNB2;TMPO;CKAP5;ANLN;CDH15;MACF1;CDH18;CDH24;ANXA2;PARVA;ASAP1;ZC3HAV1;RAB10;GPRC5A;PACSIN2;UBAP2;ARHGAP18;SNX1;SERBP1;MRE11;CDH4;STK24;EIF4H;AFDN;CTNNA1;CNN2;SCRIB;SH3GLB1;LARP1;ABCF3;NCK1;CORO1B;ABI1;PICALM;EPS8L1;EMD;MARK2;RAB1A;ERC1;RANGAP1;TLN1;NDRG1;CAPZA1;ANXA1;TWF1;CRKL;EZR;PDLIM5;TES;EHD1;WASF2;TJP2;BAIAP2L1;CAST;CLIC1;DLG1;TMOD3;ITGB1;CAPG;CLINT1;MPRIP;VAPA;SRC;DBN1;ADD1
prerank,protein phosphatase 2A binding (GO:0051721),0.4557079800646922,0.9821150911775032,0.4860050890585242,1.0,1.0,7/23,17.38%,MASTL;MAPT;ENSA;PTPA;TP53;ANKLE2;PPME1
prerank,alpha-tubulin binding (GO:0043014),0.4433707667436713,0.9806164026917128,0.4953271028037383,1.0,1.0,9/31,20.73%,RACGAP1;SETD2;TRAPPC14;TAOK1;INO80;EML4;TRPV4;DIP2B;SNCA
prerank,endopeptidase activity (GO:0004175),0.4062522225322898,0.9794802735837506,0.5555555555555556,1.0,1.0,39/257,13.83%,KEL;ESPL1;CTSE;MMP25;MMP24;MMP28;USP1;SENP1;MMP14;CASP7;TRABD2B;USP18;NLN;USP37;ADAMTS10;ADAMTS5;TASP1;PLAU;ADAMTS14;ADAMTS9;ADAMTSL2;PSMB1;HTRA2;USP16;ADAMTS2;ADAMTS16;TPP2;USP28;PSMB9;ADAM17;CASP8;CTSH;USP9X;ADAM19;USP47;HTRA3;ADAMTSL3;ADAM9;ADAMTS1
prerank,calcium:sodium antiporter activity (GO:0005432),-0.39232441955792124,-0.9779427396052025,0.49843260188087773,0.8425227691231696,1.0,3/10,5.75%,SLC8A3;SLC24A2;SLC3A2
prerank,protein phosphatase binding (GO:0019903),0.41233639058621996,0.9778324527776274,0.5505050505050505,1.0,1.0,27/117,18.54%,NEK2;MASTL;ATP2B4;ANAPC7;KCNN4;CDC27;PDLIM4;MAPT;RPA2;ANK1;MTMR9;EIF2AK3;AP3B1;AKAP11;ENSA;CDKN1B;PTPA;MTMR3;TP53;ANKLE2;ANAPC5;SIRPA;MVP;PPME1;MAPK14;BAD;KIFAP3
prerank,platelet-derived growth factor binding (GO:0048407),-0.38709503529025646,-0.9777853029924325,0.484375,0.8361404310605755,1.0,4/11,11.52%,COL6A1;PDGFRB;COL5A1;COL1A2
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.5032272353316007,0.9768066356391065,0.4947839046199702,1.0,1.0,4/11,11.05%,UBE2K;PRPF19;UBR5;UBOX5
prerank,small GTPase binding (GO:0031267),0.4119363390452392,0.9763871644222857,0.5513078470824949,1.0,1.0,37/169,12.82%,BIRC5;USP6NL;IQGAP2;RANGRF;TRIOBP;EXOC4;EVI5L;MYCBP2;OCRL;MLPH;MYO1C;AFDN;FGD4;BICD2;CDC42EP2;YBX3;RAB29;FGD1;LRRK2;ANKRD27;GCC1;GOLGA5;TBC1D7;PICALM;MAPKAP1;ERC1;RANGAP1;SRGAP2;MYO9B;LSM2;FGD6;ABCA1;RAPGEF4;NDRG1;CHM;EHD1;RANBP2
prerank,aspartic-type peptidase activity (GO:0070001),0.5028286428544995,0.9759330235126579,0.5030674846625767,1.0,1.0,1/10,2.16%,CTSE
prerank,metallocarboxypeptidase activity (GO:0004181),0.4567075850278033,0.9758642974771691,0.4894409937888199,1.0,1.0,3/26,5.83%,VASH2;AGBL2;CPXM1
prerank,glucuronosyltransferase activity (GO:0015020),0.45714253313616215,0.9744624349009283,0.46174142480211083,1.0,1.0,2/19,6.38%,LARGE1;CHSY1
prerank,hormone receptor binding (GO:0051427),-0.35973499894784633,-0.974389009491352,0.44666666666666666,0.8378532554460991,1.0,5/14,29.73%,SOCS2;PTHLH;JAK2;ADCYAP1;JAK1
prerank,calcium ion binding (GO:0005509),0.4037184166378442,0.9704721233316943,0.596,1.0,1.0,40/323,13.01%,EFCAB11;MELK;PON1;CDH15;LOXL2;SCUBE1;ADGRV1;PLSCR2;CDH18;CDH24;ANXA9;ANXA2;FBN1;ITPR1;PAM;TPM4;PRNP;CDH4;ANXA3;NDUFAB1;ANXA5;CABCOCO1;ENPP2;HPGDS;PPP3CA;ENPP3;FKBP9;ATP2A2;SLC8A1;TKT;ENPP1;TRPM2;CALM2;ANXA1;CALB1;MICU1;ITPR3;TRPM4;MAN1C1;MEX3B
prerank,SUMO transferase activity (GO:0019789),0.46612730068194974,0.9681065530619529,0.5041208791208791,1.0,1.0,7/16,24.28%,TRIM28;NSMCE2;RANBP2;EGR2;HDAC4;PIAS1;UBE2I
prerank,RNA stem-loop binding (GO:0035613),0.48998433127101015,0.9679819225743678,0.487627365356623,1.0,1.0,6/12,14.79%,DHX9;MYH10;FMR1;RC3H2;RC3H1;EPRS1
prerank,manganese ion binding (GO:0030145),0.42172833443559415,0.9675198518057807,0.5072142064372919,1.0,1.0,9/48,12.55%,LARGE1;B4GALT1;PRIMPOL;TDP2;GALNT1;B4GALT7;PIM1;MPPED2;GYG1
prerank,MAP kinase kinase kinase activity (GO:0004709),0.49565985959846565,0.9665391271044642,0.5051244509516838,1.0,1.0,3/11,9.25%,MAP3K1;MAP3K20;MAP3K4
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.3068951161130905,-0.9653289626914411,0.4869109947643979,0.854063774622275,1.0,7/25,12.90%,PARP8;TIPARP;ART3;PARP6;PARP1;SIRT5;PARP16
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.40817916287002215,0.9648426182053313,0.563894523326572,1.0,1.0,28/147,13.32%,ECT2;PCP2;RANGRF;DENND2C;FNIP1;RCBTB2;MYCBP2;DENND4C;FGD4;DNMBP;EIF2B1;DENND2A;VAV2;FGD1;ANKRD27;RAB3IL1;FARP1;RIC8B;EPS8L1;DENND5A;CYTH3;HERC2;FGD6;RAPGEF4;ARHGEF18;DENND1A;DOCK11;DOCK1
prerank,ribonuclease P RNA binding (GO:0033204),0.499052907959047,0.9635509553977796,0.5029411764705882,1.0,1.0,4/10,19.87%,RPP40;POP1;RPP30;RPP21
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.29988395508536836,-0.9594031971791295,0.5024154589371981,0.8617793693978014,1.0,4/24,4.91%,PLA2G4A;PLEKHA5;CERT1;SNX3
prerank,NF-kappaB binding (GO:0051059),0.4465854631577249,0.957795635836541,0.5006321112515802,1.0,1.0,5/24,12.79%,SETD6;GSK3B;FAF1;HDAC1;HDAC2
prerank,transferrin receptor binding (GO:1990459),0.5050429469582634,0.9576497099891426,0.5054602184087363,1.0,1.0,3/10,10.01%,RGMA;SNX1;IKBKG
prerank,protein tyrosine phosphatase activity (GO:0004725),0.40561808599920335,0.9543109533050586,0.5424628450106157,1.0,1.0,18/71,17.61%,CDKN3;EYA4;ACP1;PTPN2;CDC25B;CDC25C;CDC25A;EYA2;PTPN21;PTPRS;PTPN13;PTPRA;MTMR3;PTPRU;PTEN;PTPRK;PTPRE;CDC14A
prerank,ubiquitin-specific protease binding (GO:1990381),-0.3256803133526549,-0.9537488902370354,0.536,0.8688254316775866,1.0,10/19,24.82%,PRKN;DERL1;SELENOS;RHBDD2;SART3;SYVN1;PARK7;RAD23A;SPATA2;CHMP3
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.439438449412846,0.9530061650317534,0.5230582524271845,1.0,1.0,6/29,16.46%,SLC25A21;SLC38A7;SLC19A1;SLC25A30;SLC1A5;SLC25A22
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.400568153745642,0.9522803462490134,0.612,1.0,1.0,50/254,16.00%,NR2E3;E2F2;MYBL1;E2F3;TFDP1;TFCP2L1;MDM4;RFXAP;NFIA;ZFP62;KLF5;SRF;ELF4;NFIB;HOXC4;ELF1;GMEB1;TCF4;HOXA7;GRHL2;MYBL2;ELK1;FOXO3;IRF1;PLAGL2;HOXB3;PLAGL1;MEOX2;NR3C1;NR4A2;ZNF585B;ZNF585A;RBPJ;NR4A1;SMAD4;SOX9;ATF5;ELK4;YY1;FOXK2;RLF;SMAD3;E2F4;ZNF445;ATF1;RUNX1;NFKB1;HOXB7;ZNF112;TP53
prerank,hyaluronic acid binding (GO:0005540),-0.39137033241770747,-0.9517354363192613,0.5210084033613446,0.8669787256618623,1.0,7/10,36.23%,CEMIP;LAYN;IMPG2;C1QBP;HYAL2;LYVE1;CHODL
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.471640542433421,0.9517349617371184,0.49700598802395207,1.0,1.0,5/13,20.90%,BMP6;BMP2;SRC;BMP3;BMP5
prerank,phosphotyrosine residue binding (GO:0001784),-0.25948643417251516,-0.9509917152014354,0.5,0.8620876725535406,1.0,11/37,14.53%,PIK3R3;PIK3R1;SHE;BCAR3;PFN1;IRS1;ABL1;GRB2;PTPN11;LDLRAP1;SHC1
prerank,voltage-gated anion channel activity (GO:0008308),-0.33461579083283144,-0.9479100945610746,0.5183823529411765,0.8635218493405554,1.0,4/15,9.25%,ANO6;ANO1;GPR89B;GPR89A
prerank,GDP binding (GO:0019003),-0.23331162737093003,-0.9475252999220759,0.6164383561643836,0.8577501193349646,1.0,17/63,15.63%,RAB28;RAP1A;GNAI1;RAB27B;RAB5B;RERG;RALB;MRAS;RASL12;RAB5A;DYNC1LI1;RAB2A;RIT1;RAP2C;RAB12;ARL8B;RRAGC
prerank,pyridoxal phosphate binding (GO:0030170),0.4383931295445669,0.9473736674869133,0.5033557046979866,1.0,1.0,6/20,19.44%,PDXK;PYGB;AGXT;ABAT;ACCS;PYGL
prerank,filamin binding (GO:0031005),0.4927367655479986,0.9468862940960556,0.5165165165165165,1.0,1.0,4/11,12.98%,DPYSL4;RFLNA;DPYSL3;SYNPO2
prerank,voltage-gated potassium channel activity (GO:0005249),-0.22175057124079797,-0.9468421471014372,0.6222222222222222,0.8527191941865505,1.0,14/80,13.12%,KCNC2;HCN1;KCNB1;KCNJ3;KCNQ3;KCNH1;KCNJ6;KCNN2;KCNH7;KCNS3;KCNJ10;KCNA2;KCNA6;KCNT1
prerank,pyrophosphatase activity (GO:0016462),0.413738002536636,0.9464563584979593,0.5460455037919827,1.0,1.0,13/50,13.46%,DHX9;LHPP;NUDT5;ENPP3;PPA1;ITPA;ENPP1;TRPM2;PLPP1;PLPP5;RNGTT;DXO;NUDT4
prerank,protein kinase inhibitor activity (GO:0004860),0.41588947631304773,0.9454337704479227,0.5158371040723982,1.0,1.0,12/42,20.73%,CIT;CEP43;PARVA;NCK1;SPRED1;CDKN1B;RPTOR;QARS1;SPRED2;SH3BP5;TRIB1;SNCA
prerank,phosphoric ester hydrolase activity (GO:0042578),-0.2481381828720952,-0.9451293773805747,0.5428571428571428,0.8506079657471388,1.0,16/49,18.50%,DUSP11;PLCXD3;FRA10AC1;DUSP3;PRUNE1;ENPP6;PTPN22;ACP2;PTPRO;GDPD3;ATP1A2;GDPD1;PPP5C;EPHX2;PPP1CB;ACP6
prerank,BMP receptor binding (GO:0070700),0.4716536538166909,0.9443515515063584,0.5174506828528073,1.0,1.0,5/12,20.90%,BMP6;BMP2;SRC;BMP3;BMP5
prerank,tumor necrosis factor receptor binding (GO:0005164),0.4768991372426123,0.9430660451385076,0.5219858156028369,1.0,1.0,5/12,23.79%,TRIM37;TRAF6;TRAF2;TRAF4;BABAM2
prerank,snRNA binding (GO:0017069),0.41508591493608354,0.9426089975171126,0.5615819209039548,1.0,1.0,12/42,16.81%,COIL;LSM11;DDX39B;TUT1;LSM2;HNRNPU;SNRNP35;SF3B3;LSM7;DDX21;LSM4;PRPF4
prerank,tRNA methyltransferase activity (GO:0008175),-0.3265541748923008,-0.9422299680662809,0.5145985401459854,0.8512042810588866,1.0,7/16,35.72%,TRMT9B;THUMPD3;LCMT2;TRMT44;TYW3;TRMT12;BCDIN3D
prerank,outward rectifier potassium channel activity (GO:0015271),0.477654614638668,0.9420556976321118,0.5263157894736842,1.0,1.0,3/11,15.28%,KCNK2;PKD2;KCNT2
prerank,peptide hormone receptor binding (GO:0051428),-0.36824788316948887,-0.9414620350415108,0.56973293768546,0.8467034940208824,1.0,4/11,34.82%,PSMC5;PTHLH;ADCYAP1;GNRH1
prerank,ligand-gated cation channel activity (GO:0099094),-0.22876268104504782,-0.9390032352441339,0.673469387755102,0.846029222688031,1.0,20/75,23.61%,GRIK1;GRIN3A;GRIN2A;KCNJ3;GRIN2B;GRIK4;KCNJ6;KCNN2;CHRNA7;GRIA1;KCNJ10;GRIN1;MCOLN1;GRIA2;KCNK1;KCNJ12;GRIK2;P2RX4;KCNN3;PTK2B
prerank,cGMP binding (GO:0030553),-0.3785819219778714,-0.9382444696869424,0.546583850931677,0.8416760908138143,1.0,9/11,58.12%,PDE10A;PDE2A;PDE11A;CNGB1;CNGB3;RAPGEF2;CNGA2;CNGA4;CNGA3
prerank,adenyl nucleotide binding (GO:0030554),-0.3782620493656499,-0.9380324907597895,0.5364238410596026,0.8299575076720911,1.0,7/11,33.12%,SIL1;HSPH1;PFN1;HSPBP1;BAG3;GRPEL1;BAG2
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.3782620493656499,-0.9380324907597895,0.5364238410596026,0.8299575076720911,1.0,7/11,33.12%,SIL1;HSPH1;PFN1;HSPBP1;BAG3;GRPEL1;BAG2
prerank,cysteine-type peptidase activity (GO:0008234),0.3981536442481785,0.9346593581661978,0.5886752136752137,1.0,1.0,20/73,19.24%,ESPL1;USP1;CASP7;USP18;USP37;USP21;USP16;USP28;CASP8;CTSH;USP9X;USP47;OTUD7B;SFRP1;GGH;USP48;USP14;ATG4C;USP46;USP20
prerank,RNA binding (GO:0003723),0.39208576011292856,0.9346196026824375,0.807,1.0,1.0,341/1321,19.95%,TOP2A;BRCA1;MKI67;NUSAP1;RAD51AP1;BARD1;KPNA2;ZGRF1;HMGB2;DDX11;RBM15;PNLDC1;ZC3H7A;ILF3;SYNCRIP;SMC1A;NAP1L1;MEX3A;FLYWCH2;SETX;LBR;MACF1;ADK;PABPC4;MOV10;DEK;MYEF2;DGCR8;TRIP6;ROCK2;SREK1;LARP4B;HDGF;AGO2;ANXA2;ZC3HAV1;BICC1;SRSF4;HNRNPD;TRA2B;CNOT1;RBFOX2;ALG13;DNTTIP2;CSTF3;DNA2;PATL1;FIP1L1;ACTN4;KHDRBS1;PNISR;UBAP2;DHX9;PRKDC;DIAPH1;DDX50;SRBD1;PEG10;TNPO1;HNRNPA1;EIF4E;SRF;SARS2;SRSF10;SERBP1;CCAR1;UPF3B;FAM120A;THRAP3;PRPF38B;MAPT;YLPM1;NUDT5;MYH10;RAVER2;LSM3;FNDC3B;SLBP;MBNL3;EIF4ENIF1;EIF4H;CTNNA1;G3BP1;PSIP1;RBM25;HMGN2;SAMD4A;EXD1;CAPRIN1;ERI1;TPR;NMD3;FMR1;MAP3K20;DDX39B;PRPF40A;UBE2N;PSPC1;RRS1;TXN;HNRNPH1;NUCKS1;YBX3;NOSIP;RBMS2;FUS;SRSF7;POLR2A;MEX3C;DNAJC21;DHX8;RC3H2;MATR3;MRM1;SAP18;RPP40;PPIG;TUT7;CELF2;LARP1;TRIM28;DARS2;TUT1;HNRNPUL1;PELP1;HMGB3;DARS1;BCLAF1;NQO1;PPP1R8;PRPF3;NOL6;UTP3;WDR33;NONO;CPEB2;MRM3;RBM42;MAP4;PUM2;SF3A2;LONP1;SRPRA;PRRC2B;HMGB1;MARK2;NOL11;PCF11;RANGAP1;HOXB6;MRTO4;DDX18;SRSF3;LSM2;SCAF8;YTHDF2;HNRNPU;FASTKD5;SFPQ;RBPMS2;RARS2;TAF15;RBMS3;HNRNPL;MRPL13;SRRM1;RBM15B;SRPK1;SAMSN1;CHD2;DHX37;POP1;SNRNP35;RPP30;CRKL;CPSF4;ESF1;GANAB;SUGP2;HTATSF1;FAM32A;EZR;EXOSC7;ERH;DAP3;HNRNPH2;FUBP1;HNRNPUL2;EIF3C;SUMO2;COA6;TSR1;MRPL1;NOM1;PPP1CC;TES;HDAC2;RPS17;SSRP1;ILF2;DUT;PPAN;MEX3B;SIDT1;DXO;TCF20;POLR1G;CAST;MEX3D;LSM7;PPRC1;RBMS1;PTBP2;NUDT4;SRP72;RBM4;TUT4;DDX56;DDX21;DRG2;SMG6;LARP4;TRMT2A;DHFR;YY1;MAK16;EIF1AX;ERI3;DAZAP1;SNTB2;HLTF;RC3H1;WBP4;NOL12;EIF4A2;STRBP;PABPC1;PRRC2A;EWSR1;ZC3H14;EPRS1;LUC7L3;AQR;TFB1M;GNL3;KIN;SECISBP2;CKAP4;HNRNPA2B1;ZC3H7B;RBM19;ACO1;ZCCHC8;CNOT4;FXR1;HELB;ADD1;DDX1;IPO5;PPIL4;UNK;LSM4;NUP42;MSN;RBM27;ZC3H18;PNPT1;TEP1;RPL22L1;LARP1B;AKAP1;STXBP1;RCC2;CISD2;PURA;METTL3;RALY;RBM10;KHNYN;DENR;DHX38;SRP9;NUP98;MRPS24;UNC50;PYM1;HNRNPLL;ASCC3;BZW1;TPD52L2;PHF6;FCF1;MRPL45;EIF3H;EDC3;USO1;ZNF346;ZC3H8;LUC7L2;BUD13;SRPK2;DDX10;ABT1;MRPL42;PKN2;MRPL37;MRPL2;CWC22;MRPL20;GPATCH4;DDX59;RPL34;EXOSC10;PUS7;ANKRD17;TBL2;XRN2;CDC5L;CLK3;SPOUT1;TNRC6B;LARP7;ISG20L2;ETF1;POLR2B;TERT;DDX27;SLC25A5;PTPN1;VIRMA;HNRNPR;CCDC47;EIF3I;FARS2;KHDRBS3;SNRPB;RPP21;ARF1;IFIT2;TRA2A;SF3A3
prerank,mRNA binding (GO:0003729),0.3923279556715538,0.9341996528653793,0.644,1.0,1.0,70/249,17.81%,TYMS;RBM15;SYNCRIP;PABPC4;MYEF2;LARP4B;AGO2;SRSF4;TRA2B;RBFOX2;CSTF3;KHDRBS1;DHX9;SRBD1;SERBP1;UPF3B;MYH10;SLBP;EIF4ENIF1;G3BP1;RBM25;SAMD4A;TPR;FMR1;YBX3;RBMS2;RC3H2;RNF40;CELF2;LARP1;TUT1;PPP1R8;CPEB2;PUM2;PCF11;SCAF8;YTHDF2;HNRNPU;RBPMS2;RBMS3;HNRNPL;MRPL13;SNRNP35;FUBP1;DXO;RBMS1;PTBP2;RBM4;LARP4;DHFR;DAZAP1;RC3H1;PABPC1;LUC7L3;AQR;GNL3;SECISBP2;HNRNPA2B1;ACO1;FXR1;UNK;TP53;METTL3;KHNYN;DENR;NUP98;ANGEL2;HNRNPLL;EDC3;LUC7L2
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.40095053952977155,0.9338404458295815,0.5625,1.0,1.0,11/55,10.76%,ATP2B4;ANXA9;ANXA2;ITPR1;PKD2L2;CUL5;MCU;ATP2A2;SLC24A3;ATP2B1;TRPM2
prerank,store-operated calcium channel activity (GO:0015279),-0.3808299996561242,-0.9332689312682737,0.5630252100840336,0.8353229372898778,1.0,3/10,10.04%,TRPC5;TRPC3;TRPC1
prerank,cholesterol transfer activity (GO:0120020),0.45741369466737214,0.9322064845973304,0.5192837465564738,1.0,1.0,2/16,10.71%,GRAMD1C;ABCA1
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.3581608074902468,-0.9321297410499797,0.5696594427244582,0.8321886478373296,1.0,6/12,17.97%,PIK3R3;PIK3C2B;ATM;PIK3R6;PIK3CD;PIK3CA
prerank,calcium-dependent phospholipid binding (GO:0005544),-0.2421929000889751,-0.9320765504247627,0.5604395604395604,0.8264347158981936,1.0,6/49,3.34%,PLA2G4A;CPNE8;PCLO;MCTP1;ANXA6;SYT1
prerank,Toll-like receptor binding (GO:0035325),-0.35712585498520766,-0.9288738778652905,0.5253164556962026,0.8281994471144688,1.0,9/11,49.76%,UNC93B1;TIRAP;TOLLIP;MYD88;TLR6;CD36;TLR1;S100A9;TLR2
prerank,thioesterase binding (GO:0031996),0.4799913565253918,0.9270873841935928,0.537984496124031,1.0,1.0,5/11,21.85%,HAUS7;RAC1;TRAF6;TRAF2;TRAF4
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.4726851944992313,0.9267800794537585,0.5428994082840237,1.0,1.0,2/10,9.67%,NOX4;CYBB
prerank,cysteine-type endopeptidase activity (GO:0004197),0.3904587056757543,0.9262889365686844,0.5853403141361256,1.0,1.0,18/78,19.24%,ESPL1;USP1;CASP7;USP18;USP37;CAPN15;USP16;USP28;CASP8;CTSH;USP9X;USP47;CAPN5;SFRP1;USP48;USP14;USP46;USP20
prerank,inward rectifier potassium channel activity (GO:0005242),-0.2803873169358946,-0.926123689569174,0.5888324873096447,0.8288889520305164,1.0,10/24,30.92%,KCNJ3;KCNJ6;KCNN2;KCNJ10;KCNK1;KCNJ12;KCNN3;ABCC9;KCNJ8;KCNJ15
prerank,pentosyltransferase activity (GO:0016763),-0.2628386759650493,-0.9250151787720542,0.55,0.8257915857630543,1.0,9/36,12.90%,UPP2;PARP8;TIPARP;ART3;PARP6;PARP1;SIRT5;QTRT2;PARP16
prerank,actin monomer binding (GO:0003785),-0.29123728398165616,-0.924853710160659,0.5674418604651162,0.8204256493875819,1.0,6/22,16.22%,TMSB4X;NOS3;PFN1;ABL1;TMSB10;MTSS1
prerank,monocarboxylic acid binding (GO:0033293),0.43525653882598686,0.9228422902043124,0.5343203230148048,1.0,1.0,1/18,3.25%,CYP26B1
prerank,myosin II binding (GO:0045159),0.47981877361196024,0.9203926730183158,0.5490483162518301,1.0,1.0,3/10,9.48%,TRIOBP;STXBP5;LLGL2
prerank,diacylglycerol kinase activity (GO:0004143),-0.3576661146448502,-0.9199266763526068,0.5753012048192772,0.8254769121753279,1.0,6/11,24.53%,DGKB;DGKG;DGKI;DGKQ;DGKD;DGKK
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.40920631218493836,0.917315241709287,0.5577367205542725,1.0,1.0,12/37,16.38%,CARS2;SARS2;VARS1;DARS2;IARS2;DARS1;TARS2;PARS2;RARS2;EPRS1;QARS1;LARS1
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.30002439532570474,-0.9168193345493031,0.5772727272727273,0.8269942552424775,1.0,9/21,19.13%,AKAP8L;RYR2;AKAP6;GSKIP;AKAP7;ARFGEF2;ARFGEF1;AKAP8;KCNQ1
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.4642303771086571,0.9156257657145549,0.5473071324599709,1.0,1.0,4/12,10.37%,TGFBR3L;BMPR1A;TGFBR3;TGFBR1
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.4605729513478498,0.9152823894671102,0.5343618513323983,1.0,1.0,5/13,14.53%,LPCAT1;AGPAT2;LCLAT1;AGPAT3;AGPAT1
prerank,epidermal growth factor receptor binding (GO:0005154),-0.27894655738645824,-0.9150840869318908,0.558252427184466,0.825353468499111,1.0,9/25,20.04%,SNX4;ERBB4;TGFA;GRB2;HIP1;SNX2;SHC1;LINGO1;HBEGF
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.46764105092517827,0.9124626154234466,0.5552282768777614,1.0,1.0,5/12,19.47%,SLC19A1;SLC25A25;SLC25A42;SLC25A17;SLC25A5
prerank,zinc ion binding (GO:0008270),0.381526137328783,0.9113370496326683,0.709,1.0,1.0,50/293,15.59%,UHRF1;TK1;ACMSD;GLI2;BAZ1B;RASSF1;UPB1;ZEB1;CTCF;ADA;LVRN;PRIMPOL;MDM4;MBD1;MYCBP2;PAM;BLM;SORD;PTGR2;PDXK;ENPP2;SMPDL3A;ENPP3;PHF2;KDM2B;TRIM28;ZFYVE1;USP16;DUSP12;CDA;KMT2A;APIP;CXXC5;TRHDE;LIMS1;ENPP1;CALB1;SEC24D;ZDHHC15;TES;SMPD1;RC3H1;SMAD3;KDM5C;CA2;EPRS1;NPEPPS;RBAK;LANCL1;KAT6A
prerank,kinase activity (GO:0016301),0.382985923029733,0.9108472914661848,0.6178861788617886,1.0,1.0,29/109,18.12%,MASTL;MAP4K4;GSK3B;PMVK;PDXK;PAPSS2;IPMK;EPHA4;LRRK2;FN3K;PPIP5K1;PIK3CB;IP6K2;DGKE;PANK4;SEPHS1;AGK;MVK;PANK2;PKMYT1;PRKD1;TAOK1;TRRAP;STK39;RFK;GK5;PI4KB;GK;PKN2
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",-0.3453183532433419,-0.9101146063259288,0.5529801324503312,0.8302002457787849,1.0,5/13,31.29%,SREBF2;ECH1;IDI1;MIF;EBP
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.41287970417725267,0.9073707162426793,0.5633802816901409,1.0,1.0,1/30,0.70%,BIRC5
prerank,cell adhesion mediator activity (GO:0098631),-0.2888179515959804,-0.9070646931242143,0.6267942583732058,0.8315259016338225,1.0,8/24,18.81%,BSG;CNTN6;ESAM;BCAM;NTNG1;CNTN2;NEXN;ROBO4
prerank,adenylyltransferase activity (GO:0070566),0.4267053298318278,0.9054931999196592,0.5467349551856594,1.0,1.0,8/21,20.20%,TENT2;TENT4A;TUT1;PAPOLB;NMNAT1;COASY;GPHN;NMNAT2
prerank,palmitoyltransferase activity (GO:0016409),-0.27227852866277813,-0.9047909698838327,0.6132596685082873,0.830873146518028,1.0,11/28,23.01%,GLUL;ZDHHC5;ZDHHC1;ZDHHC13;ZDHHC7;ZDHHC8;GOLGA7;ZDHHC16;ZDHHC20;ZDHHC4;ZDHHC17
prerank,GTPase binding (GO:0051020),0.3805227282343073,0.9045486597325617,0.6963927855711423,1.0,1.0,42/194,14.81%,BIRC5;USP6NL;IQGAP2;RANGRF;TRIOBP;EXOC4;EVI5L;MYCBP2;OCRL;MLPH;MYO1C;AFDN;FGD4;BICD2;STOML2;CDC42EP2;YBX3;RAB29;FGD1;LRRK2;ANKRD27;GCC1;GOLGA5;TBC1D7;PICALM;MAPKAP1;ERC1;RANGAP1;SRGAP2;MYO9B;LSM2;FGD6;ABCA1;RAPGEF4;NDRG1;CHM;EHD1;RANBP2;EXOC8;DOCK7;EPRS1;LCP1
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.36666246288589116,-0.903767484367715,0.5545722713864307,0.8274006435153246,1.0,2/10,15.99%,SLC6A1;SLC6A11
prerank,sterol transfer activity (GO:0120015),0.4383977602258358,0.9030396315384893,0.5585464333781965,1.0,1.0,1/17,1.29%,GRAMD1C
prerank,growth factor receptor binding (GO:0070851),-0.21774284446157824,-0.9013480527672754,0.6296296296296297,0.8273431711884016,1.0,24/95,20.56%,IL1R1;PSEN1;VEGFC;SNX4;PDGFRB;PIBF1;FGF2;NCSTN;ERBB4;TGFA;FGF1;PDGFD;GRB2;HIP1;SNX2;SDCBP;SHC1;VEGFA;VEGFB;LINGO1;VEGFD;IL1RAP;HBEGF;ITGB3
prerank,ligand-gated calcium channel activity (GO:0099604),0.42972549915865166,0.9000263188634713,0.5521390374331551,1.0,1.0,6/19,12.45%,RASA3;ITPR1;TRPA1;TRPM2;ITPR3;TRPM4
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.2942063704474117,-0.8996538596585875,0.6320346320346321,0.825490325926133,1.0,6/20,15.35%,SLC39A10;SLC39A13;SLC39A7;SLC30A1;SLC30A4;SLC39A1
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.45046584881749396,0.8993414883044089,0.5677154582763337,1.0,1.0,6/15,15.92%,LPCAT1;AGPAT2;LCLAT1;AGPAT3;AGPAT1;ABHD4
prerank,glucose transmembrane transporter activity (GO:0005355),-0.32064506782025326,-0.8980952654033423,0.642023346303502,0.8232635794417903,1.0,5/17,29.16%,SLC2A1;SLC2A3;SLC2A10;SLC5A11;SLC5A3
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.2524648583281899,-0.8976074445342491,0.6594202898550725,0.8190221251128122,1.0,21/35,37.34%,TRMT9B;DTWD2;PUS10;AARS1;QTRT2;PTRH2;QTRT1;NT5C3A;LCMT2;DTWD1;ALKBH1;DUS3L;ELAC2;QRSL1;MRPL58;GATC;TYW3;TRMT12;BCDIN3D;TRPT1;DUS2
prerank,steroid hydroxylase activity (GO:0008395),0.4414455719457368,0.8970561379562432,0.5737704918032787,1.0,1.0,1/16,2.79%,CYP39A1
prerank,neuropeptide receptor binding (GO:0071855),0.44680876509992096,0.8947074522525198,0.5657708628005658,1.0,1.0,1/14,3.55%,AGRP
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.4757546944069821,0.893411493979407,0.5870870870870871,1.0,1.0,4/10,22.29%,PML;ANKRD13D;DNAJB2;DAXX
prerank,protein phosphatase activator activity (GO:0072542),0.45654149347660167,0.8929500838413585,0.5642857142857143,1.0,1.0,6/13,20.20%,PPP2R5C;CALM2;PTPA;PPP2R5B;IGFBP3;PHACTR4
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.43382017017395214,0.8910159891627425,0.579172610556348,1.0,1.0,2/14,13.64%,CAPN15;CAPN5
prerank,TBP-class protein binding (GO:0017025),0.42169434068726774,0.8906707609272105,0.5902061855670103,1.0,1.0,8/21,15.98%,PSMC2;TAF12;GTF2A1;AHR;RUVBL2;YEATS2;DR1;DRAP1
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.45843382414522327,0.8901738454900447,0.5931972789115646,1.0,1.0,1/13,2.30%,GPSM2
prerank,1-phosphatidylinositol binding (GO:0005545),0.4408238361259914,0.8890751259048636,0.5734072022160664,1.0,1.0,8/15,22.26%,SESTD1;ZFYVE16;ZFYVE1;PICALM;ZFYVE9;EEA1;SNAP91;SNX9
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.4399115189176722,0.8881879015911455,0.5763888888888888,1.0,1.0,3/14,9.82%,NOX4;CYBB;KMO
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.4612470925572053,0.8871286887210874,0.5887573964497042,1.0,1.0,4/11,17.63%,SLC19A1;SLC25A25;SLC25A42;SLC25A17
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.32538615134460014,-0.8871005616549803,0.5966101694915255,0.8361700159053959,1.0,5/14,15.47%,SLC1A2;SLC25A13;SLC25A12;SLC17A6;SLC1A1
prerank,NAD binding (GO:0051287),0.4071935227308143,0.8845839750945127,0.5801242236024845,1.0,1.0,5/26,10.56%,ZC3HAV1;CTBP1;SORD;ALDH1A1;PARP9
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.3635426383656629,-0.8845261966326665,0.6111111111111112,0.8361924204760615,1.0,4/10,7.94%,SLCO1C1;SLCO2B1;SLCO2A1;SLC22A6
prerank,transition metal ion binding (GO:0046914),0.3689879559119037,0.8829918607339876,0.787,1.0,1.0,73/397,17.48%,UHRF1;TK1;ACMSD;GLI2;LOXL3;LOXL2;BAZ1B;RASSF1;UPB1;ZEB1;CTCF;LARGE1;B4GALT1;ADA;LVRN;PRIMPOL;MDM4;MBD1;MYCBP2;PAM;TDP2;GALNT1;PRNP;BLM;SORD;PTGR2;PDXK;ENPP2;AGMO;SMPDL3A;ENPP3;PHF2;B4GALT7;KDM2B;TRIM28;SOD3;TYR;ZFYVE1;USP16;DUSP12;CDA;PIM1;KMT2A;APIP;MPPED2;CXXC5;TRHDE;LIMS1;ENPP1;CALB1;COA6;SEC24D;GYG1;ZDHHC15;TES;SMPD1;RC3H1;SMAD3;KDM5C;CA2;EPRS1;NPEPPS;RBAK;LANCL1;KAT6A;TP53;PCK2;SUV39H2;ZNF3;LACC1;CCS;ADCY2;TNFSF10
prerank,ubiquitin protein ligase binding (GO:0031625),0.37042397227965385,0.8825976613318278,0.75,1.0,1.0,46/254,15.32%,BRCA1;UBE2T;RAD18;SMC6;TRIM37;RB1;TRIOBP;GSK3B;UBE2K;GPI;NLK;CHEK2;FAF1;CXCR4;RPA2;SLF1;FANCL;ARRB1;FBXW7;PML;UBE2N;CUL5;POLR2A;RNF31;RNF40;TRIM28;MFN2;SMAD6;CUL3;AXIN2;CUL4B;PSMD1;IKBKG;HERC2;UBOX5;ARRDC1;BAG5;SUMO2;CASP8;UBE2J1;SPOP;HLTF;SMAD3;PER1;FAF2;SLC22A18
prerank,R-SMAD binding (GO:0070412),0.4299493733234867,0.8820327228461382,0.5812743823146944,1.0,1.0,7/18,19.45%,PMEPA1;SMURF1;SMAD6;SMAD4;SMAD3;SMAD2;PPM1A
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.3941488869150426,0.8813691548437494,0.5950413223140496,1.0,1.0,18/35,25.30%,AGO2;POU2F1;SMARCA4;NR3C1;HDAC1;GTF2A1;TAF4;RUVBL2;DR1;DRAP1;TP53;FOXP1;GTF2B;UBTF;H3-3A;SMARCB1;RELA;BAZ2A
prerank,RNA cap binding (GO:0000339),0.43920193175323097,0.8797383346887602,0.5877659574468085,1.0,1.0,3/16,8.24%,AGO2;EIF4E;LARP1
prerank,nuclear receptor binding (GO:0016922),0.370812754372319,0.8792601573157193,0.676923076923077,1.0,1.0,34/111,20.59%,TRIP6;CNOT1;MED14;ACTN4;ASXL1;THRAP3;LCOR;TCF7L2;MED30;ARID1A;MED24;SMARCA4;ZNHIT3;NR4A2;MMS19;GRIP1;NCOA2;PRKCB;TRIP12;NR4A1;PPID;NCOA7;MED1;SMAD3;JMJD1C;DCAF1;BRD8;TAF10;FOXP1;ARID5A;MED16;GTF2B;RNF14;MED25
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.2528643774470441,-0.8765872863631861,0.6277372262773723,0.8478648855992101,1.0,10/32,23.23%,SLC6A6;SFXN2;SLC7A5;SLC3A2;SLC1A1;SLC38A5;SLC25A38;SFXN3;SLC36A1;SLC6A7
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.38319709950564934,0.8746579019437435,0.6168327796234773,1.0,1.0,12/49,18.79%,RAD18;ZRANB3;RNF168;UIMC1;AGAP3;IKBKG;BRCC3;OTUD7B;RNF169;RAD23B;EPS15;ZBTB1
prerank,heme binding (GO:0020037),0.36810575817883256,0.873080445838312,0.6404255319148936,1.0,1.0,12/65,18.40%,DGCR8;CYP26B1;PTGES2;NOX4;CYBB;PGRMC2;CYB5B;HCCS;SRC;CYB5A;THAP4;PTGIS
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.42706135364985265,0.8726547633255937,0.576551724137931,1.0,1.0,4/14,17.22%,MINDY4;USP9X;OTUD7B;MINDY3
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.4473820134997461,0.8712119550175375,0.6085106382978723,1.0,1.0,6/12,24.91%,FXN;XDH;CISD2;ISCA2;SDHB;CIAPIN1
prerank,protein tyrosine kinase activator activity (GO:0030296),-0.2914095697714562,-0.8705138646757234,0.6637554585152838,0.855229165796202,1.0,10/19,29.93%,NRG3;GAS6;GRM5;DGKQ;AFAP1L2;EFNA5;EGF;ERBB3;PAK2;CD24
prerank,acyl-CoA hydrolase activity (GO:0047617),-0.2936695403165959,-0.870388127441994,0.671875,0.8501928055903492,1.0,5/17,24.99%,ACOT11;PPT1;ACOT7;ACOT13;ACOT6
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.3104870035986203,-0.865478211851284,0.6573426573426573,0.8551689743309383,1.0,5/15,15.47%,SLC1A2;SLC25A13;SLC25A12;SLC17A6;SLC1A1
prerank,androgen receptor binding (GO:0050681),-0.2709720682231475,-0.8651544579630897,0.7208121827411168,0.8505911095857017,1.0,8/25,20.36%,EP300;PRPF6;PRMT2;KDM4C;DDX5;TGFB1I1;PARK7;SNW1
prerank,phosphoric diester hydrolase activity (GO:0008081),0.39438543078557586,0.8635797433331881,0.6242568370986921,1.0,1.0,12/35,18.03%,APEX2;TDP2;ENPP2;SMPDL3A;ENPP3;MPPED2;ENPP1;SMPD1;PLCB4;SMPD3;GDE1;SMPD2
prerank,metalloaminopeptidase activity (GO:0070006),0.4301864273680317,0.8621909090112578,0.6267409470752089,1.0,1.0,4/16,14.91%,MMP14;LVRN;TRHDE;NPEPPS
prerank,alkali metal ion binding (GO:0031420),0.4358095627282881,0.862133984003243,0.5922865013774105,1.0,1.0,3/13,10.88%,PDXK;ACAT1;DRG1
prerank,ATPase regulator activity (GO:0060590),-0.23637501203198485,-0.8619842899607082,0.75177304964539,0.8515614960346699,1.0,8/38,10.56%,ATP1B1;DNAJC24;DNAJC19;SIL1;DNAJA1;HSPH1;ATP1B3;PFN1
prerank,5'-3' RNA polymerase activity (GO:0034062),0.3944548180167303,0.8612306446730571,0.6068376068376068,1.0,1.0,4/27,7.55%,TENT2;POLR1A;POLR1B;POLR2A
prerank,active ion transmembrane transporter activity (GO:0022853),-0.24241082231460992,-0.85997473184946,0.7152777777777778,0.8503873638997197,1.0,7/37,7.94%,SLCO1C1;SLC22A8;SLCO2B1;COX4I1;COX5A;SLCO2A1;SLC22A6
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.41468541882223253,0.8598847769601695,0.5967336683417085,1.0,1.0,6/22,15.31%,ZRANB3;RNF168;UIMC1;IKBKG;OTUD7B;RNF169
prerank,UDP-glycosyltransferase activity (GO:0008194),0.3641224310025502,0.8592819711382346,0.6592592592592592,1.0,1.0,6/70,6.38%,HAS3;HYAL1;LARGE1;B4GALT1;B3GNT8;CHSY1
prerank,RNA polymerase II complex binding (GO:0000993),0.388469813487954,0.8580410385405729,0.6096385542168675,1.0,1.0,8/32,12.87%,AGO2;DHX9;ELOF1;PCF11;SCAF8;HNRNPU;BRD4;RPRD1A
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.28324759272388544,-0.8562673933047343,0.6889952153110048,0.8528513201687861,1.0,5/21,25.57%,GLRB;CHRNA7;GRIK2;P2RX4;P2RX7
prerank,nucleotide diphosphatase activity (GO:0004551),-0.3089473671489873,-0.8555831378220062,0.6402877697841727,0.8490717081422595,1.0,6/14,22.67%,FHIT;NUDT3;ENPP4;ENPP5;NUDT6;NUDT12
prerank,MAP kinase phosphatase activity (GO:0033549),-0.328173963490066,-0.8553236685717024,0.6863354037267081,0.8444773518804952,1.0,4/12,28.43%,DUSP3;DUSP1;DUSP8;DUSP6
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.310900423814913,-0.8551677100702789,0.6785714285714286,0.8397501430088221,1.0,6/15,17.97%,PIK3R3;PIK3C2B;ATM;PI4KA;PIK3CD;PIK3CA
prerank,calcium channel inhibitor activity (GO:0019855),0.4441903634196802,0.8520797617789774,0.6138032305433186,1.0,1.0,3/11,10.79%,ITPR1;MCUB;CALM2
prerank,endoribonuclease activity (GO:0004521),-0.2485778133029681,-0.8517745546380069,0.6918238993710691,0.8415019698318442,1.0,13/32,27.61%,AGO1;AGO3;NYNRIN;DICER1;RIDA;ENDOV;ZC3H12A;EXOG;NOB1;TSNAX;RNASEL;INTS11;ZC3H12B
prerank,glycerophospholipid flippase activity (GO:0140333),0.4351763140254184,0.8504097388417569,0.609308885754584,1.0,1.0,2/11,4.62%,ABCA4;ABCB4
prerank,N-acyltransferase activity (GO:0016410),0.3890502163898879,0.8502117820155167,0.6349397590361445,1.0,1.0,3/32,3.17%,NAT14;CERS6;CERS5
prerank,metalloexopeptidase activity (GO:0008235),0.3744991294093881,0.8498582586057537,0.6530837004405287,1.0,1.0,11/51,18.03%,VASH2;MMP14;LVRN;AGBL2;CPXM1;CPQ;TRHDE;NPEPPS;AGTPBP1;METAP1;DPEP1
prerank,GABA receptor binding (GO:0050811),0.4303832204542463,0.8462618561538057,0.6202898550724638,1.0,1.0,1/11,3.15%,TRAK1
prerank,I-SMAD binding (GO:0070411),0.4213124466351471,0.8460196789860922,0.6107954545454546,1.0,1.0,6/13,17.44%,SMURF1;SMAD6;TGFBR1;SMAD4;SMAD3;SMAD2
prerank,mRNA 5'-UTR binding (GO:0048027),0.3923596416553012,0.8432903075925573,0.6400506970849176,1.0,1.0,4/24,8.24%,SYNCRIP;MYH10;FMR1;LARP1
prerank,transcription coactivator binding (GO:0001223),0.3959026445502017,0.8414826816611792,0.6102564102564103,1.0,1.0,5/20,14.18%,CIT;AHR;RORA;SMAD4;SMAD3
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.3520741909253974,0.8387472449757393,0.7803410230692076,1.0,1.0,31/181,14.18%,RBL1;SETD6;RB1;MIER1;RBBP8;GSK3B;DDRGK1;ACTN4;DHX9;BHLHE41;FAF1;MKKS;TCF7L2;ARID1A;ELK1;SMARCA4;MIER3;TEAD3;MTA3;PARP9;TAL1;HDAC1;NCOA2;TAF4;RBPJ;HDAC2;NCOA7;HEY2;MED1;ARNT;SMAD3
prerank,growth factor activity (GO:0008083),-0.21338364061068804,-0.837570190668678,0.775,0.8631931236785344,1.0,15/74,20.04%,NRG3;VEGFC;JAG1;FGF2;IGF2;TGFA;GRN;FGF1;VEGFA;JAG2;VEGFB;VEGFD;INHBA;CSPG5;HBEGF
prerank,carboxypeptidase activity (GO:0004180),0.3776022076982485,0.8337185205195039,0.6373239436619719,1.0,1.0,4/35,9.16%,VASH2;AGBL2;CPXM1;SCPEP1
prerank,RNA polymerase core enzyme binding (GO:0043175),0.37330139572012777,0.8324713947088184,0.6539833531510107,1.0,1.0,8/33,12.87%,AGO2;DHX9;ELOF1;PCF11;SCAF8;HNRNPU;SPTY2D1;RPRD1A
prerank,ribosomal small subunit binding (GO:0043024),0.4078027167141719,0.8282854376653689,0.6373626373626373,1.0,1.0,8/17,23.83%,EIF4H;LARP1;CPEB2;PIM1;MTIF3;PTCD3;EIF4B;ABCE1
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.40825579283975555,0.827156908507916,0.6316507503410641,1.0,1.0,5/14,18.50%,CASP8AP2;APAF1;CTSH;BCL2L13;BAD
prerank,translation elongation factor activity (GO:0003746),-0.29605105217812555,-0.823008168417169,0.7162629757785467,0.8858404394011257,1.0,5/14,24.98%,EEF1A1;EEF2;EEF1B2;TSFM;EIF5A2
prerank,signaling receptor complex adaptor activity (GO:0030159),0.365844971009597,0.8225444949922173,0.6817640047675805,1.0,1.0,8/38,12.17%,SPAG9;FRS2;LRRK2;NCK1;MMS19;GRIP1;MAPK8IP3;NCK2
prerank,UDP-galactosyltransferase activity (GO:0035250),0.4253171453458158,0.8204519849831449,0.6611195158850227,1.0,1.0,2/10,7.94%,B4GALT1;B4GALT7
prerank,phosphatidylinositol binding (GO:0035091),0.34819773182812197,0.8203855051677501,0.7238883143743536,1.0,1.0,30/91,22.26%,ITPR1;NUMA1;SNX1;PARD3B;MAPT;SESTD1;ZFYVE16;ZFYVE1;PICALM;SNX27;PITPNB;PIGU;AIDA;APPL2;ITPR3;DENND1A;MITD1;EXOC8;C2CD2L;PASK;PLEKHF2;ZFYVE9;DPEP1;EEA1;SNAP91;MYO1E;PHF12;GPAA1;APPL1;SNX9
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",-0.33217828597410326,-0.8196494347745439,0.7236024844720497,0.8870363080959787,1.0,2/11,20.76%,DDAH2;PADI2
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.28195649632292286,-0.8190718157021168,0.7458333333333333,0.8780309461062532,1.0,7/17,28.77%,EPHA5;EPHB2;EPHA8;EFNB3;EPHB4;EPHA2;EPHB3
prerank,ephrin receptor activity (GO:0005003),-0.28195649632292286,-0.8190718157021168,0.7458333333333333,0.8780309461062532,1.0,7/17,28.77%,EPHA5;EPHB2;EPHA8;EFNB3;EPHB4;EPHA2;EPHB3
prerank,hexose transmembrane transporter activity (GO:0015149),-0.3184840566152344,-0.8181772541417603,0.6928104575163399,0.8743696455615643,1.0,2/12,14.62%,SLC2A1;SLC2A3
prerank,gap junction channel activity (GO:0005243),0.3878400327970834,0.8169739071085346,0.666243654822335,1.0,1.0,3/22,12.58%,GJD3;GJC1;GJA1
prerank,wide pore channel activity (GO:0022829),0.38205624734431676,0.8169697703970794,0.6658354114713217,1.0,1.0,3/23,12.58%,GJD3;GJC1;GJA1
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.42637252415349264,0.816813172938428,0.6587887740029542,1.0,1.0,2/10,12.60%,CASP7;CASP8
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.38838990136666274,0.8166258439398896,0.6549560853199499,1.0,1.0,5/20,14.53%,LPCAT1;AGPAT2;LCLAT1;AGPAT3;AGPAT1
prerank,cyclic nucleotide binding (GO:0030551),-0.26019266686257464,-0.8151191330964501,0.7426160337552743,0.8747615660851137,1.0,6/21,18.18%,HCN1;KCNH1;CNBD2;PDE10A;PDE2A;PDE4D
prerank,receptor ligand activity (GO:0048018),0.341859668197528,0.8148033168943382,0.8488488488488488,1.0,1.0,17/245,12.26%,TNFSF13B;HMGB2;ARTN;WNT2B;ERFE;SFRP2;BMP6;IL18;INSL6;FAM3C;WNT6;AGT;HMGB1;EDA;CNTF;BMP2;WNT9A
prerank,calcium activated cation channel activity (GO:0005227),0.38455854578498405,0.8075388280963226,0.6461748633879781,1.0,1.0,5/17,14.58%,KCNN4;KCNMB2;KCNMB3;TRPM4;KCNMB4
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.40172682666944876,0.8056130179698333,0.6823855755894591,1.0,1.0,4/15,15.56%,SETD3;KMT2A;KMT2D;SETD4
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.3848363157236099,0.8048055947700614,0.6557823129251701,1.0,1.0,4/18,10.37%,TGFBR3L;BMPR1A;TGFBR3;TGFBR1
prerank,neuropeptide hormone activity (GO:0005184),0.3733739452320678,0.8040569082316187,0.6726342710997443,1.0,1.0,1/22,3.55%,AGRP
prerank,DNA-binding transcription factor binding (GO:0140297),0.3379258634914529,0.8036283624718755,0.8254764292878636,1.0,1.0,35/189,16.69%,RBL1;CBX5;RB1;MIER1;RBBP8;GSK3B;DDRGK1;FHL2;DHX9;BHLHE41;EIF4E;CTBP1;SRF;MKKS;TCF7L2;ELK1;YAP1;MIER3;HMGB1;TEAD3;MTA3;CXXC5;RUNX1T1;TAL1;HDAC1;RBPJ;HDAC2;TWIST1;HEY2;SMAD3;TLE4;TLE3;TP53;PURA;RERE
prerank,muscle alpha-actinin binding (GO:0051371),0.39473134748610417,0.8024997830065279,0.6634615384615384,1.0,1.0,4/15,15.27%,PDLIM4;PDLIM5;SYNPO2;PKD2
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.3669214367699804,0.7998430076168636,0.660574412532637,1.0,1.0,4/22,13.27%,ILF3;CPEB2;RBMS3;MEX3D
prerank,alanine transmembrane transporter activity (GO:0022858),-0.3073716201933985,-0.7978535997262357,0.708904109589041,0.8998225054459322,1.0,2/12,5.75%,SLC6A6;SLC3A2
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.3183279093031873,-0.7974450844438367,0.719626168224299,0.895487544130078,1.0,4/11,29.16%,SLC2A10;SLC5A11;SLC2A9;SLC5A3
prerank,cell-cell adhesion mediator activity (GO:0098632),0.36062007028061,0.7967191856381812,0.7056128293241696,1.0,1.0,11/42,17.51%,ANXA2;RAB10;DSCAML1;DSCAM;ANXA1;EMB;PDLIM5;BAIAP2L1;TMOD3;SIRPA;CD47
prerank,voltage-gated chloride channel activity (GO:0005247),-0.32067590837142407,-0.7964526665982136,0.7322580645161291,0.8921618011355053,1.0,4/10,22.74%,ANO6;ANO1;CLCN2;CLCN4
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.4226747404918686,0.7958757097368631,0.6854103343465046,1.0,1.0,5/10,25.16%,SIRPA;CD47;DSG2;CXADR;CD200
prerank,myosin V binding (GO:0031489),-0.28369012706606633,-0.7868104818688091,0.737037037037037,0.9034542355859048,1.0,8/15,27.68%,RAB6B;RAB27B;RAB11A;RAB39B;RAB3D;RAB6A;RAB3B;RAB14
prerank,sulfuric ester hydrolase activity (GO:0008484),0.3987859202057703,0.7867716731587073,0.7090352220520674,1.0,1.0,5/12,19.01%,SULF2;SULF1;ARSB;ARSI;ARSG
prerank,potassium ion leak channel activity (GO:0022841),0.3832758779508852,0.7857112582685819,0.6835443037974683,1.0,1.0,3/15,12.70%,KCNK2;KCNK12;KCNK6
prerank,NADP binding (GO:0050661),0.35392421074300884,0.7833734288789747,0.6738351254480287,1.0,1.0,8/32,20.05%,GMDS;LBR;DPYD;TM7SF2;DHFR;DHCR7;CRYZL1;ME3
prerank,aminopeptidase activity (GO:0004177),0.35951721594786373,0.782961038046797,0.6862745098039216,1.0,1.0,6/26,17.78%,MMP14;LVRN;TRHDE;CTSH;NPEPPS;METAP1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.3388327748434576,0.7827230055399961,0.7198275862068966,1.0,1.0,17/54,21.76%,MIER1;UPB1;DARS1;NADSYN1;MIER3;HDAC8;HINT1;HDAC1;ASRGL1;HDAC2;NTAN1;NTAQ1;MIER2;ASPA;HDAC4;NAAA;SIRT2
prerank,acid-thiol ligase activity (GO:0016878),0.3918447738857633,0.7827071171848423,0.6901408450704225,1.0,1.0,2/13,14.11%,ACSS1;AACS
prerank,hexosyltransferase activity (GO:0016758),0.3268120482678028,0.7807603957038702,0.7887755102040817,1.0,1.0,12/101,12.55%,POMT1;HAS3;HYAL1;LARGE1;B4GALT1;B3GNT8;CHSY1;B4GALT7;HAS1;POFUT1;TMTC4;GYG1
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.402420233708467,0.7802473236256293,0.7124087591240876,1.0,1.0,2/11,12.60%,CASP7;CASP8
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.4008218547560461,0.7788970359412122,0.7155688622754491,1.0,1.0,3/11,12.31%,ITPR1;TRPC7;ITPR3
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.39267239765692086,0.7777411493277153,0.6923076923076923,1.0,1.0,5/12,20.18%,PDE3B;PDE7B;PDE7A;PDE4A;PDE4B
prerank,endopeptidase inhibitor activity (GO:0004866),0.3274724241520628,0.7775094479253234,0.7753164556962026,1.0,1.0,7/82,9.66%,SERPINB8;SERPINA9;ANXA2;PRNP;SERPINE1;ROCK1;AGT
prerank,endopeptidase activator activity (GO:0061133),0.40910478199049877,0.7762044469181796,0.6913946587537092,1.0,1.0,3/10,20.60%,PSMD14;ADRM1;PSME3
prerank,G protein-coupled receptor binding (GO:0001664),-0.16545822333534474,-0.7748654889559319,0.9166666666666666,0.9186001299346006,1.0,24/132,17.68%,PRKN;GNAI1;GNA12;HOMER1;BICD1;ARHGEF12;DNAJA1;GNAL;ITGB4;GNA14;ACE;GPRASP2;PACRG;AGTR1;PSMC5;STUB1;TAFA5;PTCH1;SDCBP;S1PR1;DVL1;LRP6;USP33;PICK1
prerank,syntaxin-1 binding (GO:0017075),-0.24364281467769494,-0.7748092378409787,0.7905138339920948,0.9136899678832171,1.0,8/22,17.61%,UNC13B;SYT1;SYNPR;SNPH;CPLX1;SNAP25;VAMP3;SYPL1
prerank,neurexin family protein binding (GO:0042043),0.40010536465361457,0.7725302772230375,0.7123076923076923,1.0,1.0,4/10,19.39%,NLGN3;SYTL4;NLGN2;SYTL5
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.3491611954904285,0.7715253416584917,0.7255139056831923,1.0,1.0,11/33,21.41%,AGO2;DHX9;ELOF1;PCF11;SCAF8;HNRNPU;RPRD1A;DRAP1;RPRD1B;GTF2B;SMYD2
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.3934338557363728,0.7701377270181655,0.7151335311572701,1.0,1.0,3/11,24.67%,SLC25A47;SLC25A29;SLC22A4
prerank,tRNA binding (GO:0000049),-0.2050864626260897,-0.7686117036994599,0.8879310344827587,0.9184917530101757,1.0,20/43,36.70%,EEF1A1;TRMT9B;AARS1;NSUN2;SARS1;DALRD3;TRMT10B;KARS1;TRMT10A;RPUSD4;IGHMBP2;YARS2;ALKBH1;PTCD1;YRDC;XPOT;TRMT10C;PUS1;HSD17B10;SEPSECS
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.3794155706215136,0.7678560679408083,0.6917613636363636,1.0,1.0,4/14,17.98%,MTHFR;PYCR1;DHFR;BLVRB
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.394862795813034,0.7672761485344974,0.7256371814092953,1.0,1.0,3/10,18.03%,DPYSL4;DPYSL3;DPEP1
prerank,Tat protein binding (GO:0030957),-0.3140580352763445,-0.7658366389509669,0.7640117994100295,0.9180113732838049,1.0,2/10,7.54%,ACTB;DNAJA1
prerank,hormone activity (GO:0005179),0.33270685719143017,0.7653608870212981,0.7516268980477223,1.0,1.0,4/54,9.66%,AGRP;ERFE;INSL6;AGT
prerank,phosphatase activity (GO:0016791),0.32430785632968606,0.7639181290215306,0.782791185729276,1.0,1.0,10/73,14.28%,PON1;LHPP;OCRL;LPIN2;PHOSPHO2;DUSP12;PLPP1;PLPP5;PPP1CC;ARMT1
prerank,general transcription initiation factor binding (GO:0140296),0.35455300864143113,0.762947058740185,0.7238805970149254,1.0,1.0,8/25,15.98%,PSMC2;TAF12;GTF2A1;AHR;RUVBL2;YEATS2;DR1;DRAP1
prerank,ribonuclease activity (GO:0004540),0.3329089657118028,0.7623689890751026,0.7415485278080698,1.0,1.0,12/56,16.54%,AGO2;RNASE6;RNASEH2A;RPP40;CNOT6;PPP1R8;RNASE1;EXOSC7;RNASE12;SMG6;CNOT7;KHNYN
prerank,tropomyosin binding (GO:0005523),-0.26695831380117097,-0.7615315434792906,0.7890909090909091,0.91978545049004,1.0,2/16,6.71%,S100A6;NEBL
prerank,potassium:proton antiporter activity (GO:0015386),0.3902652333411268,0.759147535033494,0.7142857142857143,1.0,1.0,1/10,8.75%,SLC9A5
prerank,enoyl-CoA hydratase activity (GO:0004300),0.3967704687433584,0.7570575475512923,0.7331288343558282,1.0,1.0,1/10,2.74%,ECHDC3
prerank,snoRNA binding (GO:0030515),0.34631881314662233,0.7548883863503524,0.7346437346437347,1.0,1.0,6/30,13.60%,PRKDC;NUDT5;DHX37;TSR1;NUDT4;DDX21
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.31875362332924057,0.7547498351910863,0.8134556574923547,1.0,1.0,20/100,16.93%,RACGAP1;IQGAP2;ARFIP1;GBF1;MAPT;SESTD1;ZFYVE16;ZFYVE1;MAPKAP1;OSBPL8;SNX27;CYTH3;CLVS2;DENND1A;BTK;GSDMD;ATG2A;DAPP1;SH3PXD2B;VEPH1
prerank,mitogen-activated protein kinase binding (GO:0051019),0.3404404399483856,0.7535138320644595,0.698159509202454,1.0,1.0,7/29,20.66%,PPM1D;TPR;MAPKAPK3;MAPK14;DUSP7;ATF7;MAPKAPK2
prerank,anion transmembrane transporter activity (GO:0008509),0.3803812510640854,0.7526381649129397,0.7308823529411764,1.0,1.0,3/12,10.98%,SLC19A1;SLC4A2;SLC39A8
prerank,transforming growth factor beta receptor binding (GO:0005160),0.36665859286996166,0.7521005226020179,0.7150610583446404,1.0,1.0,6/18,17.44%,TGFBR3L;TGFBR3;SMAD6;TGFBR1;SMAD3;SMAD2
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.3921130321911027,0.7501513803235874,0.7466863033873343,1.0,1.0,2/11,9.24%,PIGN;PTDSS2
prerank,potassium channel regulator activity (GO:0015459),0.32340121377866743,0.7473307363239059,0.7651006711409396,1.0,1.0,12/49,18.28%,WNK1;KCNMB2;KCNMB3;KCNIP3;AKAP9;ENSA;DLG1;ADRB2;KCNMB4;DPP6;WNK3;AMIGO1
prerank,cation transmembrane transporter activity (GO:0008324),0.3299510869371706,0.7433591533289932,0.7809419496166484,1.0,1.0,10/48,18.95%,SLC25A15;SLC38A7;SLC25A2;SLC38A9;SLC15A4;SLC1A5;SLC36A4;SLC7A1;SLC6A9;SLC38A2
prerank,potassium channel activity (GO:0005267),0.30932866340446497,0.7417692138019812,0.8128898128898129,1.0,1.0,15/89,15.72%,AQP1;CCDC51;KCNN4;KCNK2;KCNH4;KCNH8;GRIK3;KCNMB2;KCNMB3;KCNK12;KCNK6;KCNMB4;PKD2;KCNT2;KCNB2
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.3542694043527695,0.737435718589042,0.7635402906208718,1.0,1.0,8/20,25.15%,SENP1;USP21;USP9X;USP47;EIF3H;COPS5;USP25;UFSP2
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.3697720312772342,0.7371312141204782,0.7503467406380028,1.0,1.0,5/13,17.54%,GSK3B;EZR;SOX9;PRKAR2B;PRKAR2A
prerank,GTP binding (GO:0005525),0.3059826523284862,0.7369122040317293,0.8957915831663327,1.0,1.0,35/172,18.23%,RANBP17;TUBB6;TUBA1C;TUBE1;RHOA;RAB10;RRAD;RHOT1;RAP2A;ATL2;ATL3;RAB22A;RAB29;RASEF;TUBD1;LRRK2;RHOQ;DNM2;DRG1;RAC1;RND2;TSR1;RRAS;SEPHS1;DRG2;ARF4;ARL4A;GNL3;RHOC;ARF3;RRAS2;RAB13;ARL5A;NRAS;KRAS
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.23337305165897704,-0.7346671706421903,0.8651162790697674,0.9527911882365939,1.0,8/23,29.02%,PLCB3;PLCG1;PLCE1;CHRM3;PLCH1;PLCB1;PLCD1;PLCD3
prerank,mannose binding (GO:0005537),-0.2808917992600055,-0.7335219991689407,0.8282208588957055,0.9491269035086562,1.0,8/12,53.20%,CLN5;LMAN2L;LMAN2;LMAN1;ACR;COLEC11;LMAN1L;CLEC4D
prerank,sodium channel regulator activity (GO:0017080),0.3273472558052095,0.7331482746889464,0.7638888888888888,1.0,1.0,3/37,4.48%,ATP2B4;RANGRF;NEDD4
prerank,death domain binding (GO:0070513),-0.28128864478605625,-0.7331336382249728,0.8215384615384616,0.9445615181606744,1.0,6/11,21.91%,CRADD;BCL2;IRGM;DAPL1;BCL2L1;RACK1
prerank,sterol binding (GO:0032934),0.3185141330623216,0.7313610121235951,0.7761033369214209,1.0,1.0,17/56,20.99%,GRAMD1C;TSPO2;SOAT1;OSBPL8;ABCA1;SCAP;RORA;SOAT2;SIDT1;VDAC2;STARD3;SYP;ERLIN1;INSIG2;GRAMD1B;TSPO;INSIG1
prerank,secondary active transmembrane transporter activity (GO:0015291),0.31842471234817277,0.7312573028070717,0.794928335170893,1.0,1.0,9/51,13.57%,SLCO4A1;SLC20A2;SLC35D1;SLC35D2;SLC16A10;SLC16A2;MCU;SLC25A30;SLCO3A1
prerank,galactosyltransferase activity (GO:0008378),0.373068399306908,0.7306484170929544,0.7626112759643917,1.0,1.0,2/11,7.94%,B4GALT1;B4GALT7
prerank,guanyl ribonucleotide binding (GO:0032561),0.3032930033238825,0.7295499415733915,0.9168336673346693,1.0,1.0,39/196,18.23%,RANBP17;TUBB6;TUBA1C;TUBE1;RHOA;RAB10;RRAD;RHOT1;RAP2A;SLC19A1;ATL2;ATL3;RAB22A;RAB29;RASEF;TUBD1;LRRK2;RHOQ;DNM2;MPPED2;MIEF1;DRG1;RAC1;RND2;TSR1;RRAS;SEPHS1;GNAI3;DRG2;ARF4;ARL4A;GNL3;RHOC;ARF3;RRAS2;RAB13;ARL5A;NRAS;KRAS
prerank,chemoattractant activity (GO:0042056),0.3293919378958932,0.726642642071994,0.7693251533742331,1.0,1.0,1/26,1.39%,HMGB2
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.3613014298636814,0.7247675836153773,0.7478753541076487,1.0,1.0,4/13,18.45%,SLC38A7;SLC15A4;SLC7A1;SLC25A29
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.3642882000779407,0.7236737555005558,0.7417503586800573,1.0,1.0,4/12,26.43%,SLC9A5;LETM1;SLC9B2;SLC9A8
prerank,ribosome binding (GO:0043022),0.31830134231779034,0.7225542165300117,0.7774049217002237,1.0,1.0,13/46,19.52%,SERBP1;ERI1;FMR1;EFL1;NCLN;CPEB2;EIF3C;SRP72;MAIP1;PYM1;MTIF3;ETF1;CCDC47
prerank,protein kinase C activity (GO:0004697),0.35641548240211124,0.7215212351888463,0.7439544807965861,1.0,1.0,7/14,21.11%,PRKCB;PRKCA;PRKCE;PRKCI;PRKD1;PRKCD;PRKD3
prerank,translation initiation factor activity (GO:0003743),0.3236298404643555,0.7186675656004606,0.7571265678449259,1.0,1.0,13/36,23.22%,AGO2;EIF4E;EIF2B1;EIF3C;EIF4A2;EIF3H;MTIF3;EIF3I;EIF2D;COPS5;EIF5;EIF2B5;EIF3B
prerank,MAP kinase activity (GO:0004707),0.3597879124068524,0.7176465034649113,0.7511111111111111,1.0,1.0,2/14,4.15%,NLK;MAPK4
prerank,protease binding (GO:0002020),0.3039670981027398,0.7148249004091423,0.8475798146240988,1.0,1.0,19/99,17.14%,BRCA2;FADD;ANXA9;GSK3B;ANXA2;PRNP;LCOR;DERL2;SERPINE1;RIOK3;BDKRB2;ADRM1;INSL3;ITGB1;ITGAV;TP53;PTEN;STIM1;LDLR
prerank,frizzled binding (GO:0005109),0.3324159713931665,0.7137701120443667,0.7848837209302325,1.0,1.0,5/34,15.25%,WNT2B;RNF43;WNT6;WNT9A;SFRP1
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.3128973993955825,0.713519783606994,0.8052805280528053,1.0,1.0,13/53,20.37%,SLC25A15;SLC38A7;SLC25A2;SLC38A9;SLC15A4;SLC1A5;SLC25A22;SLC36A4;SLC7A1;SLC6A9;SLC38A2;SLC1A3;SLC7A11
prerank,double-stranded RNA binding (GO:0003725),0.3072499289941764,0.7126008000027775,0.8397905759162304,1.0,1.0,14/70,16.04%,ILF3;DGCR8;AGO2;DHX9;EIF4H;FMR1;RC3H2;HNRNPU;ILF2;SIDT1;RC3H1;STRBP;FXR1;MSN
prerank,phosphatidic acid binding (GO:0070300),0.3453589335568895,0.7068549883008332,0.7845744680851063,1.0,1.0,7/19,22.62%,PACSIN2;SESTD1;MAPKAP1;GSDMD;SMPD3;GRAMD1B;RAPGEF6
prerank,deubiquitinase activity (GO:0101005),0.29879396932052743,0.7061932652778408,0.8658280922431866,1.0,1.0,26/88,22.38%,MINDY4;USP1;USP18;USP37;PSMD14;USP21;USP16;USP28;USP9X;USP47;BRCC3;OTUD1;OTUD7B;USP48;MINDY3;EIF3H;USP14;USP46;USP20;OTUD3;PAN2;TANK;COPS5;ZRANB1;MYSM1;USP2
prerank,mannosyltransferase activity (GO:0000030),0.3342719266436617,0.7017062865513335,0.7976952624839949,1.0,1.0,4/21,15.74%,POMT1;TMTC4;ALG8;PIGM
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.35630755914785694,0.7011154093743696,0.7821067821067821,1.0,1.0,1/11,3.50%,MAP4K2
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.22151486120166847,-0.7002259882580151,0.9020618556701031,0.9792084744923715,1.0,8/24,23.01%,GLUL;ZDHHC1;ZDHHC7;ZDHHC8;GOLGA7;ZDHHC20;ZDHHC4;ZDHHC17
prerank,nucleobase-containing compound kinase activity (GO:0019205),-0.2438429847568355,-0.6998311980394519,0.8968253968253969,0.9746127741037244,1.0,9/17,29.64%,AK3;NME6;CMPK1;AK5;AK4;CMPK2;CLP1;AK1;NME2
prerank,cholesterol binding (GO:0015485),0.3098714425289863,0.6996547828398179,0.8060200668896321,1.0,1.0,11/47,16.90%,GRAMD1C;TSPO2;SOAT1;OSBPL8;ABCA1;SOAT2;SIDT1;VDAC2;STARD3;SYP;ERLIN1
prerank,CoA-ligase activity (GO:0016405),0.34718437630234333,0.6967749247360855,0.7762039660056658,1.0,1.0,2/14,14.11%,ACSS1;AACS
prerank,protein phosphatase regulator activity (GO:0019888),0.30346885626543685,0.6965725956888915,0.8304535637149028,1.0,1.0,17/53,21.14%,PPP2R3A;PPP1R7;PPP2R5C;CALM2;PPP2R2D;ENSA;PPP1R15B;PTPA;PPP2R5B;ANKLE2;PPP2R1B;PPME1;PPP6R2;BOD1L1;PHACTR4;PPP4R1;EIF2AK2
prerank,alpha-actinin binding (GO:0051393),0.3252213672519767,0.6944248072035922,0.7886792452830189,1.0,1.0,5/24,15.27%,PDLIM4;CACNA1C;PDLIM5;SYNPO2;PKD2
prerank,clathrin adaptor activity (GO:0035615),0.34589035395408063,0.6940222643034287,0.796398891966759,1.0,1.0,2/15,5.55%,STON1;STON2
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.2715287347095631,-0.6910465251083404,0.8613569321533924,0.9785392404501428,1.0,5/11,28.79%,PPP1R1A;PPP1R11;PPP1R14A;PABIR1;PPP1R14B
prerank,phospholipase C activity (GO:0004629),-0.21680781392539286,-0.6885177242064612,0.92,0.9761859236465891,1.0,8/25,29.02%,PLCB3;PLCG1;PLCE1;CHRM3;PLCH1;PLCB1;PLCD1;PLCD3
prerank,sodium:proton antiporter activity (GO:0015385),0.3474327385368005,0.6826831077939471,0.7880116959064327,1.0,1.0,1/11,8.75%,SLC9A5
prerank,anion:anion antiporter activity (GO:0015301),0.33218276131313657,0.6824644772274217,0.8088033012379643,1.0,1.0,2/17,8.29%,SLC19A1;SLC4A2
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.31882493619335606,0.6780234629594579,0.8134146341463414,1.0,1.0,5/24,14.82%,PMVK;PPIP5K1;IP6K2;DTYMK;AK7
prerank,GTPase activity (GO:0003924),0.28439063846986573,0.6775492494451771,0.92992992992993,1.0,1.0,32/192,15.78%,RAB33B;RHOA;GNG8;ABCA4;RHOT1;RAP2A;ATL2;EFL1;ATL3;RAB22A;GNA13;RAB29;LRRK2;AGAP3;MFN2;GNAQ;RHOQ;TPPP;DNM2;SRPRA;RAB1A;DRG1;RAC1;RND2;TSR1;RRAS;GNAI3;DRG2;GNG5;GFM2;RHOC;MFN1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.32437055547161314,0.6768805576437257,0.8233082706766918,1.0,1.0,2/21,12.23%,ANXA9;CHRNB1
prerank,ribosomal large subunit binding (GO:0043023),0.3435940751109735,0.6756742194061852,0.8156748911465893,1.0,1.0,2/11,9.19%,NMD3;CPEB2
prerank,potassium ion antiporter activity (GO:0022821),0.3310027849995574,0.6749222207185104,0.8094575799721836,1.0,1.0,2/15,9.45%,SLC9A5;SLC24A3
prerank,proton transmembrane transporter activity (GO:0015078),-0.18707363567729546,-0.6717606629856742,0.984,0.988001645810805,1.0,11/39,24.77%,COX4I1;COX5A;NDUFA4;UQCR10;UQCRQ;COX8A;CLCN4;COX5B;CTNS;UQCRC1;ATP6V1B2
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.31184395863551506,0.6690223448283553,0.8170580964153276,1.0,1.0,3/25,9.82%,CYP26B1;MICAL3;KMO
prerank,hydro-lyase activity (GO:0016836),0.2932564828765769,0.6676615974648542,0.8344748858447488,1.0,1.0,7/41,16.77%,GMDS;ECHDC3;PCBD2;APIP;CA2;ACO1;ECI1
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.3362209667294414,0.6667652826772381,0.8215827338129497,1.0,1.0,12/12,66.40%,ELOVL4;OPN4;GNAT2;OPN1SW;OPN5;RHO;OPN1MW;OPN1MW3;RRH;GPR52;GPR88;OPN3
prerank,carboxylic ester hydrolase activity (GO:0052689),0.2813836065083964,0.66647694192768,0.8761706555671176,1.0,1.0,14/85,17.57%,PON1;ENPP2;BCHE;TARS2;ACHE;DAGLB;APMAP;CA2;LPL;PON2;ABHD4;NOTUM;GDE1;PNPLA7
prerank,sulfotransferase activity (GO:0008146),0.3013676577572788,0.6658478788709092,0.8173076923076923,1.0,1.0,4/33,10.61%,CHST15;CHST3;UST;HS2ST1
prerank,phospholipase binding (GO:0043274),0.3357419077477727,0.6638990062338721,0.8198581560283688,1.0,1.0,7/13,25.69%,ARHGAP6;PDPK1;BTK;SRC;FYN;PAFAH1B1;BLNK
prerank,lipoprotein particle binding (GO:0071813),0.3185974814148093,0.6623133632347076,0.8283485045513654,1.0,1.0,4/20,17.14%,COLEC12;MAPT;LPL;LDLR
prerank,sialyltransferase activity (GO:0008373),0.31014397546097067,0.6618923616755915,0.8103225806451613,1.0,1.0,6/20,15.40%,ST8SIA2;ST3GAL3;ST3GAL5;ST3GAL4;ST3GAL1;ST3GAL2
prerank,NAD+ binding (GO:0070403),0.3348481016546797,0.6618327508857181,0.8151862464183381,1.0,1.0,2/12,10.56%,ZC3HAV1;PARP9
prerank,N-acetyltransferase activity (GO:0008080),0.31322784829761147,0.661723954931446,0.8209549071618037,1.0,1.0,1/19,2.00%,NAT14
prerank,semaphorin receptor activity (GO:0017154),0.3385116842352578,0.6508702243441912,0.8277372262773722,1.0,1.0,6/11,23.44%,PLXNB2;PLXNB1;PLXND1;PLXNA2;PLXNB3;PLXNA1
prerank,exoribonuclease activity (GO:0004532),0.3272812304558009,0.6483208699050543,0.8484398216939079,1.0,1.0,4/12,18.53%,CNOT6;EXOSC7;CNOT7;EXOSC10
prerank,phosphatidylcholine transporter activity (GO:0008525),0.3153568703518325,0.6474017746708628,0.8433734939759037,1.0,1.0,3/17,10.71%,ABCB4;PITPNB;ABCA1
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.28046695760339546,0.6466107919614678,0.8620320855614974,1.0,1.0,10/60,11.86%,FGFR4;FGFR2;KIT;MUSK;PDGFRA;CRIM1;EPHA4;FGFRL1;DDR2;ROR1
prerank,acetylcholine receptor activity (GO:0015464),0.30433955174519256,0.6458131351746613,0.8445273631840796,1.0,1.0,2/22,12.23%,ANXA9;CHRNB1
prerank,phosphatidate phosphatase activity (GO:0008195),0.3243929033012933,0.6454264854253533,0.8230088495575221,1.0,1.0,3/13,12.37%,LPIN2;PLPP1;PLPP5
prerank,ferrous iron binding (GO:0008198),0.3067500851338329,0.6432394031394706,0.8553459119496856,1.0,1.0,2/21,3.86%,FXN;FTO
prerank,methyltransferase activity (GO:0008168),0.27783843084531984,0.6413001939970406,0.8555304740406321,1.0,1.0,10/46,17.60%,METTL27;AMT;EEF1AKMT2;MGMT;ASMT;METTL4;ARMT1;MRM2;METTL3;NSUN3
prerank,serine-type endopeptidase activity (GO:0004252),-0.1538777845782167,-0.6397178104463529,1.0,1.0,1.0,15/80,29.62%,PCSK5;PIK3IP1;PCSK6;FURIN;PARL;MMP2;RHBDF1;PRSS12;PCSK1;RHBDF2;MBTPS1;FAP;MASP1;HGF;PRSS36
prerank,metal ion:proton antiporter activity (GO:0051139),0.31928478421784556,0.6389804852727794,0.8533519553072626,1.0,1.0,4/13,26.43%,SLC9A5;LETM1;SLC9B2;SLC9A8
prerank,omega peptidase activity (GO:0008242),0.2698922511830314,0.6388977392681234,0.9107142857142857,1.0,1.0,26/89,22.38%,USP1;USP18;USP37;PSMD14;USP21;USP16;USP28;ASRGL1;USP9X;USP47;BRCC3;OTUD1;OTUD7B;GGH;USP48;MINDY3;USP14;USP46;USP20;OTUD3;PAN2;TANK;COPS5;ZRANB1;MYSM1;USP2
prerank,triglyceride lipase activity (GO:0004806),-0.2075749078526769,-0.6385138951617019,0.9620853080568721,1.0,1.0,7/20,36.46%,ABHD5;PLA2G15;PNPLA2;PNPLA3;LIPE;DDHD2;LCAT
prerank,thiol-dependent deubiquitinase (GO:0004843),0.269283120143793,0.6381272350916584,0.8962264150943396,1.0,1.0,24/83,22.38%,USP1;USP18;USP37;PSMD14;USP21;USP16;USP28;USP9X;USP47;BRCC3;OTUD1;OTUD7B;USP48;MINDY3;USP14;USP46;USP20;OTUD3;PAN2;TANK;COPS5;ZRANB1;MYSM1;USP2
prerank,amino acid transmembrane transporter activity (GO:0015171),0.27600522632995234,0.6379942517979554,0.8879120879120879,1.0,1.0,13/47,21.75%,SLC38A7;PDPN;SLC38A4;SLC16A2;SLC38A9;SLC1A5;SLC36A4;SLC7A1;SLC25A29;SLC38A2;SLC7A11;SLC25A44;SLC6A13
prerank,ion channel inhibitor activity (GO:0008200),0.28636835918797243,0.6377435346496952,0.8473193473193473,1.0,1.0,7/35,13.58%,ITPR1;NEDD4;WNK1;KCNMB2;MCUB;CALM2;ENSA
prerank,organic anion transmembrane transporter activity (GO:0008514),0.26706091614018196,0.6376575569093728,0.9272727272727272,1.0,1.0,24/134,18.95%,SLC25A15;SLC25A21;SLCO4A1;SLC38A7;PDPN;SLC19A1;SLC25A2;SLC35D1;SLC35D2;SLC25A25;SLC39A8;GJA1;SLC38A9;SLCO3A1;SLC19A2;SLC15A4;SLC1A5;SLC25A22;SLC25A42;SLC36A4;SLC7A1;SLC25A17;SLC6A9;SLC38A2
prerank,ADP binding (GO:0043531),0.2967117658353822,0.634280951136791,0.8598484848484849,1.0,1.0,6/25,15.42%,MYH10;LONP1;MIEF1;MYO9B;MSH6;PRKAG1
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.22272164963486774,-0.6236805166811533,0.9365079365079365,1.0,1.0,2/16,12.48%,SLC44A1;SLC22A5
prerank,Wnt-activated receptor activity (GO:0042813),-0.22616279057073363,-0.6213808966513986,0.9365671641791045,1.0,1.0,5/15,26.44%,FZD2;FZD4;FZD1;TSPAN12;FZD8
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.3247401060582171,0.6210373605763223,0.86,1.0,1.0,3/10,16.56%,SETDB2;ASH1L;SUV39H2
prerank,estrogen receptor binding (GO:0030331),0.2774721990522056,0.6183202774423356,0.8777239709443099,1.0,1.0,8/32,18.92%,CNOT1;LCOR;MMS19;PPID;MED1;DCAF1;TAF10;ARID5A
prerank,NADPH binding (GO:0070402),0.30664587296494006,0.6162347719520457,0.8696275071633238,1.0,1.0,1/13,2.63%,LBR
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.2854708783946758,0.6124436573224329,0.8751576292559899,1.0,1.0,6/21,20.18%,PDE3B;PDE7B;PDE1A;PDE7A;PDE4A;PDE4B
prerank,ephrin receptor binding (GO:0046875),0.2943341945346593,0.6121243935010033,0.8639798488664987,1.0,1.0,8/21,23.99%,EFNA1;EFNB1;ANKS1B;EFNB2;SRC;PTPN1;FYN;CRK
prerank,FMN binding (GO:0010181),-0.23975218525373218,-0.6103441902208174,0.9184952978056427,1.0,1.0,6/11,38.00%,NOS3;MTRR;NOS1;NDOR1;DUS2;PNPO
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.22781611225411022,-0.6094674388032103,0.9551724137931035,1.0,1.0,5/14,33.33%,SLC26A11;SLC25A11;SLC26A2;SLC26A6;SLC26A8
prerank,nucleoside diphosphate kinase activity (GO:0004550),-0.22675508982660592,-0.6083008389956314,0.9468085106382979,1.0,1.0,7/14,29.64%,NME6;CMPK1;AK5;AK4;CMPK2;AK1;NME2
prerank,cation channel activity (GO:0005261),0.2541099901812922,0.6064681037005606,0.94258872651357,1.0,1.0,12/94,12.45%,AQP1;ANXA9;ANXA2;TRPA1;PKD2L2;CALHM2;CUL5;MCU;SLC24A3;TRPM2;PIEZO1;TRPM4
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.3090034829331898,0.6047437267811476,0.8702397743300423,1.0,1.0,5/12,24.23%,PHF2;JMJD1C;KDM4B;HR;KDM1A
prerank,protein phosphorylated amino acid binding (GO:0045309),0.26370938927403226,0.604061092954081,0.8963963963963963,1.0,1.0,11/42,20.49%,NEDD4;FBXW7;VAV2;SAMSN1;CRKL;NCK2;PIN1;SHB;YES1;PTPN5;SHF
prerank,transforming growth factor beta binding (GO:0050431),0.27958171860139713,0.6032081404115196,0.8795811518324608,1.0,1.0,5/23,18.29%,TGFBR3L;TGFBR3;TGFBR1;ITGAV;LTBP1
prerank,G protein-coupled receptor activity (GO:0004930),0.25420724285203167,0.6028764732367569,0.9829659318637275,1.0,1.0,24/239,16.47%,GPR171;LPAR3;ADGRV1;LPAR1;GALR1;NPFFR2;ADGRL1;GPR173;CXCR4;BDKRB2;S1PR2;TAPT1;NPR3;P2RY1;GLP2R;ADGRG2;ADRB2;ELOVL4;GPR156;LANCL1;GABBR2;CYSLTR2;ADGRD1;GPR135
prerank,phosphatase inhibitor activity (GO:0019212),0.28077064432173304,0.5987891931289858,0.8833967046894804,1.0,1.0,5/20,19.78%,ANP32E;ENSA;PPME1;STYX;BOD1L1
prerank,Hsp90 protein binding (GO:0051879),0.27032673044419797,0.5961959271160474,0.9090909090909091,1.0,1.0,5/33,12.95%,MAPT;HDAC8;NR3C1;AHR;PPID
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.31159747532335735,0.5900778105831513,0.8980797636632201,1.0,1.0,4/10,17.54%,PKIG;PRKAG1;PRKAR2B;PRKAR2A
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.27561119572544285,0.5886918645172529,0.8741976893453145,1.0,1.0,7/24,20.66%,MYLK3;PHKA2;CAMK1D;MAPKAPK3;CAMKV;DAPK1;MAPKAPK2
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.2756001830155274,0.5875129944440083,0.8977407847800237,1.0,1.0,6/30,17.06%,SLC25A37;SLC39A11;SLC39A8;SLC39A6;SLC30A10;SLC25A28
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.2721328598277003,0.584648375368888,0.885997521685254,1.0,1.0,7/23,22.24%,PDE3B;PDE7B;PDE1A;PDE7A;PDE4A;PDE4B;ADPRM
prerank,O-methyltransferase activity (GO:0008171),-0.24303377945585058,-0.5817584162313808,0.9413489736070382,1.0,1.0,4/10,24.48%,COQ3;CMTR1;MEPCE;COMT
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.2983266158961428,0.5794552690810115,0.8916913946587537,1.0,1.0,2/11,13.46%,NUDT5;NUDT4
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.2876874395455527,0.5774180817765998,0.889958734525447,1.0,1.0,4/16,16.46%,SLC38A7;SLC25A30;SLC1A5;SLC25A22
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.2447210543808851,0.57160453523288,0.9465968586387434,1.0,1.0,17/74,18.96%,ADK;PDXK;PAPSS2;IPMK;PIK3CB;DGKE;PANK4;AGK;MVK;PANK2;RFK;GK5;NOL9;PI4KB;GK;GALK2;COASY
prerank,RNA methyltransferase activity (GO:0008173),0.2676585594382448,0.5703836838785024,0.9212598425196851,1.0,1.0,5/19,19.59%,METTL4;MRM2;METTL8;METTL3;TGS1
prerank,cytochrome-c oxidase activity (GO:0004129),-0.1989603564158946,-0.5699454397061346,0.9793103448275862,1.0,1.0,5/15,23.70%,COX4I1;COX5A;NDUFA4;COX8A;COX5B
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.2649845247626592,0.5683089918487019,0.9142857142857143,1.0,1.0,3/27,9.70%,SLC9A5;SLC8A1;CNNM4
prerank,O-acyltransferase activity (GO:0008374),0.2608724558011618,0.5670398158930885,0.9371980676328503,1.0,1.0,3/30,12.24%,LPCAT1;SOAT1;SOAT2
prerank,adrenergic receptor binding (GO:0031690),0.27882657779001485,0.5669421240420873,0.9025367156208278,1.0,1.0,1/16,4.48%,NEDD4
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.2952767920040196,0.5635368457081674,0.8905325443786982,1.0,1.0,3/10,21.51%,KDM2B;KDM4B;KDM2A
prerank,histone demethylase activity (GO:0032452),0.2613126970487509,0.5621949364118037,0.9333333333333333,1.0,1.0,9/27,25.29%,PHF2;KDM2B;KDM5C;JMJD1C;KDM4B;KDM2A;HR;KDM1A;KDM5A
prerank,calcium channel activity (GO:0005262),0.23649001229799985,0.5618198459484312,0.9543568464730291,1.0,1.0,15/84,16.33%,ANXA9;ANXA2;PKD2L2;CACNA2D3;CUL5;MCU;SLC24A3;CACNA1C;TRPM2;TRPC7;TRPM4;ITGAV;PKD2;TPCN2;CACNB4
prerank,serine-type peptidase activity (GO:0008236),-0.12835030902098368,-0.5599046244983049,1.0,1.0,1.0,8/96,13.71%,PCSK5;PIK3IP1;PCSK6;FURIN;TPP1;PARL;MMP2;RHBDF1
prerank,cytokine activity (GO:0005125),0.23509769153400345,0.5598022260145098,0.9718026183282981,1.0,1.0,10/131,12.26%,WNT2B;CKLF;BMP6;IL18;FAM3C;WNT6;HMGB1;CNTF;BMP2;WNT9A
prerank,solute:sodium symporter activity (GO:0015370),0.25976740283825955,0.5579494557015607,0.9188191881918819,1.0,1.0,1/27,4.17%,SLC20A2
prerank,transaminase activity (GO:0008483),0.28430771861417314,0.5559521501678356,0.9181818181818182,1.0,1.0,2/11,10.26%,AGXT;ABAT
prerank,low-density lipoprotein particle binding (GO:0030169),0.27351313554860857,0.5552511663732231,0.9262734584450402,1.0,1.0,1/16,3.18%,COLEC12
prerank,C-C chemokine receptor activity (GO:0016493),0.2610181367381571,0.5542364796904754,0.9377382465057179,1.0,1.0,1/21,6.03%,CXCR4
prerank,glutathione transferase activity (GO:0004364),0.2613522233878979,0.5497632508982649,0.9208173690932312,1.0,1.0,6/23,22.35%,HPGDS;LANCL1;GSTT1;MGST3;GSTM5;GSTZ1
prerank,SH2 domain binding (GO:0042169),0.24922472582814292,0.5461893502895885,0.9302045728038508,1.0,1.0,6/31,17.85%,NLK;KHDRBS1;AFAP1;SRC;SH3PXD2B;TRPV4
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.2488313662957836,0.5451793951294721,0.931899641577061,1.0,1.0,1/29,1.89%,HPSE
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.2209512939328732,-0.5444250991635065,0.9726443768996961,1.0,1.0,3/10,17.70%,CACNA1B;CACNB2;CACNB1
prerank,peptide N-acetyltransferase activity (GO:0034212),-0.2243928648667195,-0.5441173792242249,0.9597523219814241,1.0,1.0,5/10,32.95%,NAA25;NAA80;NAA30;NAA10;NAA16
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.23549140081492798,0.5437726347590132,0.9433760683760684,1.0,1.0,10/55,18.95%,SLC38A7;PDPN;SLC38A4;SLC19A1;SLC16A2;SLC38A9;SLC19A2;SLC36A4;SLC7A1;SLC38A2
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.27640775488135044,0.5423379428164404,0.9202363367799113,1.0,1.0,1/12,5.22%,B3GNT8
prerank,phosphatidylglycerol binding (GO:1901611),0.2723818950507516,0.5408274805073005,0.922173274596182,1.0,1.0,2/13,14.38%,STOML2;GSDMD
prerank,peptidase activator activity (GO:0016504),0.2552308346370544,0.5389720780047265,0.9405204460966543,1.0,1.0,6/22,20.93%,CASP8AP2;PSMD14;ADRM1;PSME4;PSME3;TANK
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.22918490592817947,0.5363599239556972,0.9588607594936709,1.0,1.0,10/72,14.56%,ANXA9;ANXA2;SESTD1;PICALM;MAPKAP1;TWF1;SVIL;SNX18;GSDMD;CAPG
prerank,cytokine receptor binding (GO:0005126),0.22688942220829075,0.5360331119161625,0.9615384615384616,1.0,1.0,10/83,17.44%,FADD;TRIP6;IL18;TGFBR3;CNTF;ADAM17;SPRED1;SMAD3;SPRED2;SMAD2
prerank,chemokine activity (GO:0008009),0.24408634061853934,0.5317294276146913,0.9473053892215569,1.0,1.0,1/31,5.09%,CKLF
prerank,N-methyltransferase activity (GO:0008170),0.2538494784013908,0.5316711345191091,0.939820742637644,1.0,1.0,4/20,15.10%,SETD3;METTL15;METTL5;TFB1M
prerank,endopeptidase regulator activity (GO:0061135),0.2343067688250742,0.5292636472158639,0.9529675251959686,1.0,1.0,10/40,24.14%,PSMD14;ADRM1;CAST;USP14;PROS1;PSME3;TFPI;PSMF1;RECK;ITIH2
prerank,iron ion binding (GO:0005506),0.23224409563694295,0.5251556267187779,0.9610678531701891,1.0,1.0,4/48,7.80%,FXN;FTO;AGMO;PHF2
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.23176341963531508,0.5240394670509658,0.9496080627099664,1.0,1.0,3/46,6.10%,LARGE1;B3GNT8;PIGA
prerank,CXCR chemokine receptor binding (GO:0045236),0.27003954554014187,0.5233896695549533,0.9455081001472754,1.0,1.0,11/11,73.01%,ITCH;CXCL9;CXCL2;CXCL13;CXCL1;CXCL5;PPBP;PF4;YARS1;CXCL10;CXCL12
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.23561906075162586,0.5204083560218276,0.9573690621193667,1.0,1.0,2/26,6.38%,B3GNT8;CHSY1
prerank,nucleoside-diphosphatase activity (GO:0017110),0.262557978170221,0.5195677372868922,0.9384384384384384,1.0,1.0,2/12,16.67%,NUDT5;SLC25A42
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.18110463213994454,-0.5180260788897619,0.9867109634551495,1.0,1.0,13/15,54.15%,SLC4A8;SLC26A2;SLC26A6;CFTR;SLC26A8;SLC4A11;SLC26A4;SLC26A7;SLC4A3;SLC26A3;SLC4A1;SLC26A5;SLC26A1
prerank,chemokine receptor binding (GO:0042379),0.23429304230418005,0.5137473138753513,0.9577464788732394,1.0,1.0,2/35,12.73%,CKLF;ITCH
prerank,rRNA binding (GO:0019843),0.2258649837978585,0.5104076302704443,0.9552752293577982,1.0,1.0,6/42,13.60%,MRPL18;ERI1;RRS1;FASTKD5;PPAN;DDX21
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.21081734482923054,-0.5102225073599497,0.975975975975976,1.0,1.0,3/10,28.43%,DUSP1;DUSP8;DUSP6
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.21081734482923054,-0.5102225073599497,0.975975975975976,1.0,1.0,3/10,28.43%,DUSP1;DUSP8;DUSP6
prerank,mechanosensitive ion channel activity (GO:0008381),0.2581906186904976,0.5095516714621381,0.9512937595129376,1.0,1.0,3/12,20.10%,PIEZO1;PIEZO2;TMEM63A
prerank,solute:proton symporter activity (GO:0015295),0.24843010923764303,0.5090704989009412,0.9579375848032564,1.0,1.0,5/16,22.24%,SLC39A8;SLC15A4;SLC15A1;SLC17A5;SLC11A2
prerank,C-C chemokine binding (GO:0019957),0.23751800149747213,0.5051831705893444,0.9576923076923077,1.0,1.0,1/22,6.03%,CXCR4
prerank,antiporter activity (GO:0015297),0.2405658335232208,0.5028752784295552,0.9600499375780275,1.0,1.0,3/20,13.24%,SLC35D1;SLC35D2;SLC25A30
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.2509970119667247,0.5006080407644401,0.9538904899135446,1.0,1.0,1/12,5.73%,FRS2
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.22607051255590374,0.49869397775825397,0.9656862745098039,1.0,1.0,7/31,21.60%,AQP1;PKD2;KCNA1;KCNQ4;SLC12A8;KCNK5;KCNC4
prerank,phosphate ion binding (GO:0042301),-0.2062515691689681,-0.49764889815492885,0.9854227405247813,0.9995543353211612,1.0,10/10,79.39%,RPH3A;PDE2A;ADSS1;CHST14;SLC34A2;G6PC1;MTHFD2;RELA;PNP;ADSS2
prerank,ubiquitin-dependent protein binding (GO:0140036),0.25677880994225466,0.4944042726045267,0.9357142857142857,1.0,1.0,10/10,74.34%,ANKRD13D;DNAJB2;DNAJC2;IDE;ANKRD13A;USP15;FAN1;FAAP20;LAPTM5;ANKRD13B
prerank,AMP binding (GO:0016208),0.2528526361912762,0.49224214531830707,0.9596412556053812,1.0,1.0,4/11,23.18%,MPPED2;PRKAG1;PYGL;PRKAG3
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.22614138898956804,0.4856457100097841,0.96625,1.0,1.0,5/25,15.86%,SESTD1;ZFYVE1;MAPKAP1;PLEKHA1;DAPP1
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.25357422374976196,0.48478734830558434,0.9648609077598829,1.0,1.0,1/11,12.23%,CHRNB1
prerank,kinase inhibitor activity (GO:0019210),0.21792550503680727,0.4837852908550257,0.9744186046511628,1.0,1.0,7/33,20.73%,PARVA;NCK1;CDKN1B;QARS1;SH3BP5;TRIB1;SNCA
prerank,peptidase inhibitor activity (GO:0030414),0.21599153385372089,0.47982539706720995,0.9868263473053892,1.0,1.0,9/33,24.17%,CAST;SIMC1;USP14;PROS1;TFPI;PSMF1;RECK;ITIH2;GPC3
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.20319361196856506,0.4756104325857632,0.9905362776025236,1.0,1.0,4/75,5.53%,PTGR1;RDH11;RDH12;SORD
prerank,fibroblast growth factor receptor binding (GO:0005104),0.22385237932902527,0.4667763060549264,0.9720372836218375,1.0,1.0,1/21,5.73%,FRS2
prerank,cAMP response element binding (GO:0035497),0.24327872479057344,0.4653400589106208,0.9707692307692307,1.0,1.0,4/10,24.06%,CREB5;CREB3L2;ATF7;ATF2
prerank,receptor antagonist activity (GO:0048019),0.2252433281004709,0.4618935054709292,0.9713506139154161,1.0,1.0,17/17,77.50%,DKK3;LRPAP1;PXDN;DKK4;IL1RN;DKK1;ADH7;WFIKKN2;DKKL1;AGTR2;WFIKKN1;FST;IGSF1;CCL5;ESR2;IL18BP;DKK2
prerank,carbohydrate kinase activity (GO:0019200),-0.17958696880296277,-0.4606875169823939,0.9877675840978594,1.0,1.0,11/11,82.06%,HK1;NAGK;POMK;KHK;XYLB;HK3;GALK1;HK2;GNE;FGGY;GALK2
prerank,chemokine receptor activity (GO:0004950),0.21296639250008242,0.45970818127139196,0.9763387297633873,1.0,1.0,1/24,6.03%,CXCR4
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.19089001806673345,0.44979623681398806,0.9937434827945777,1.0,1.0,6/73,11.81%,GALR1;BDKRB2;S1PR2;NPR3;NLRP6;GLP2R
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.22029126641111743,0.4488712291818034,0.9794520547945206,1.0,1.0,4/14,22.33%,CIAO3;ACO1;ISCA2;SDHB
prerank,protein phosphatase inhibitor activity (GO:0004864),0.20340895054420238,0.44788657791358927,0.9831730769230769,1.0,1.0,5/26,19.78%,PPP1R8;ENSA;PPP1R14C;PPME1;BOD1L1
prerank,CCR chemokine receptor binding (GO:0048020),-0.13554103305265805,-0.446723552744375,0.9945945945945946,0.996917110039282,1.0,28/28,86.48%,CX3CL1;NARS1;CCL13;CCL19;CCL15;CCR2;CCL2;CCRL2;CCL5;CCL4;CCL8;MSMP;CCL7;DEFB130A;CCL1;CCL3;CCL11;DEFB1;CXCL13;XCL1;CCL17;CCL22;CCL24;CCL26;CCL25;CCL14;CNIH4;NES
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.2061580179841755,0.4446912042901979,0.983273596176822,1.0,1.0,3/32,9.08%,FTO;KDM2B;HSPBAP1
prerank,solute:anion antiporter activity (GO:0140323),0.2186226917539284,0.4380546246236177,0.978448275862069,1.0,1.0,1/14,8.29%,SLC4A2
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.19422776504798223,0.4378143245395746,0.9920091324200914,1.0,1.0,6/40,14.84%,SETD3;ASMT;METTL4;DNMT3A;ARMT1;METTL8
prerank,retinoid X receptor binding (GO:0046965),0.21948437915235974,0.434708492669274,0.9791044776119403,0.9987115314486809,1.0,3/11,20.59%,NR4A2;ARID5A;MED25
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.2220798045920197,0.42878064662859094,0.9893939393939394,0.9978966564158939,1.0,4/10,23.13%,DSE;GLCE;GNE;DSEL
prerank,telomerase RNA binding (GO:0070034),0.1980318935183447,0.42651039026626963,0.9936548223350253,0.9962256183784624,1.0,6/22,19.75%,HNRNPU;SMG6;TEP1;EXOSC10;TERT;SNRPB
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.21109091741344116,0.4133878362624608,0.9898550724637681,0.9966038674281139,1.0,4/11,22.76%,NAA20;NAA60;NAA40;NAA50
prerank,cytokine receptor activity (GO:0004896),0.16913375384286067,0.3993832759394735,0.9979274611398964,0.9966290282966688,1.0,2/83,5.79%,IL1RL1;LEPR
prerank,gated channel activity (GO:0022836),0.1800700650493841,0.3648427286734194,0.9957142857142857,0.9978572324312143,1.0,3/14,20.10%,PIEZO1;PIEZO2;TMEM63A
